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Introduction
Against a background of demographic changes in the world population, the medical 
field encounters increasing numbers of patients with compromised medical conditions, 
medication-related issues and unfavourable anatomical factors. With respect to the 
field of orthopaedics and implant dentistry, a growing number of patients are treated 
with endosseous implants to restore deteriorating joints or replace lost teeth because 
of trauma, decay or periodontal diseases. To date in the United States alone, over 
600.000 joint replacements are performed annually.1 The global market for implant 
dentistry is estimated at ~2.8 billion Euro in 2011 and expected to increase within the 
upcoming five years to well over 3.0 billion Euro in 2020.2
 In the last decade, the clinical use of endosseous implants has evolved into a 
predictable treatment modality in both orthopedic and dental practices.3,4 However, 
with promising survival data of endosseous implants in favorable clinical conditions 
also comes a shift toward implant placement in more challenging clinical cases with 
increased failure rates as a result.5,6 Nowadays, patients ask for a high standard of 
care, minimally invasive surgical interventions, and reliable implants that provide 
long-term survival and restore a high degree of quality of life. For this purpose, not 
only new surgical approaches (e.g. immediate, early implant placement) have been 
introduced, also conventional loading protocols have been revised to fulfil the patient 
needs. For the future, biological requirements of load-bearing endosseous implants 
need to be optimized in order to increase the clinical success in these challenging 
conditions. An increasing number of animal models is available for preclinical 
evaluation of the tissue response to endosseous implants.7 It should be emphasized 
that the majority of these models utilize optimal conditions regarding implant 
placement (i.e. fully surrounded by bone tissue or even initial bone-to-implant contact 
at installation) and regenerative capacity (i.e. healthy animals at a relatively young 
age). As the development of endosseous implants with optimal osteophilic character-
istics still remains a challenge in the field of bone implantology, these should also be 
tested in more compromised animal models.8
 The following section will briefly describe the sequence of healing events 
concerning peri-implant osteogenesis followed by a general overview of the important 
aspects in optimizing the clinical performance of endosseous implant materials. The 
final section of this introduction describes different in vivo animal models to evaluate 
the osteophilic properties of surface modifications on bone implants.
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Peri-implant bone healing
Survival of endosseous implants starts with biomechanical fixation into the surrounding 
bone tissue that evolutes into a biological fixation without an intervening layer of 
fibrous tissue, a biological process known as osseointegration.9 It is a continuous 
biological process with distinct phases that follow the same cascade of (extra)cellular 
reactions as regular wound healing after fractures in bone,10 i.e. inflammation, repair 
and remodeling.11,12 After implant site preparation peri-implant bone healing starts 
with a blood clot together with an inflammatory response.13 Subsequently, fibrin and 
structural proteins from the blood clot provide a 3D provisional matrix adjacent to and 
in the vicinity of the implant surface. This layer of proteins contains adhesive molecules 
(e.g. fibronectin and osteopontin) that attract undifferentiated mesenchymal stem 
cells and pre-osteogenic cells to the implant surface. After adhesion on the implant 
surface, osteogenic cells change shape and start to secrete a calcified collagen-free 
layer on the implant surface that contains calcium, phosphorus, osteopontin and 
bone sialoprotein. This initial calcified layer is formed directly on the implant surface 
and shows high resemblance to bone cement lines in natural bone tissue.14 At the 
same time, macrophages in the peri-implant region assist in the resorption of necrotic 
bone fragments by osteoclasts. This process is of particular importance, as it plays 
an important role in the initiation of peri- implant osteogenesis. Simultaneously, os-
teoprogenitor cells differentiate into osteoblasts and become secretively active and 
lay down a collagenous bone matrix onto the cement line at the implant surface. 
Subsequently, this matrix mineralizes into woven bone and ultimately into mature 
bone by remodelling. Bone resorption, bone formation and bone remodelling are 
continuous and essential processes for the survival of bone implants, not only at the 
early stage of biological fixation of endosseous implants, but also for the durability of 
the bone-to- implant interface.15
Controlling the bone-to-implant interface
Bone implants are usually made of titanium or titanium alloy because of its outstanding 
load bearing properties. However, the biological response of native bone toward 
titanium bone implants is limited. Therefore, extensive research has been put forward 
to optimize the biological (mechanical) performance of these implants, involving 
refinements in surgical techniques, surface topography and/ or chemistry.
Surgical techniques
As an absolute prerequisite for successful osseointegration of endosseous implants 
made of bone compatible materials, primary stability is essential.9,16 In order to achieve 
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sufficient primary stability, surgical techniques and skills have shown to be of significant 
importance.17,18 The original drilling protocol for dental implant placement prescribed 
an implant site preparation that exactly matches the final diameter of the implants, 
known as the ‘press-fit’ implant placement procedure. However, in compromised 
clinical cases such as implants sites with low bone density, grafted sites and clinical 
cases with reduced healing times (e.g. immediate or early loading), refinements in 
surgical protocols have been introduced to improve the primary stability of bone 
implants.19 In challenging cases, implant success rate can increase significantly by 
changing only the surgical protocol.20 For example, by placing an implant bicortically, 
thus penetrating two layers of cortical bone, a higher primary implant stability can be 
reached.21 In addition, undersized drilling have become the protocol of choice for 
most of the implant systems that are available at this moment.20,22 In this procedure, 
the final drill has a significantly smaller diameter in comparison to the diameter of the 
implant. As a consequence, not only the mechanical interlocking increases between 
the implant surface and native bone, also small bone fragments are translocated 
during implant placement. It is assumed that these bone particles can have an 
additional osteogenic effect in the early phase of osseointegration.23
Surface modifications
In addition to surgical techniques, implant surface characteristics play an important 
role in successful biomechanical fixation of endosseous implant material. Surface 
modification techniques attempt to improve the early osseointegration of bone implants 
by either focusing on the physical properties (i.e. roughness) and/or chemical properties 
(i.e. coating deposition) of the implant surface.
Implants and surface roughening
Moderately roughened titanium surfaces not only create a larger surface area for 
bone bonding, they also show higher osteophilic potential in comparison to smooth 
titanium surfaces.24 It is assumed that the presence of small etching grooves 
facilitates protein adhesion and stimulates cell migration on the implant surface.25,26 
Consequently, the machined titanium surface has gradually been replaced and 
most of today’s commercially available oral endosseous implants have been treated 
to obtain moderately roughened surfaces. Different approaches are available for 
surface roughening, amongst which subtractive procedures, such as grit-blasting 
and acid etching, are most frequently used. Beside these micro-scale approaches, a 
new trend has been introduced recently, which involves nano-level refinements of 
the topographical surface characteristic.27 It is hypothesized that the obtained 
nanopatterns can mimic the nano-crystalline structure of bone material structural 
extracellular matrix, attracting structural proteins and osteogenic cells to the implants 
surface that improve the bone bonding properties of the implant surface.28
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Implants and coating deposition
Beside subtractive procedures, additive surface techniques (i.e. coatings) have 
demonstrated to account for beneficial osteophilic properties of an implant surface. 
Especially the use of bioceramics (i.e. calcium phosphate-based, CaP) has demonstrated 
to maximize the early onset of bone formation at the implant surface. Already more 
than 20 years ago, numerous studies reported on the superior osteophilic properties 
of CaP-based coated implants in comparison to non-coated surfaces.29-31 The 
attractive properties of these coated surfaces are ascribed to the high resemblance 
of the crystallographic structure of natural bone mineral. Furthermore, partial 
dissolution of the CaP coating brings Ca2+ and PO43- ions into the interstitial space. 
The presence of these ions is assumed to have a stimulating effect osteoprogenitor 
cells.32,33 Not only different phases of CaP have been successfully used as a coating 
material, also bioactive silicate-based glass (BG) coatings have been described as 
osteopromotive surfaces.34 These coatings are able to directly bind to bone because 
of the formation of a hydrated silica layer and hydroxyl apatite on the surface; the 
presence of a hydrated silica layer is additionally supposed to have an effect on 
osteoblast proliferation and differentiation.35
 Bone is not only composed of inorganic components. It is a composite material 
with an inorganic CaP-phase embedded in an extracellular organic matrix (ECM). 
The ECM mainly consists of collagenous fibrous proteins (Type 1; >90%), enzymes 
and growth factors. ECM-based coatings have recently been explored to accelerate 
peri-implant osteogenesis. In vitro and in vivo data have already confirmed the 
osteopromotive properties of these coatings.36,37 Still, future research is needed to 
unravel the specific pathways behind the osteogenic capacity of these coatings.
 In addition, new coating strategies improve the osteophilic characteristics of an 
implant surface involving the use of anabolic therapeutic agents for the pharmaco-
logical enhancement of osseointegration.38 For example, strontium (Sr) has been 
positively incorporated into CaP-based coatings because of its physical and chemical 
resemblance to Ca2+ ions and its assumed metabolic effect on bone turnover. Based 
on positive in vivo results, this indicates that the addition of a therapeutic agent can 
have a local metabolic effect, especially in clinical cases with osteopenic conditions.39
Coating deposition techniques
Various coating deposition techniques are available for providing an implant surface 
with the aforementioned (in)organic components. However, not all coating deposition 
techniques are suitable for the deposition of components with an organic or inorganic 
origin. Plasma-spraying, RF magnetron sputtering and pulsed laser deposition are 
highly suitable for the deposition of inorganic constituents, while these physical 
coating deposition techniques have their limitations for the deposition of coatings that 
include therapeutic agents or other components of organic origin. These limitations 
GENERAL INTRODUCTION
1
15
relate to the relatively high temperatures during the coating deposition process itself 
or these used for crystallization of the inorganic layer.40  Alternatively, wet-chemical 
coating techniques have been explored, such as electrospray deposition (ESD) or 
coating deposition via biomimetic precipitation, that allow for the incorporation of 
organic and therapeutic biomolecules for enhanced bone regeneration.41
Animal models for the evaluation of the osteophilic 
properties of endosseous implants
Before newly-developed surface modifications for endosseous implants can be 
introduced for clinical application, it is of utmost importance that the biocompatibility 
and safety of these surfaces are warranted. Although in vitro testing can give more 
insight in the fundamental basics behind the biological processes of peri-implant 
osteogenesis, still in vitro testing does not allow evaluation of their effects on bone 
metabolism and the actual tissue response. Therefore, the use of in vivo animal 
models is still of significant importance. Multiple animal models are available to 
understand the specific contribution of surface design features on osseointegration 
of endosseous implants.7  Specific intra-oral in vivo implantation models are available 
for the preclinical evaluation of functional loading of actual size dental bone implants.42 
Furthermore, properly designed in vivo experiments even allow for the concurrent 
evaluation of the biological and biomechanical quality of the bone-to-implant 
interface.43 Also, in vivo data obtained by destructive mechanical torque-out tests 
can be of significant value prior to clinical application of surface modifications, since 
the final goal after implant placement is to achieve a strong mechanical interlocking 
between the native bone and the implant surface. However, one should be cautious 
when comparing in vivo data between studies. Tissue response and peri-implant 
bone formation can vary significantly because of differences in animal species, 
animal populations, used implants sites (i.e. trabecular or cortical bone) and local 
bone conditions. For example, small animals show a faster healing response 
compared with large animals. Also, rodents as a population, demonstrate a highly 
uniform genetic background, whereas larger animal (e.g. goats) usually form a rather 
heterogeneous population. This can hamper statistical evaluation of obtained in vivo 
data.
 Therefore, extrapolating in vivo data to the human situation should be executed 
with ultimate cautiousness. Age related issues such as wound healing and regenerative 
capacity of humans is often significantly different in comparison to animals. Also 
human bone conditions and implant locations can differ significantly in available 
bone quantity and quality. Most animal models comprise a bony environment with 
sufficient bone quantity with no need for additional grafting procedures, as often is 
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seen in clinical cases. However, in most clinical cases, a necessity for bone grafting 
procedures is present, such as sinus floor elevations and buccal contour augmentations, 
to prevent exposure of the implant surface through the bony wall. Finally, it should be 
emphasized that for the correct assessment of in vivo data on peri-implant osteogenesis, 
animal model experiments should be designed in a correct way followed by 
well-performed statistical analyses.
Objectives of this thesis
The main objectives of the current thesis were to i) evaluate the osteophilic properties 
of a broad panel of surface modifications for endosseous implants using different, 
well-established, preclinical animal models, and ii) elucidate whether the application 
of a coating on an endosseous implant surface is justified for future clinical indications 
in implant therapy.
 More specifically, the research described in this thesis can be divided into three 
parts. First, the in vivo performance of a broad spectrum of surface modifications in 
one single animal model was addressed. Secondly, the long-term clinical performance 
(i.e. survival and success) of commercially available CaP-coated implants was 
analyzed. Finally, the in vivo performance of ceramic-based coating in different 
osseous environments was evaluated. Consequently, the following specific sub-aims 
were addressed:
1. To evaluate the osteophilic capacity of different ceramic-based coatings in 
comparison to titanium surfaces obtained via different subtractive procedures 
within one in vivo experimental setup;
2. To systematically appraise and meta-analyze long-term survival data of CaP- 
coated dental implants in clinical trials;
3. To systematically appraise and evaluate long-term success data of CaP plasma- 
spray coated dental implants in clinical trials;
4. To evaluate the biological performance of dental implants coated with different 
ratios of hydroxyapatite (HA) and bioactive glass (BG) in a dog mandible model;
5. To evaluate the biological performance of electrosprayed CaP nanocrystals and 
collagen type-I coatings in vivo to determine to what extent these coatings can 
improve the osteogenic potential of an implant surface in challenged conditions 
(i.e. a 1 mm gap-model) using a dog implantation model;
6. To determine whether the biological and mechanical properties at the implant/
bone interface of screw-type dental implants are influenced by (i) the presence 
of a bioactive HA- or composite HABG-coating, and (ii) the type of surgical 
technique used for implant placement (i.e. mono- vs. bicortical).
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Introduction
An expanding and aging world population increases the demand for implantable 
devices and scaffolds to replace damaged tissues and to restore function.1,2 In view 
of bone implants, patients require safe and reliable devices with short recovery times, 
minimal postoperative complications and a long-term survival.3,4 In the field of oral 
implantology, increasing numbers of dental implants are placed globally to support 
(complete or partial) prosthetic devices.5 High survival and success rates (up to 90% 
after 10-years follow-up) have been reported for these implants in favorable clinical 
conditions,6 but implant failure is still significant in compromised clinical cases with 
systemic malconditions, impaired bone healing (i.e. osteoporosis), or insufficient 
bone quantity and quality.7,8
 To warrant long-term implant success in a compromised condition, osteophilic 
implants, i.e. implants that favor bone apposition, are required.9 Since the implant 
surface directly interacts with bone tissue, research has been focused on the application 
of surface modification techniques that improve the osteophilic characteristics of 
implant surfaces to evoke early peri-implant bone formation.10-12 The used approaches 
focus on the alteration of physical properties (roughness) and/or chemical characteristics 
of the metallic implant surface (i.e. titanium or titanium-alloy) and are based on either 
subtractive (i.e. grit blasting, acid etching)13 or additive (i.e. coating deposition) 
procedures.14 The most common surface modification for bone implants is surface 
roughening.15 Rougher surfaces create a larger contact area for interaction with bone 
tissue in comparison to smooth surfaces. Further, the presence of micro-porosities 
and small etching grooves is hypothesized to enhance protein adhesion, stimulate 
cell migration on the implant surface and hence facilitate early bone formation.16,17
 Beside subtractive procedures, additive techniques in the form of implant 
surfaces coated with bioactive ceramics (e.g. calcium phosphate, CaP) have shown 
superior osteophilicity compared to non-coated surfaces.18-21 Hypothetically, this 
enhanced osteophilicity is related to the (superficial) dissolution of the CaP coating 
that results in a release of calcium (Ca2+) and phosphate (PO43-) ions in the peri- 
implant region.22 Mechanistic studies have shown that especially Ca2+ ions have a 
positive effect on the differentiation of osteoprogenitor cells23-25 and both ions 
enhance the precipitation of a carbonated calcium phosphate layer that has a high 
crystallographic resemblance to the natural bone mineral.26,27 It was shown that the 
osteophilic properties of the ceramic coating are influenced by the crystal phase, 
chemical composition and crystallinity of the applied CaP ceramic.28,29 
 Hydroxyapatite (HA),30 tricalcium phosphate (TCP),31 and octacalcium phosphate 
(OCP),32 have been successfully used for the deposition of ceramic-based coatings. 
In addition to CaP coatings, bioactive silicate-based glass (BG) coatings are 
suggested to exhibit osteopromotive characteristics.33,34 It has been demonstrated 
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that the formation of a hydrated silica layer and hydroxyl carbonate apatite on the 
glass surface have a osteopromotive effect on  osteoblast proliferation and differen-
tiation.35
 Ceramic-based coatings can be deposited by various techniques, including 
plasma-spraying, magnetron sputtering or pulsed laser deposition (PLD).15,16 Plas-
ma-spraying is a popular procedure in the field of dentistry and orthopedics for the 
deposition of CaP-based coatings on metallic bone implants. Numerous in vivo 
studies have been published on the beneficial biological performance of plasma- 
sprayed CaP surfaces.37-39 Still, the clinical use of these coatings is hampered by 
concerns regarding coating delamination and fragmentation at the implant/coating 
interface that jeopardizes the long-term performance of these implants.40 Magnetron 
sputtering and pulsed laser deposition can overcome these problems and have 
demonstrated to generate thin, well-adherent coatings while preserving the 
osteopromotive properties of the CaP ceramic.41,42
 Alternatively, wet-chemical coating techniques, such as electrospray deposition 
(ESD) or coating deposition via biomimetic precipitation, have been introduced 
for coating deposition of CaP ceramics under physiological conditions (i.e. low 
temperature and pressure) and for simultaneous incorporation of organic components 
and therapeutic agents into a CaP ceramic coating.43 Because this additionally 
allows for deposition of less stable CaP phases, partial coating dissolution and 
release of incorporated compound can induce a local anabolic effect, which 
stimulates the bone remodelling process at the peri-implant interface.44 Furthermore, 
these wet-chemical coating procedures make it possible to deposit coatings on 
scaffolds of complex 3D architectures that are frequently used for the regeneration of 
craniofacial skeletal defects.43 
 All aforementioned surface modifications and coating procedures were shown to 
exhibit beneficial potential in the early process of peri-implant bone formation. Still, 
straightforward  comparison and extrapolation of different in vitro and in vivo results 
for each individual study remains bothersome due to a lack of suitable models that 
allow for simultaneous evaluation of multiple surface modifications. Specific 
parameters and differences in bone healing in each experimental setup can influence 
the performance of a coating or surface modification. Furthermore, most of the 
experimental animal models only allow for the inclusion of a limited number of 
experimental groups. Therefore, this study was initiated to evaluate the osteophilic 
capacity of a broad range of seventeen different surface modifications within one in 
vivo experimental setup. For this purpose, a bone conduction chamber cassette 
model was used on the transverse process of a goat. The validity of this model has 
been described in literature for pre-clinical evaluation of surface modifications for 
bone implants. It allows for simultaneous comparison of different surface modifications 
and the effects on bone ingrowth and bone metabolism under unloaded conditions.45,46 
OSTEOPHILICITY OF SURFACE MODIFICATIONS IN A GOAT MODEL
2
25
In order to determine the osteophilic capacity of different ceramic-based coatings in 
comparison to different titanium surfaces obtained via subtractive procedures (i.e. Ti, 
GB and GAE), histological and histomorphometrical analyses in terms of bone-to-
implant contact percentage (BIC%), relative bone area (BA%) and maximum bone 
height (BH) were used.
Materials and methods
Research objectives and experimental study design
This study was initiated to evaluate the osteophilic capacity of different ceramic-based 
coatings in comparison to titanium surfaces obtained via different subtractive procedures 
within one in vivo experimental setup. For this purpose, a bone conduction chamber 
model on the goat transverse processes was used as previously designed by Wilson 
et al (2006).45 
 A power calculation was performed, using online software that was developed 
by Lenth and coworkers at the University of Iowa.47 According to previous studies, an 
effect size (f) of 0.2 was assumed, an error probability of 0.05, standard deviation 
(SD) of 0.1, and a power (P) of 0.85, leading to a minimal required sample size (n) of 10.
Sample preparation and characterization
Polyacetal chamber cassettes designed for bone conduction evaluation were used, 
as previously described by Kruyt et al. (2006).46 Each cassette contained ten titanium 
plates, forming five osteoconductive channels. After fixation of the cassette on the 
transverse processes, the bottom part of the channels was exposed to the underlying 
bone and the top part was open for the overlying soft tissues.
 Commercially available machined titanium (Ti-6Al-4V) plates were cut into 
rectangular shaped samples (12 x 9 x 1 mm) to fit tightly into the chamber cassettes 
(Figure 1a). The samples were left untreated or Al2O3 grit blasted on one side to 
create micro-roughened surfaces. Subsequently, the scaffolds were cleaned 
ultrasonically in acetone (15 min) and isopropanol (15 min) and thereafter air-dried. 
Finally, coating procedures were applied according to Table 1. 
 In brief, pulsed laser deposited (PLD) sol-gel HA coatings, were provided by 
SolmateS, Enschede, the Netherlands. Coatings of low and high crystallinity were 
obtained by adjusting deposition parameters.48 Electrostatic Spray deposited (ESD) 
HA coatings were generated using a commercially available ESD device (ES-2000S, 
Fuence Co., Ltd., Japan) at the department of Biomaterials, Radboudumc, Nijmegen, 
the Netherlands. For coating deposition, carbonate apatite (HA) nanoparticles 
(20nm) were obtained from Berkely Advanced Biomaterials Inc. (San Leandro, CA, 
USA). Coatings were produced as previously described by De Jonge et al.49 Substrate 
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temperature was set at 25°C, the nozzle-to-substrate distance was fixed at 40mm 
and the spraying time was 30 min. After deposition, the samples were air-dried. 
Plasma-sprayed CaP ceramic coatings of low, medium and high crystallinity were 
provided by CAM Bioceramics, Leiden, the Netherlands.50 Biomimetic coatings were 
generated at MIRA-Institute for Biomedical Technology and Technical Medicine, 
University of Twente, Enschede, the Netherlands. The biomimetic apatite coatings 
were deposited in a two-staged procedure by heterogeneous nucleation of a thin and 
amorphous calcium phosphate layer in supersaturated SBF.51 OCP/(Sr) coatings 
were generated by immersing the samples in SBF solutions followed by a simulated 
calcifying solution, as described previously.52-54 After coating deposition, all samples 
were cleaned with demineralized water and air dried overnight. For radiofrequent 
magnetron sputter-coatings, a commercially available sputter unit was used (Edwards 
High Vacuum ESM100 system, Sussex, UK) at the department of Biomaterials 
(Radboudumc, Nijmegen, the Netherlands). The target materials for coating deposition 
were HA granulated powder (Cam Bioceramics BV, Leiden, the Netherlands), or 
bioactive glass S53P4 granulates (Vivoxid Ltd. Turku, Finland). For the TCP coatings, 
Figure 1a-b  (a) Schematic drawing of the goat transverse process model and the 
position of the cages on the processes L2-L3 (b) Image of the polyacetal conduction 
cage containing the titanium plates, the exposed trabecular bone and the fixation of 
the cage on the transverse process.
A
B
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copper discs with a plasma-sprayed β-TCP coating were used as a target material. In 
order to obtain coatings with a comparable thickness, coating deposition procedures 
varied in time (HA: 4h, TCP: 2h, BG/HA 100/300: 6h, BH/HA 100/50: 6h) as described 
by Wolke et al. (1994).55 After processing, all TCP, HABG as- sputtered coatings 
received an additional heat-treatment for 2 hour at 650°C and HA coatings were heat 
treated for 2 hours at 550°C. Subsequently, sterilization of the sputter coatings was 
performed by autoclavation.
 Average surface roughness value (Ra) was determined for each experimental 
group, using a Universal Surface Tester (UST; Innowep, Wurzburg, Germany). Fourier- 
transform infrared spectroscopy (FTIR, Perkin- Elmer, Massachusetts, USA) and 
X-ray diffraction (XRD, Philips θ-20 diffractometer) were used to monitor the crystal 
phase crystallinity and molecular structure of the deposited coatings. Micro-porosity 
Table 1  Overview of the experimental groups that were generated after surface 
modifications and coating deposition and the mean ± standard deviation value of 
surface roughness (Ra µm) measurements.
Substrate Surface Coating 
technology
Group Ra (µm) ± SD
Titanium Machined - Ti 0.77 ± 0.08
Grit Blasted GB 1.22 ± 0.03
Grit Blasted/ Acid 
Etched
GAE 1.04 ± 0.13
Titanium Grit Blasted Pulsed Laser 
Deposition
PLD HA L 1.06 ± 0.08
PLD HA H 1.28 ± 0.01
Titanium Grit Blasted Electrospray 
Deposition
ESD HA 1.30 ± 0.07
Titanium Grit Blasted Plasma- 
Spraying
Plasma HA L 6.95 ± 0.72*
Plasma HA M 6.48 ± 1.12*
Plasma HA H 7.13 ± 0.56*
Titanium Grit Blasted Biomimetic BIO HA 1.20 ± 0.06
BIO OCP 1.24 ± 0.08
BIO OCP Sr L 1.17 ± 0.12
BIO OCP Sr H 1.64 ± 0.19
Titanium Grit Blasted Magnetron 
Sputtering
Sputter HA 1.23 ± 0.03
Sputter TCP 1.13 ± 0.01
Sputter HABG L 1.03 ± 0.04
Sputter HABG H 1.27 ± 0.06
* : significant different (p<0.05)
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and qualitative surface characterization were carried out by (back)scattered electron 
(BSE) imaging using an environmental scanning electron microscope (ESEM, XL30 
ESEM-FEG, Philips, Eindhoven, The Netherlands).
 Subsequently, the cassettes were aseptically assembled (Figure 1b). The position of 
the samples was randomly distributed per cassette to prevent potential confounders 
in scaffold position on the transverse process. Finally, the assembled cassettes 
containing all surface modified titanium plates were sterilized using low temperature 
ethylene oxide (EO) gaseous sterilization (Synergy Health plc, Venlo, the Netherlands).
Animals and surgical procedure
After the approval of the ethical committee of the Radboudumc (Nijmegen, the 
Netherlands; DECABC 2011.III.006), ten adult Dutch Saane milk goats (weight ~60kg, 
age ~24 months) were purchased. National guidelines for care and use of laboratory 
animals were observed. The animals were allowed to acclimatize for four weeks, after 
which surgical procedures were performed under general anesthesia. After intubation, 
the animals received a subcutaneous injection of prophylactic antibiotic Albipen® 
(15%, 3ml/50kg, Intervet BV, Boxmeer, the Netherlands) to reduce the risk of 
peri-operative infections and Finadyne® to reduce immediate post-operative pain. 
General anesthesia was achieved and maintained by Isoflurane® (Rhodia Organique 
Fine Limited, Avonmouth, Bristol, England). Before surgery, the soft tissues were 
shaved and cleaned with a 10% povidone-iodine solution. The experimental setup 
and surgical approach have been described in detail by Wilson et al. (2006).45 In 
brief, a midline skin incision was made from T8-T5 to expose the fascia. Then, the 
attached muscles were bilaterally retracted to expose the underlying transverse 
processes L2 and L3 (Figure 1a). After decortication of the processes using a bone 
rasp, the trabecular bone was flattened to create an even surface for placement of the 
cassettes. One cassette was mounted on each transverse process. Two pilot holes 
were drilled under saline irrigation and two self-tapping screws were used for cage 
attachment (Figure 1b). After the cages were mounted, light finger pressure was 
applied on the titanium plates to ensure direct contact with the underlying trabecular 
bone. Subsequently, the muscles, fascia and skin were closed in layers using 
resorbable sutures (Vicryl 4.0, Ethicon Products, Amersfoort, the Netherlands). 
Immediately and for three consecutive days after surgery, all goats received a 
subcutaneous injection of Albipen® (7.5 ml/50kg, Intervet BV, Boxmeer, the 
Netherlands) to reduce post-operative infections and Temgesic® (0.015 mg/kg; 
Reckitt Benckiser Healthcare, Hull, England) for post-operative pain reduction.
Implant retrieval and analysis
After 12 weeks of healing, the animals were euthanized by an overdose of Nembutal® 
(Apharmo, Arnhem, the Netherlands) and the transverse processes containing the 
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cassettes were retrieved. The cassettes were first stored in 4% formaldehyde for one 
week, then the cassettes were dehydrated gradually in ethanol solutions from 70% to 
100% ethanol, and embedded in methyl methacrylate (MMA). Subsequently, three 
centrally located, non-decalcified, thin longitudinal sections (10-15 µm) were made 
along the axis of the transverse process using a modified sawing microtome 
technique, as described previously.56 Then, sections were etched by EtOH/HCL and 
stained with methylene blue/basic fuchsin and histologically evaluated (25x 
magnification) for total tissue response and bone formation in the channels using a 
light microscope (Axio Imager Microscope Z1, Carl Zeiss Micro imaging GmbH, 
Göttingen, Germany). For histomorphometrical analysis, digital image analysis 
software (Leica Qwin Pro-image analysis software, Leica Imaging Systems, 
Cambridge, UK) was used. The osteophilic capacity of each surface condition was 
determined by setting an individual region of interest for each channel. A custom 
macro was used to determine maximum bone height (bone peak), bone-to-implant 
contact (BIC%) along the total length of the channel and the relative bone area (BA%) 
in each channel (Figure 2a-c). The average of measurements based on three 
histological sections was used for statistical analysis.
Figure 2a-c  Schematic overview of the method to determine a) bone to implant 
contact percentage (BIC%) b) bone area (BA%) and c) maximum bone height, within 
the region of interest (red box).
A B C
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Statistical analysis
The histomorphometrical parameters (BIC%, BA% and BH) are displayed in boxplots 
and statistically analyzed using Prism 5 (GraphPad Software Inc. San Diego, CA, 
USA). Mean values and standard deviations (SD) were calculated. The method of 
Kolmogorov and Smirnov was used to confirm that the data were sampled from 
populations that follow Gaussion distributions. For comparison of surface conditions 
on histomorphometric parameters, repeated measurements ANOVA were used with 
a Tukey’s Post-Hoc Multiple Comparison Test. Additionally, Student’s unpaired t-tests 
were performed to determine differences in implant surface properties between the 
non-coated (Ti,GB,GAE) and coated surfaces. Differences were considered 
statistically significant at p<0.05.
Results
Surface characteristics of titanium bone implants for enhanced 
bone conduction properties
Surface topographical evaluation of the included surface modifications (after 
subtractive or additive surface modification procedures) is presented in Table 1. 
Mean surface roughness (Ra) of machined titanium (TI; Ra= 0.77µm ± 0.08) was 
increased upon grit blasting (GB; Ra=1.22µm ± 0.13) and acid etching (GAE; 
Ra= 1.04µm ± 0.13). Generally, mean surface roughness after coating deposition 
(i.e. PLD, ESD, biomimetic precipitation and magnetron sputtering) ranged from 
Ra= 1.04 to 1.64µm. However, plasma-sprayed coatings exhibited significantly 
(p<0.05) rougher surfaces with Ra=6.95 to 7.13µm. Scanning electron microscopy 
(SEM) confirmed the microtopographical differences between the experimental 
surfaces, as displayed in detail in Figure 3. Briefly, high magnification SEM images 
showed uniformly roughened surfaces for GB and GAE surfaces. For all coating 
procedures, a homogenous surface coverage was observed. In detail, a flake-like 
structure was visible for the biomimetic coating procedure, while the plasma-sprayed 
coatings revealed a globular and spherical morphology that reflects the partial 
melting of precursor powders. Similar to the results, described by Habibovic et al.51,54 
FTIR  spectra (data not shown) and XRD analysis (Figure 4a-b) of the experimental 
surfaces confirmed that coatings displayed reflection peaks characteristic for apatite 
at 26 and 32 °2Ɵ, except for thin ESD and magnetron sputtering coatings as well as 
uncoated Ti substrates. Measurements of coating thickness revealed that the 
experimental coatings could be categorized into two groups; i) plasma-sprayed and 
biomimetic coatings of high thickness (>50µm) and ii) thin coatings generated by 
PLD, ESD or magnetron sputtering (<50µm).
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Figure 3  High- magnification SEM images of the surface conditions, generated on 
Ti-6Al-4V alloy. Surface condition and magnification are indicated at the top right and 
bottom of the image.
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Transverse process cassette model for comparative evaluation of 
surface modifications
Surgical procedures were without complications. Postoperative recovery was uneventful 
and all animals remained in good overall condition, without any signs of infections or 
impaired function. At implant retrieval, no signs of inflammation were observed and 
the cages were well attached to the underlying transverse processes.
Histological appearance of bone-to-implant response and 
histomorphometric evaluation
Histological analysis of the chamber cassettes demonstrated uneventful healing 
without any signs of an inflammatory response. For most of the cassettes, fibrous 
tissue ingrowth was observed from the overlying soft tissues into the osteoconductive 
channels. Occasionally, an intervening layer of soft tissue was observed between the 
titanium scaffold and the underlying decorticated transverse processes. Overall, 
Figure 4a-b  XRD analysis of the generated coatings on Ti after heat treatment. 
a) >50µm, b)<50µm.
A
B
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bone ingrowth appeared in most of the channels, starting from the base of the bony 
structure into the channels in a needle-like architecture. For most of the surface 
modifications, no significant bone apposition was observed onto the surface modified 
walls of the chamber. Interestingly, for the plasma-sprayed coatings, a clear osteo-
conductive pattern was observed onto the coated surface (Figure 5a). At higher 
magnification, osteocytes could be distinguished in the newly formed bone tissue, 
which is indicative for bone maturation and lamellar bone formation (Figure 5b).
 Backscattered electron microscopy (BSEM) demonstrated cracks in a number of 
samples, marked by the black arrows, due to the histological processing and MMA 
embedding. BSEM and histological sections were comparable in qualitative observations 
of the bone formation pattern in the osteoconductive channels (Figure 5c).
Figure 5a-c  Images representing the 12 weeks timepoint. (a) histological overview 
of the different surface conditions demonstrating bone ingrowth from the base of the 
transverse processus (b) Higher magnification imaging with maturation of bone and 
the development of osteons close to the implant surface (c) Backscattered electron 
imaging with close resemblance to the histological stained sections. Black arrows 
indicating cracks in the MMA due to histological processing.
A
B C
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 Standardized measurements of the individual regions of interest (ROI) demonstrated 
equal areas for the different surface modifications (Figure 6). Bone formation was 
histomorphometrically quantified after 12 weeks of healing by means of bone-to- 
implant contact (BIC%), relative bone area (BA%), and maximum bone height (BH), in 
an individualized ROI per osteoconductive channel. Data are displayed in box plots 
(Figure 7).
 In Figure 7a, bone-to-implant contact (BIC%) is graphically depicted for the 
different surface modifications. After 12 weeks (low (L), medium (M) and high (H)) 
crystalline plasma-sprayed coatings demonstrated significantly (P<0.01; Figure 7a) 
higher BIC% (L: 19.8 ± 11.4%; M: 21.7 ± 7.8%; H: 15.8 ± 12.6%) compared to 
un-coated surfaces (Ti: 0.9 ± 0.6%; GB: 2.3 ± 1.3%; GAE: 2.0 ± 1.8%). Regarding 
BA%, plasma-sprayed coatings demonstrated significantly (p<0.01; Figure 7b) 
higher relative bone mass in the channels (L: 11.7 ± 8.1%; M: 13.3 ± 1.9%; H: 12.3 ± 
5.5%) compared to un-coated surfaces (Ti: 1.1 ± 1.1%; GB: 1.6 ± 1.2%; GAE: 1.5 ± 
1.2%). Figure 7c shows the data on maximum bone height (BH) for the different 
surface conditions. In the present study, only plasma-sprayed coatings demonstrated 
significantly (p<0.01) higher maximum bone peaks after 12 weeks (L: 2919.4 ± 
2350.6µm; M: 3334.7 ± 1816.5µm; H: 3373.7 ± 2871.5µm), in comparison to 
un-coated surfaces (Ti: 379.3 ± 301.1µm; GB: 896.2 ± 533.5µm; GAE: 634.0 ± 
554.7µm).
Figure 6  Box-and-whisker plot showing the total area of the osteoconductive 
channels for each surface modification. Total BA for the thick coatings (>50µm) was 
found not to be significantly smaller in comparison to the thinner coatings (<50µm).
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Figure 7  Results of histomorphometrical and statistical analyses showing a) bone 
to implant contact percentage; b) bone area; and c) maximum bone height after 12 
weeks of healing. #= Ti;  = GB; Δ = GAE.
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Discussion
In the present study, a bone conduction chamber cassette model on the goat 
transverse process was used to evaluate the osteophilic capacity of different surface 
modifications within one in vivo experimental setup. After a twelve-week implantation 
period, bone area, bone-to-implant contact and maximum bone height were determined 
inside each individual chamber. These histomorphometrical data demonstrated a 
superior bone response of plasma-sprayed CaP coatings compared to un-coated 
surfaces (Ti, GB and GAE).
 A wide variety of animal models are available to pre-clinically evaluate the 
osteophilic properties of a titanium implant surface. Generally, these models comprise 
an anatomical location in which the implant is completely surrounded by native bone 
immediately after implant placement.57,58 This ideal osseous environment is likely to 
overshadow implant surface effects related to osteophilicity, and hence are not useful 
for deciphering the effect of surface properties on bone tissue responses.59 In view 
of the clinical situation, implants are frequently placed in cases in which a gap is 
present between the implant surface and the native bone, such as cases that involve 
implant placement immediately after tooth extraction.60 In these clinical cases, an 
implant is desired with optimal osteophilic characteristics that stimulates bone 
apposition beginning at the implant surface and spreading towards the native 
bone.61,62 Since we were specifically interested to evaluate the osteophilic capacity of 
a broad range of different surface modifications within one in vivo experimental setup, 
a bone conduction chamber cassette model was used on the transverse process of 
a goat. The bone-chamber cassette model in its current design was originally 
developed and validated by Wilson et al. in 2005. It has shown to be a valid model to 
evaluate the osteoconductive properties of biomaterials and their effect on bone 
metabolism in a non-loaded environment.45 In the present study, the placement of 
the cassettes on decorticated bone allows for discrimination of true surface property 
effects on several histomorphometrical parameters (i.e. bone-implant contact, bone 
area, and bone height) related to osteophilicity. With slight modifications to the 
original model, the present study addressed these histomorphometrical parameters 
using titanium plates with different surface modifications.
 Histological evaluation demonstrated that bone formation occurred in two ways. 
First, bone was formed starting from the base of the transverse processus into the 
chambers in a needle-like architecture. It was defined as bone ingrowth and is not 
related to the osteoconductive properties of the implant surface, but may rather be 
related to capillary filling of the chamber, as described in previous studies.45 The 
other type of bone formation was characterized by bone apposition along the 
modified surfaces flanking the channel and was defined as osteoconduction. The 
latter type of bone formation likely is influenced by the implant surface and is related 
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to the degree of spreading and migration of (pre)osteogenic cells on the implant 
surface and subsequently the amount of bone ingrowth and bone contact.16,45 In the 
present study, this second type of bone formation was observed most extensively for 
the plasma-sprayed CaP coatings.
 Histomorphometrical analyses indicated that plasma-sprayed CaP coatings 
have a beneficial effect on bone formation in comparison to non-coated controls 
regarding bone-to-implant contact and bone area. This observation corroborates 
earlier reports, in which CaP plasma-sprayed coatings positively influence the early 
bone response around titanium bone implants.37-39 The reason for the enhanced 
osteoconductive behavior of the coating may be found in the topographical charac-
teristics of the plasma-sprayed coatings. In the present study, plasma-sprayed CaP 
coatings distinguished themselves from all types of CaP coatings by their considerably 
higher surface roughness (Ra: 6.48-7.13µm) compared to all other modified surfaces. 
This increase in micro-roughness generates a significant surface enlargement for 
precipitation of a carbonated apatite layer and protein adsorption. It is generally 
accepted that moderately rough implant surfaces (Ra 1-2µm) are optimal to increase 
peri-implant bone formation in comparison to smooth or rougher surfaces.63,64 This 
may indicate that the plasma-sprayed implants in the present study exceed the 
optimal roughness. On the other hand, a systematic review by Shalabi et al. (2006) 
demonstrated that a broader range in surface roughness (Ra 0.5- 8.5µm) positively 
influences the peri-implant bone response.13
 Another reason for the positive biological response to the plasma-sprayed 
implant surface has been extensively described in literature and is related to the 
partial dissolution of amorphous regions within plasma-sprayed CaP coatings 
resulting into abundant release of calcium (Ca2+) and phosphate (PO43-) ions in the 
peri-implant region.22 The exact molecular pathways behind the influence of Ca2+ 
ions on bone remodelling are not completely clear. However, it has been described 
that local super-saturation of Ca2+ ions within the peri-implant region influences the 
morphology and osteogenic differentiation of specific cell types such as pre-osteo-
blasts.25,65 Additionally, the presence of Ca2+ ions stimulates apatite nucleation and 
the precipitation of a carbonate calcium phosphate layer. This apatite layer shows a 
high degree of crystallographic resemblance to native bone which allows for the 
attraction of proteins to the implant surface that trigger osteogenic cells to form 
bone.26
 After 12 weeks of healing, no significant histomorphometrical differences were 
observed for effects of coating crystallinity, irrespective of the applied coating 
procedure. This corroborates previous in vivo data by Chang and coworkers. In their 
study, titanium implants containing CaP coatings with a different degree in crystallinity 
were placed in the canine femur. After 1, 4, 12 and 26 weeks, the implants were 
histologically and histomorphometrically evaluated. They concluded from their results 
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that the presence of a CaP coating enhanced early bone formation in comparison to 
non-coated implants, but the degree in crystallinity did not significantly influence the 
early bone response after several time points.66 Still, there is evidence showing that 
amorphous plasma-sprayed CaP coatings are beneficial for the early in vivo bone 
response because of higher dissolution rates in comparison to high crystalline 
plasma-sprayed CaP coatings.67
 In the present study, ceramic coatings were generated, based on different 
phases of CaP ceramics (i.e. HA, OCP and TCP), as a composite coating incorporating 
bioactive glass or by the addition of therapeutic agents (i.e. strontium). In order to 
generate these coatings, different deposition techniques (PLD, ESD, magnetron 
sputtering, plasma-spraying by biomimetic precipitation) were used that resulted in a 
significant variation in coating thickness. Coating deposition by PLD, ESD and 
magnetron sputtering generated relatively thin (<50µm) coatings, whereas after 
plasma spraying and biomimetic precipitation, relatively thick (>50µm) coatings were 
obtained. In view of the effects of coating thickness on the region of interest and 
related quantitative histomorphometric parameters, our measurements demonstrated 
equal regions of interest among the groups, which makes that our quantitative 
assessment can be regarded as reliable. Moreover, this also rules out effects of 
coating thickness on the quantitative parameters themselves, leaving other properties 
as remaining possible causes for histomorphometric differences.
 For this study, a composite of bioactive glass (BG) and HA, with a high (H) and 
low (L) concentration BG was included. Based on previous studies,33,68 it was 
hypothesized that these coatings possess higher bioactive potential in comparison 
to pure CaP coatings due to the formation of a hydrated silica layer and hydroxyl 
carbonate apatite (HCA). This layer not only resembles the mineral phase of bone, 
but also has a positive effect on osteoblast differentiation.34,35 Although a tendency 
towards a higher bone-area was noticeable for the HABG L coating, no significant 
differences were observed between the HABG coatings and the un-coated surfaces. 
Since a hydrated silica layer of at least 10µm thickness is needed at the implant 
surface to improve the biological potential of the implant surface,69 it can be 
hypothesized that the HABG coatings were too thin for the formation of such a silica layer. 
Another possible explanation can be found in the coating procedure itself. Previous 
in vitro data has demonstrated that magnetron sputtering can change the elemental 
composition of the BG target material. As a result, the weight percentage SiO2 in the 
coating decreases <40%.70 This negatively affects the osteopromotive properties of 
the coating, since it is well known from literature that only bioactive glasses with 
weight percentages SiO2 between 40-60% have osteopromotive properties.69,71 
 For two of the OCP coatings, high and low concentrations of strontium (Sr) were 
incorporated to the coating because of the ascribed metabolic effect on bone 
turnover and the close chemical resemblance to calcium ions. Although the precise 
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underlying cellular pathways are still not clear, it is generally accepted that strontium 
can have a positive effect in the reduction of bone resorption and stimulation of bone 
formation in vivo, especially in osteopenic conditions.72,73 However, histomorpho-
metrical data in the present study demonstrated no beneficial osteoconductive effect 
for the addition of an OCP-Sr coating to a titanium surface. We speculate that the 
therapeutic dose of the incorporation of Sr in the coatings was too small to have a 
significant additive effect on the bioactive properties of the coating.
 Finally, it should also be emphasized that the absence of significant differences 
in bone response between some of the coatings and un-coated surfaces, can be 
ascribed to the used animal population. Usually, in vivo studies on surface modifications 
include highly standardized and homogenous animal populations (i.e. mostly rodents) 
with a uniform genetic background. For the present study, Dutch Saane milk goats 
were obtained with a certain variation in age and weight. This can be considered a 
rather heterogeneous animal population with a significant variation in bone response 
resulting in histomorphometrical data with relatively large standard deviations. 
However, a heterogeneous experimental population partly resembles the clinical 
situation in which patients (of variable age and weight) also display a certain variation 
in wound healing and peri-implant osteogenesis. 
 Further, it has to be noticed that the chamber cassette model on the decorticated 
goat transverse processus is a screening model that particularly allows for the 
evaluation of clinically relevant physico-chemical properties responsible for the 
osteophilic capacity of an implant surface. Interpretation of the current data should 
be done with care because, in this in vivo model, the implant surface was placed on 
top of the host bone. This is in contrast with the clinical situation in which bone 
implants are always (partly) surrounded by native bone upon implant installation. 
 In summary, the present study demonstrates that the deposition of a CaP coating 
with a high roughness has a beneficial effect on the osteophilic capacity of titanium 
in a chamber cassette model. Still, more research is needed to unravel the physi-
co-chemical property responsible for this effect and to understand the fundamental 
pathways in the bone formation process that account for this biological response.
Conclusion
It can be concluded that (i) the chamber cassette model is a valid model to determine 
the in vivo effect of different surface characteristics on the osteophilicity of a titanium 
implant surface in one individual animal, and (ii) under the current experimental 
conditions, plasma-sprayed CaP coatings have a superior osteophilic effect 
compared to non-coated titanium surfaces and a wide range of CaP and/or bioactive 
glass-based coatings deposited using alternative techniques.
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Introduction
Through the last decades prosthetic rehabilitation of completely or partially edentulous 
patients with implant-borne removable or fixed dentures has developed into a practical 
and predictable treatment option.1,2 However, failures do occur and are in large 
attributable to a failure in bone formation in support of osseointegration.3,4 In particular, 
low bone quantity or density as well as delayed or impaired bone healing are correlated 
with osseointegration failure.5 
 Prospectively, the universal prevalence of subjects with such challenging bone 
conditions will increase. For example, global ageing of populations will lead to a 
major worldwide increase of systemic diseases as osteoporosis or diabetes. Which 
are associated with low bone quantity/density or delayed/impaired bone healing.6,7
 Especially for such more challenging situations, improved implant stability as 
well as accelerated bone healing have been shown for certain surface modifications 
of dental titanium implants.8-11 Surface modifications of dental titanium implants are 
in general accomplished by surface roughening or by altering the chemical 
composition. Various methods have been developed in order to create roughened 
surfaces, e.g. titanium plasma spraying, grit-blasting, acid etching, and anodization. 
Coating of dental titanium implants with calciumphosphate (CaP) ceramic is the most 
frequently used method for changing the chemical surface composition.12  It is well 
known, that following implantation, the release of calcium phosphate into the peri- 
implant region increases the saturation of body fluids and results in the precipitation 
of a biological apatite onto the surface of the implant13,14 and that this layer of 
biological apatite might contain endogenous proteins and serve as a matrix for 
osteogenic cell attachment and growth.15 Because the biological fixation of titanium 
implants to bone tissue is faster with a calcium phosphate coating than without,16,17 
it seems rational to assume that the bone healing process around the implant is 
enhanced by the formation of the aforementioned biological apatite layer.
 To date plasma-spraying is mostly used to coat titanium dental implants for 
clinical use. One of the major concerns with plasma-sprayed coatings is the possible 
delamination of the coating from the surface of the titanium implant and failure at the 
implant/coating interface. It is supposed, that the discrepancy in dissolution behavior 
between amorphous and crystalline calcium phosphate phases that make up the 
coating led to delamination, particle release and thus the clinical failure of implants.18-22 
However, the scientific literature is not consistent. For example, a meta-analytical 
approach to clinical trials published between 1990 up to 1999 reporting on the 
outcome of calcium phosphate ceramic coated dental implants could not verify 
inferiority as regards implant survival.19
 Hence, especially because it might be assumed that the growing universal 
prevalence of patients with challenging bone conditions such as low bone quantity/
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density or delayed/impaired bone healing could be paralleled by an enhanced global 
use of calcium phosphate ceramic coated dental implants, the aims of the current 
review were (1) to systematically appraise, and (2) to evaluate long-term survival data 
of calcium phosphate coated dental implants in clinical trials published between 
2000 and 2011.
 Furthermore, because there is no convincing evidence that late post loading 
failure at the implant/coating interface will in general occur, it was hypothesized that 
annual failure rates of calcium phosphate coated dental implants do not increase 
progressively on the long-term.
Materials and methods 
Background
As a recent meta-analytical review already investigated clinical trials published 
between 1990 up to 1999 reporting on survival of calcium phosphate ceramic coated 
dental implants,19 it was decided to consider only literature published thereafter (from 
2000 up to 2011) for the current assessment.
Outcome variables
The primary outcome variable was percentage annual failure rate (AFR) and the 
secondary outcome variable was percentage cumulative survival rate (CSR). The 
phrase ‘survival rate’ was used to describe the long-term efficacy of functional 
implants according to the definitions proposed by Kirsch and Ackerman23 as well as 
by Albrektsson and Sennerby,24 supposing that an immobile asymptomatic implant 
should be seen as a survived dental implant. In order to answer the proposed 
hypothesis, the term ‘annual failure rate’ was used to describe the implant percentage 
that failed during a period of one year.
Inclusion criteria
For the purpose of the present study it was decided to include randomized controlled 
clinical trials (RCT), propective clinical trials (PCT) as well as retrospective analysis of 
cases (RA) presenting survival data on the topic of calcium phosphate coated dental 
implants.
Additionally, the following detailed inclusion criteria were operated:
1. Inclusion of ≥ 10 subjects;
2. Mean follow- up time ≥ 5 years;
3. Implant survival data (CSR) had to be presented clearly as overall percentage or 
as life table-analysis;
4. Patients with untreated periodontitis had to be excluded;
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5. Barrier membranes or grafting procedures (i.e.: bone or bone substitutes) were 
not applied;
Studies that did not meet all above mentioned inclusion criteria were excluded.
Search strategy 
An extensive search in the electronic databases of the National Library of Medicine 
(http://www.ncbi.nlm.nih.gov), The Cochrane Central Register of Controlled Trials and 
the ISI Web of Knowledge, was carried out for articles published between January 
2000 and November 2011. Only publications in English were considered and the 
search was narrowed to human trials. The following detailed search strategy was 
applied: “(CaP[All Fields] OR (“calcium phosphate” [Substance Name] OR “calcium 
phosphate” [All Fields]) OR (“durapatite” [MeSH Terms] OR “durapatite” [All Fields] 
OR “hydroxyapatite” [All Fields]) OR (“durapatite” [MeSH Terms] OR “durapatite” [All 
Fields] OR “hydroxyapatite” [All Fields])) AND (“dentistry”[MeSH Terms] OR 
“dentistry” [All Fields]) AND Implants [All Fields] AND (“humans”[MeSH Terms] AND 
English [lang] AND (“2000/01/01”[PDAT]: 2011/11/23”[PDAT])). Furthermore, the 
reference lists of related review articles and publications selected for inclusion in this 
review were systematically screened.
Study selection
Two independent reviewers (Bart van Oirschot [BO] and Rüdiger Junker [RJ]) initially 
screened the publication titles and abstracts as identified by the electronic as well as 
manual search for possible inclusion. Full texts of all papers that were considered 
eligible for inclusion by one or both of the reviewers were obtained for further 
assessment against the stated inclusion criteria (Figure 1). Both reviewers used a 
data extraction form to extract the data independently. Any disagreement between 
the reviewers regarding inclusion of a certain publication or data extraction were 
resolved by discussion.
Results
Study selection
The electronic search in the database of the National Library of Medicine, The 
Cochrane Central Register of Controlled Trials and the ISI Web of Knowledge, resulted 
in the identification of 385 titles. As already mentioned, these titles were initially 
screened by the two independent reviewers for possible inclusion, resulting in further 
consideration of 29 publications. Screening the abstracts led to 20 full text articles, 
which are detailed in Table 1. From these articles, fifteen reports were excluded for 
reasons mentioned in Tables 1a and 1b.25-39 Finally, five of these original research 
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reports could be selected for evaluation and are summarized in Table 1.20,40-43 No 
additional publications were identified by manual search for inclusion. Thus, a total of 
five articles were included for analysis (Figure 1). Regarding data extraction and 
interpretation, any disagreement between the reviewers was resolved by discussion.
Overall Results
One of these studies was a randomized controlled clinical trial,20 three were 
prospective clinical trials41-43 and one a retrospective analysis40 (Table 1). Three 
publications used life tables to report cumulative survival rates,20,41,42 whereas in two 
papers40,43 overall percentages were used. Considerable variation was found to be 
present between the included research papers with regard to implant system used, 
implant diameter, implant configuration, implant length, anatomical region of implant 
placement (i.e. maxilla, mandible, anterior, posterior) and thereby bone quantity as 
well as bone quality, loading protocol, overall treatment protocol, age range, number 
of included subjects, as well as drop outs. All five studies included for analysis report 
survival rates after five years.20,40-43 Moreover, two publictions present survival rates 
up to six20 and seven years42 and two papers40,41 report survival rates up to ten years. 
On the long-term, three publications implied significant bone loss adjacent to calcium 
phosphate coated implants.20,40,41 
Individual study results
In brief, Thierer et al.43 report for their prospective clinical trial a cumulative implant 
survival rate after 5 years of 97%. Progressive implant loss or significant peri-implant 
bone loss were not observed. Similar results were found in the prospective clinical 
trial of McGlumphy et al.42 They report implant survival rates of 94% after 5 and 7 
years. Again, progressive implant loss or progressive peri-implant bone loss were not 
observed. Comparable cumulative survival rates (5 years: 94%, 10 years: 93%) were 
retrieved from the retrospecive analysis of cases of Artzi et al.40 However, on the 
long-term significant peri-implant bone loss occured. Furthermore, Tinsley et al.20 
report for their prospective clinical trial a cumulative implant survival rate after 6 years 
Table 1b  Reason for exclusion and the frequency of occurrence.
Reason for exclusion Frequency
Inclusion of < 10 subjects 0
Mean follow- up time < 5 years 3
Insufficient data on implants survival data (CSR) 10
Patients with untreated periodontitis were included 0
Additional grafting procedures and barrier membranes were used 3
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as high as 100% with coexisting significant peri-implant bone loss. Likewise are the 
reported data of Binahmed et al.41 At 5 years, they found a cumulative survival rate of 
98% (100% in the mandible and 91% in the maxilla). In addition, the cumulative survival rate 
after 10 years was 96% (99.6% in the mandible and 88% in the maxilla). However, their 
reported success data after 10 years (85% in the mandible and 71% in the maxilla) 
indicate significant peri-implant bone loss. Moreover, as in the reports of Artzi et al.40 
and Tinsley et al.20 progressive bone loss around some implants was found.
Quantitative data synthesis
This study aims at performing a meta-analysis on the long-term survival of calcium 
phosphate ceramic coated dental implants. As mentioned before, considerable 
variation was found to be present between the included studies with regard to implant 
Figure 1  Selection process.
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systems used, implant diameter, implant configuration, implant length, anatomical 
region of implant placement, loading protocol, overall treatment protocol, age range, 
number of included subjects, as well as drop outs. Nevertheless, it was decided for 
the purpose of the current investigation to take into account only implant location (i.e. 
maxilla or mandible) as a possible co-variable with regard to implant survival. The 
estimation of percentage of total implants in function could finally be established on 
data retrieved from four studies.40-43 For maxillary implants data from three papers40-42 
and for mandibular implants data from four reports were used. 20,40-42 Since the 
studies included report on a variety of time intervals, first a failure rate on a one year 
basis was calculated for each interval in each study. For any given study the smallest 
intervals reported were used, and it was assumed that within these intervals the 
failure rate was constant. Using this, the mean annual failure rate (AFR) for that interval 
can be calculated. Say the fraction implants in function at the beginning of a k year 
interval is f1, and it is f2 at the end of the interval, then:
Using this formula for all included studies for each year a series, up until 10, of AFR’s 
could be calculated. Per year a meta analysis was done to estimate a weighted 
average of the AFR for that year. Weighing was done with the reciprocal standard 
error variances and tested for homogeneity. If homogeneity was rejected at a level of 
0.05, the estimated heterogeneity variance was estimated and added to the pooled 
variance.
 After meta analysis for each year a AFR and its standard error was available (Table 2). 
To analyse the effect of the chain of failure rates and their respective standard errors on 
the level of survival at a certain point in time, to our knowledge no analytical methods 
are available. Therefore, this process was simulated. This required a number of steps.
1. First, for any given AFR and standard error, a logit transformation was done. This 
transformation is needed to allow for the asymmetrical distributions of fractions 
close to 0. From each of the transformated distribution 3000 samples were drawn 
and back transformed to fractions. Thus a detailed distribution of the AFR for a 
given year is obtained, with the proper standard error and the skewed shape 
belong to fractions close to 0.
2. Subsequently from each of these 10 distributions a 1000 draws are performed, 
this simulates a 10 year follow up for a population of 1000 implants. This yields 
the mean cumulative survival for each year in the entire 10 year period.
  That in itself can be obtained much easier by coupling the mean AFR’s from the 
meta analysis:
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  However, this does not give information about the uncertainty around this 
estimate. Therefore a last stage in the simulation was done:
3. The process under 2 was repeated 1000 times. For each point in time this now 
delivers not only a mean survival rate, but also distribution around it, indicating 
the level of uncertainty of those rates.
As statistical software R, version 2.10.1. was used.
Statistical analysis
For overall estimates of weighted mean annual failure rates (AFR) heterogeneity was 
found and explained by the anatomical site of implantation (i.e. maxilla versus 
mandible). On the other hand, for none of the ten years under investigation, 
homogeneity has been rejected for studies that report on either maxillary or 
mandibular data. The estimates of weighted mean AFR detailed for upper and lower 
jaw are presented in Table 2. It was estimated that during the first year of function the 
weighted mean AFR-percentage was 0.46 (SE: 0.68) in the maxilla and 0.03 (SE: 
0.21) in the mandible. Accordingly, the percentage of implants in function after the 
first year was estimated to be 99.54% in the maxilla and 99.97% in the mandible. 
Obviously, in the maxilla the estimates of the weighted mean AFR-percentage 
increased over the years up to 2.60 (SE: 1.18) during the fourth year of function and 
to 1.38 (SE: 1.31) in the years nine and ten.
 During the first two years of function the difference of the estimates for the maxilla 
and the mandible did not reach statistical significance (p > 0.05). In the years thereafter, 
the estimated percentage of mandibular implants in function was statistically 
significant higher than the percentage of maxillary implants in function (p < 0.05). 
After ten years, the mean percentage of implants in function was estimated to be 
89.6% in the maxilla and 99.2% in the mandible (Table 2). The per year estimates of 
the percentage of implants in function together with the corresponding lower and 
upper borders of the intervals of the estimates are presented in Figures 2, 3 and 4.
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Figure 2   Estimates of the overall percentage of mandibular and maxillary implants 
in function.
Figure 3  Estimates of the percentage of mandibular implants in function.
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Discussion
Especially throughout early phases of bone-to-implant healing, calcium phosphate 
ceramic coatings have the potential to compensate for challenging bone conditions 
such as delayed or impaired bone healing and low bone quantity or density. For that 
reason, the increasing universal prevalence of subjects with such challenging bone 
conditions might be paralleled by an enhanced global use of calcium phosphate 
ceramic coated dental implants. However, the long term survival of calcium phosphate 
coated dental implants might be adversely affected by coating delamination.21 Still, 
the scientific literature is not consistent. For example, in a meta-analytic review of the 
literature from 1990 to 1999, inferior implant survival rates of calcium phosphate 
coated dental implants could not be verified.19 Accordingly, to get more insight into 
the long-term performance of calcium phosphate coated dental implants, the aims of 
the current review were (1) to systematically appraise, and (2) to meta-analyse 
long-term survival data of calcium phosphate coated dental implants in clinical trials 
as published between 2000 and 2011. Additionally, it was hypothesized that annual 
failure rates of calcium phosphate coated dental implants do not increase 
progressively on the long-term. This H0-hypothesis cannot be rejected. Nonetheless, 
it should be kept in mind that the estimates of the weighted mean percentage annual 
Figure 4  Estimates of the percentage of maxillary implants in function.
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failure rates and their respective standard errors that were eventually used to simulate 
the effect of a chain of failure rates were calculated on a limited quantity of reports 
and implants. For the total amount of implants in function (i.e. maxillary and 
mandibular implants) data from originally 959 implants retrieved from four papers,40-43 
for maxillary implants data from originally not more than 213 implants from three 
publications40-42 and for mandibular implants data from originally 878 implants from 
four clinical trials20,40-42 could be included for analysis. Only two of these studies 
presented survival data after 10 years.40,41 Furthermore, no more than one of these 
studies was a randomized controlled clinical trial,20 whereas three were prospective 
clinical trials41-43 and one a retrospective analysis of cases40 for which selection and 
reporting bias might be greater as compared with randomized clinical trials.44 In view 
of the statistical analysis, the eventually determined mandibular estimates of weighted 
mean percentage annual failure rates are very low (range: 0.03 – 0.20), whereas their 
corresponding standard errors (range: 0.21 – 0.41) are relatively high, which results in 
a simulated 95% confidence interval of the per year estimates of implants in function 
after a certain year of zero. This should be interpreted with causion and understood 
as a very low expected variance for the estimates of implants in function after a 
certain year. Nevertheless, with regard to the variables annual failure rate and 
cumulative survival rate, statistical homogeneity, which indicates experimental 
consistency,45 was found between all five evaluated reports. 
 Furthermore, the current finding of not progressively increasing annual failure 
rates of calcium phosphate coated dental implants on the long-term is in agreement 
with the meta-analytical review of Lee et al. (2000). Conversely, the current estimates 
of percentage of implants in function differ from their results.19 For example, after 
eight years Lee et al. report cumulative survival rates as low as 79.2%,22 whereas the 
present corresponding estimates of the 95% confidence intervals of percentages of 
implants in function range between 90.4% and 99.3%. However, this difference might 
be explained by the use of different implant systems and may not be related with 
implant coating. In light of this, it should be stated that the present review did not 
include original studies that were already evaluated by Lee et al. This was done in 
order to be able to compare the results of both meta-analyses. In addition, the current 
ten year estimates of percentage of implants in function (range: 87.5% - 99.2%) are 
comparable with the recently reviewed ten years survival data for dental implants 
without calcium phosphate coating (82% - 98%).46 Moreover, the estimated 99.2% of 
mandibular implants in function after ten years correspond very well with the long-term 
98.9% cumulative survival rate of Ekelund et al.47 On the other hand, the estimated 
87.5% – 91.5% for maxillary implants in function after ten years are lower than the 15 
years survival rates for dental implants without calcium phosphate coating (95.4% - 
100%) as published by Jemt.48 However, in our opinion this dissimilarity as well as the 
statistically significant difference for the survival estimates for maxillary as compared 
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to mandibular implants might be influenced by several conditions but should not be 
related to calcium phosphate implant coatings.49
 Nevertheless, three pubications indicate on the long-term significant, possibly 
progressive bone loss adjacent to calcium phosphate coated implants (Artzi et al. 
2006; Binahmed et al. 2007; Tinsley et al. 2001). As a result, in these study populations 
progressively increasing annual failure rates of calcium phosphate coated dental 
implants could develop. However, progressive bone loss adjacent to calcium 
phosphate coated implants should not be read as progressive bone loss due to 
calcium phosphate coated implant surfaces. There is evidence that also implants 
without surface coating may show progressive bone loss on the long-term.50
Conclusion
Within the limits of this meta-analyic approach to the literature, we conclude that: (1) 
published long-term survival data for calcium phosphate coated dental implants are 
very limited, (2) annual failure rates of calcium phosphate coated dental implants do 
not increase progressively, and (3) long-term cumulative survival rates for calcium 
phosphate coated dental implants are comparable to data published for non-coated 
implants.
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Introduction
Implant placement has become an important treatment option in dentistry for the 
rehabilitation of fully or partially edentulous patients.1,2 Nowadays, dental implants 
can serve as reliable longlife abutments in a wide range of indications.3 High survival 
and success rates are reported in optimal conditions. Still clinical failures are 
considerable in compromised situations (e.g. osteoporotic patients and implant sites 
with insufficient bone quality or quantitiy). Especially in these cases, accelarated 
bone formation is essential to maintain implant stability and to achieve a strong 
mechanical implant-bone fixation.
 It has been well described that a calcium phosphate (CaP) plasma-spray coating 
can have a biological advantage in the early biological fixation of titanium bone 
implants.4,5 Early implant stability and strong mechanical interlocking can be 
achieved, because of increased percentages of bone-to-implant contact (BIC%) in 
comparison to non-coated titanium implants.6 Still, the clinical application of this type 
of CaP-coated implants remains controversial because of concerns regarding 
long-term implant survival and success. The occurrence of increased crestal bone 
resorption as well as implant mobility have been reported.7-11 Overall cumulative 
implant survival is often used to describe the long-term prognosis of a dental implant 
system. Dental implant survival has been described by Albrektsson and co-workers 
as an implant being asymptomatic and in fuction.12,13 Although clinical studies to the 
long-term follow-up of calcium phosphate plasma spray coated implants are limited, 
still meta-analytical evaluation of these publications demonstrated no increased 
implant failure in time, with survival rates after 10 year ranging from 87% to 89%, 
which is comparable to the long-term survival of non-coated implants.8,14
 However, implant survival does not concern the quality of the remaining device.12 
As ongoing marginal bone loss might jeopardize long-term implant surival, more 
definite criteria should be explored to quantify the efficacy of a dental implant 
system.15 Numerous criteria for implant success have been suggested. Currently, the 
strict criteria outlined by Albrektsson and co-workers are frequently referred to as the 
gold standard for implant success. Among other parameters, a proposed criterion is 
that the marginal bone loss should not exceed 1.5mm in the first year of function and 
0.2mm on each subsequent annual year.16,17 While for the clinician marginal bone 
loss is, in the absence of clinical symptoms, a leading parameter for the judgment of 
implant performance, it should be emphasized that this criterion by Albrektsson is 
challenged by others.18 They state that this criterion is incorrect, because of a wide 
range of available implant systems and hence variatons in peri-implant bone 
resorption. Accordingly, they suggest four hypothetical patterns of marginal bone 
loss after the first year of function: (1) a low-rate of marginal bone loss over the years 
(Albrektsson pattern); (2) a low-rate of marginal loss in the first few years followed by 
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rapid loss of bone support; (3) a high-rate of marginal bone loss in the first few years 
followed by almost no bone loss; and (4) a continuous high-rate of marginal bone 
loss leading to complete loss of bone support. Schwartz-Arad and co-workers indicate 
that pattern two (2) can be related to CaP-coated dental implants, demonstrating a 
low rate of bone resorption during the first few years followed by significant marginal 
bone loss as can occur over a short period.19 A retrospective study by Artzi et al., 
underlines this proposed pattern of bone loss around CaP coated implants.15 Their 
long-term observations demonstrated significant differences between accumulative 
survival and success after 10 years of follow-up (p<0.05).
 Based on these publications, progressive peri-implant bone resorption and 
decreased implant success in time were hypothesized (H1). Therefore, it is of clinical 
relevance to appraise the relevant literature to elucidate the bone resorption dynamics 
of CaP-coated dental implants in time. The aims of the current review were (1) to 
systematically appraise, and (2) to evaluate long-term success data of calcium 
phosphate plasma-spray coated dental implants in clinical trials published between 
2000 and 2013.
Materials and methods 
Outcome variables
To describe the long-term qualitative efficacy of functional implants, the outcome 
variables a) percentage annual complication rate (ACR) and b) percentage cumulative 
success rate (CSR) were determined, as presented in the selected articles.
Search strategy
A systematical online and manual search was performed in the electronic databases 
of the National Library of Medicine (http://www.ncbi.nlm.nih.gov), The Cochrane 
Central Register of Controlled Trials and the ISI Web of Knowledge for articles on 
human trials, published in English between 2000 and 2013. The following research 
question was formulated an entered into the Pubmed.com search- engine: “(CaP[All 
Fields] OR (“calcium phosphate” [Substance Name] OR “calcium phosphate” [All Fields]) 
OR (“durapatite” [MeSH Terms] OR “durapatite” [All Fields] OR “hydroxyapatite” 
[All Fields]) OR (“durapatite” [MeSH Terms] OR “durapatite” [All Fields] OR 
“hydroxyapatite” [All Fields])) AND (“dentistry”[MeSH Terms] OR “dentistry” [All Fields]) 
AND Implants [All Fields] AND (“humans”[MeSH Terms] AND English [lang] AND 
(“2000/01/01”[PDAT]: 2013/11/30”[PDAT])). In addition, manual search was performed 
of the bibliographies of all full-text articles and related reviews, selected from the 
electronic search.
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Inclusion of studies 
Titles and abstracts from the search were initially screened by two independent 
reviewers (BO and RJ) for possible inclusion. A data extraction form was used by the 
reviewers for independent full text analysis. Any disagreement between the reviewers 
regarding data extraction were resolved by discussion.
Inclusion criteria
Human trials eligible for inclusion were verified according to the following criteria 
(Table 1a):
1  Randomized controlled clinical trials (RCT), prospective clinical trials (PCT) as 
well as retrospective analysis of cases (RA) with a minimum 5-year follow-up;
2  Studies with at least 10 subjects;
3 Studies reporting on cumulative implant success data (CSR) that clearly 
presented implant success data as overall percentage or as life-table analysis;
4 Studies that reported on patients with untreated periodontitis had to be excluded;
5  Studies that used barrier membranes or grafting procedures (i.e. bone or bone 
substitute) were not applied.
Supplementary quantitative data synthesis
The goal of this study was to estimate, year by year, the long-term success of calcium 
phosphate plasma-spray coated dental implants over a 10 year period. This estimate 
is the result of a multi-stage process starting with a series of 10 meta-analyses, one 
for each year in the follow-up period. The included studies generally report on 
complication rates and implant success after the first year of function and multiple 
years thereafter. First an annual complication rate was calculated for each interval in 
each study. By assuming that the annual complication rate (ACR) is constant over 
such a period of time, each study can contribute an ACR for any given year, as long 
as that year is in the follow-up period for that study. Subsequently, for each of the 10 
years, a meta analysis was done to estimate a weighted average of the ACR for that 
year. Weighing was done with the reciprocal standard error variances and tested for 
homogeneity. If homogeneity was rejected at a level of 0.05, a random effect model 
was used. If not, a fixed effect model was applied. After analysing an ACR and its 
standard error was available for each year (Table 3). Finally, in order to explore the 
effect of the chain of complication rates and their respective standard errors on the 
level of success at a certain point in time, no analytical methods are availble to our 
knowledge. Therefore the proces was simulated, as previously described by Van 
Oirschot et al.14 As statistical software both for the meta-analyses as well as the 
simulation, statistical software R, version 3.0 was used.
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Results
Study selection
The electronic search in the database of the National Library of Medicine, The 
Cochrane Central Register of Controlled Trials and the ISI Web of Knowledge, yielded 
645 titles. No additional publications were identified by manual search. A subsequent 
title and abstract exploration resulted in the identification of 20 full text articles. The 
characteristics of the selected studies are shown in Table 1a. On basis of the inclusion 
criteria, 12 studies were excluded  for reasons mentioned in Table 1b.20-32 Finally, 
eight articles were selected for further analysis.9,15,19,23,33-36 No additional publications 
were identified by manual search for inclusion. In the reviewed studies different 
criteria for success were applied. However, implant success was always defined by a 
set of success criteria including parameters such as immobility of the implant when 
tested clinically, no evidence of peri-implant radiolucency, no persistent pain, no 
discomfort, no infection, as well as maximum values for the amount of acceptable 
marginal bone loss. In principle, the success criteria used in the different studies 
varied only regarding thresholds for the maximum values of marginal bone loss that 
was accepted after a certain time period. The applied success criteria and upper 
limits for the amount of marginal bone loss (MBL) within the different studies are 
presented in Table 2.
Characteristics of included studies
Eight studies were included in the systematic review. The characteristics of the 
selected studies are shown in Table 1b and 2. A randomized controlled clinical trial by 
Tinsley et al. had the highest level of evidence.9 Four were prospective clinical 
trials23,33,34,36 and three retrospective analyses  (Table 1a).23,33,34,36,15,19,35 In five 
publications, life tables were used to report on cumulative implant success,9,23,33-35 
whereas in three papers15,19,36 overall percentages were used.15,19,36 In six of the 
included studies, inclusion and exclusion criteria were described for patient 
selection.9,15,23,33,34,36 In general, patients who were excessive smokers or had active 
periodontal disease or cases that needed bone augmentation procedures, were 
excluded. Additionally, considerable variation existed between the included research 
papers with regard to implant system used, implant diameter, implant configuration, 
implant length, anatomical region of implant placement (i.e. maxilla, mandible, 
anterior, posterior) and thereby bone quantity as well as bone quality, loading 
protocol, overall treatment protocol, age range, number of included subjects, as well 
as drop outs. In six studies, implants were placed in the upper and lower jaw.15,23,33-36 
Whereas in two studies, implants were only placed in the maxilla19 or mandible.9 Four 
of the studies15,19,23,36 used well esthablished crtiteria by Albrektsson et al.,16 one9 
used criteria by Spiekermann et al.37 Whereas three studies used self defined criteria 
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for implant success.33-35 In principle, the success criteria used in the different studies 
were comparable and varied only regarding the maximum values for the amount of 
marginal bone loss that was accepted after a certain time period. All eight included 
studies reported on cumulative success rates after 5 years. Four publications 
presented implant success after 6 years9,19,23,35 and three papers reported on 
success up to 12 years (Table 2).15,19,33 In 5 publications significant progressive bone 
loss adjacent to calcium phosphate coated implants was observed, leading to a 
decrease in implant success on the long-term.9,15,19,33,35 Cumulative success rates 
after 5 years ranged from 86% to 97.4%.9,34 Whereas after 10 years cumulative 
success rates dropped, ranging from 82%  to 54%.15,33 After 10 years of follow-up, 
Artzi et al. reported that 24.8% of the surviving implants were considered as 
unsuccessfull because of clinical complications. Tinsley et al. reported after 6 years 
of follow-up that 17% of the implants were failing according to their criteria due to 
progressive bone loss.
Statistical analysis
The estimation of overall success percentage could finally be established on data 
retrieved from six studies.15,23,33-36 For maxillary implants, data from four papers15,19,34,35 
and for mandibular implants data from four reports were used.9,15,34,35 For overall 
estimates of weighted mean annual complication rates (ACR) heterogeneity was found 
and explained by the anatomical site of implantation (i.e. maxilla versus mandible). 
On the other hand, for none of the 10 years under investigation, homogeneity has been 
rejected for studies that reported on either maxillary or mandibular data. The estimates 
of weighted mean ACR for upper and lower jaw are presented in Table 3. It was 
estimated that during the first year of function the weighted mean ACR-percentage 
was 1.6 (SE: 0.6) in the maxilla and 0.8 (SE: 0.4) in the mandible. Accordingly, the 
percentage of successful implants after the first year was estimated to be 98.4% 
in the maxilla and 99.2% in the mandible. The estimates of the weighted mean 
ACR-percentage increased over the years up to 2.6 (SE: 0.7) during the fifth year of 
function for the maxilla, to 9.4 (SE: 8.4) for the mandible in the tenth year.
 After 10 years, the mean percentage of successfull implants was estimated to be 
71.1% in the maxilla and 72.2% in the mandible (Table 3). The per year estimates of 
the percentage of successful implants with the corresponding lower and upper 
borders of the intervals of the estimates are presented in Figure 1a-c.
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Figure 1  Estimates of a) the overall percentage of mandibular and maxillary successful 
implants; b) the percentage of maxilary implants, and c) the percentage of mandibular 
successful implants.
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Discussion
CaP-coated implants can have short-term biological benefits in terms of higher bone-
to-implant contact and early peri-implant bone formation in comparison to non-coated 
implants.4,5,38 Still, the clinical use of this type of implants remains controversial 
because of coating-related biological complications in long-term follow-up. Therefore, 
an electronic search from January 1st 2000 up to November 1st 2013 was conducted 
for English language articles on long-term clinical success of calcium phosphate 
plasma-spray coated implants. The objectives of the present review were (1) to 
systematically appraise, and (2) to evaluate long-term success data of calcium 
phosphate plasma-spray coated implants in clinical trials. It was hypothesized (H1) 
that annual complication rates increase and consequently accumulative success rate 
decreases on the long-term.
 Statistical analysis demonstrated that the determined estimates of weighted 
mean percentage annual complicatoin rates were relatively low after 4 years (range: 
0.4 – 1.6), whereas after 10 years the percentages increased to 7.5% for the maxilla 
and 9.4% for the mandible. These estimates seem to confirm the proposed, long term 
progressive bone loss pattern of CaP-ceramic coated dental implants. Hence, we tend 
not to reject the H1-hypothesis of increasing annual complication rates synonymous 
with decreased accumulative success rates on the long term.
 The long-term efficacy of dental implants is commonly described in terms of 
survival rate and/or success rate. A previous meta-analytical review on the long-term 
survival of CaP-coated implants report estimated overall implant survival rates of 
>88% after 10 years.14 This is comparable to survival data of non-coated implants. 
Survival rate is ususally defined as implants that are asymptomatic and in function12,13 
and does not reflect the level of bone fixation.12,13 Potential progressive peri-implant 
bone loss, which can jeopardize the long-term survival is irrelevant in this definition.12 
Success rates are based on more definite clinical and radiographic criteria, including 
the level and time course of marginal bone resorption. However, a comparison in 
terms of long-term implant success is complex, since no consensus for implant 
success criteria is available.39 Success criteria by Albrektsson et al., which are often 
used as gold standard for implant success, state that the marginal bone loss (MBL) 
should not exceed 1.5 mm in the first year of function and 0.2mm on each subsequent 
annual year16,17 In a retrosprective study by Artzi et al. in 2006, it was concluded that 
after short term follow-up (5yr) CaP-coated implants showed a high success rate. 
However, a significant difference could be observed between implant survival and 
success after long-term obervation.15
 In the present review, cumulative success rates after 5 years, as reported in the 
included studies, ranged for mandibular implants from 86%  to 97.4%.9,34 For maxillary 
implants this was 86.7% to 98.0%.15,19 The amount of marginal bone loss was not 
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always presented and could not be calculated according to the MBL-criterion outlined 
by Albrektsson et al. (1994). Furthermore, different success criteria were used based 
on either Albrektsson et al. (1994), Spiekermann et al. (1995) or self-defined criteria. 
Considering an observation period of more than 5 years, the overall cumulative 
success rate ranged from 54% to 82%.15,33 Similar to the observation period of 5 years, 
the amount of marginal bone resorption was not always presented. Interesstingly, 
four of the included studies on the long-term efficacy of CaP dental implants, reported 
a significant and progressive bone loss adjacent to calcium phosphate coated 
implants after 6 years.9,15,19,33 That means that the CaP-coated implants under study 
developed progressively increasing annual complication rates. As already mentioned 
above, statistical analysis demonstrated that the determined estimates of weighted 
mean percentage annual complicatoin rates were relatively low after 4 years (range: 
0.4 – 1.6), whereas after 10 years the percentages increased to 7.5% for the maxilla 
and 9.4% for the mandible. Hench, these estimates seem to confirm the proposed, 
long term progressive bone loss pattern of CaP-ceramic coated dental implants. 
However, it should be kept in mind, that the presented estimates of the weighted mean 
percentage annual complication rates and corresponding errors were calculated on 
a limited number of reports and considerable variation existed between the studies 
regarding study design, implant systems used, jaw region, loading protocol and years 
of follow-up.
 In line with the findings of increasing annual complication rates synonymous with 
decreased accumulative success rates on the long term are the results of a previous 
study by Schwartz-Arad et al. (2005). Within this publication a hypothetical marginal 
bone loss pattern for CaP-coated dental implants was suggested. This pattern was 
characterized by a low rate of bone resorption during the first years followed by a 
significant marginal bone loss long term. The 5 year results in the present review 
seem to substantiate the hypothesized low rate of marginal bone loss for CaP-coated 
dental implants during the first years after installation.18 However, the presented 
results after 12 years are more difficult to interpret. The included population in this 
study consisted of 120 individuals treated from 1988 to 1997. A total of 232 HA-coated 
implants were placed in the maxilla. Mean follow-up was 60 months (SD: +/- 32.3 
months) with a range of 12 to 152 months. However, success rates were not presented 
and the given MBL data seemed to represent values corresponding to the mean 
observation period of 60 months. Hence, it is not feasible to give a meaningful 
interpretation regarding the long-term performance of the used implants.
 Significant differences between long-term survival and success rates of CaP-coated 
implants may involve coating related complications. For the present meta-analysis, 
only long-term clinical studies on plasma-sprayed CaP coatings could be obtained. 
These coatings can vary in thickness (ranging from a few micrometers to a few 
millimeters), composition and cristallinity. The discrepancy in dissolution rate between 
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the various coating components can cause internal stress in the coating. Subsequent 
coating-delamination or failure of the coating-implant interface can then negatively 
influence the long-term implant maintenance.15 Also, it has been demonstrated that 
soft-tissue invasion can occur due to coating degradation.40 Furthermore, it has been 
suggested that plasma sprayed CaP-coated implants, when exposed to the oral 
cavity, are more at risk for bacterial infection and peri- implant bone resorption.41 
Consequently, when bone resorption does occur, it is more rapid and progressive 
due to the presence of the coating.18 Therefore, other coating techniques, such as 
magnetron sputter-deposition, sol-gel coating or biomimetic precipitation have been 
developed to overcome the above mentioned technical complications. With these 
improved coating techniques, it is possible to produce thinner, well adherent coatings 
with a high degree in cristallinity, without negatively influencing the bioactive properties of 
the coating.42 Multiple short-term pre-clinical studies demonstrated that magnetron 
sputtered CaP-coatings have a beneficial effect on early peri-implant bone formation 
in comparison to non-coated Ti surfaces,43, 44 without causing long-term complications 
in the second stage of osseointegration.45 However, clinical studies are still needed 
to evaluate the long-term behavior of these coatings in humans.
 Progressive peri-implant bone loss is not only ascribed to the presence of a 
plasma-sprayed calcium phosphate coating. There is evidence that also implants 
without a surface coating show progressive bone loss on the long-term.39 In a recent 
systematic review about the longevity of teeth and implants, Tomasi and co-workers 
(2008) found in prospective studies on the long-term survival of titanium implants 
(observation period of 10 to 20 years), survival rates of 82% to 99%.46 Artzi et al. 
(2006) found a similar survival rate (92.8%) for CaP-coated implants after 10 years. 
Still, according to the used success criteria by Albrektsson et al. (1994), the reported 
success rate of 54% after 10 years of follow-up may be indicative that the survival 
rates go downward on a long time basis. Therefore, future reports on the survival rate 
of implants within this study population will be helpful to rule out, whether the 
MBL-criterion according to Albrektsson et al., is a valid tool to estimate the long-term 
performance of CaP-coated dental implants.
 Furthermore, it needs to be adressed that these success criteria by Albrektsson 
(1994), used in a certain number of the included studies for this review, were disputed 
during the 7th European Workshop on Periodontology (2010). It was discussed by 
several experts that progressive marginal bone loss always follows peri-implant 
infection and should not be accepted after the initial bone remodelling fase. Finally, 
with the development of new implant sytems and modified implant-abutment 
connections, new parameters have been introduced to assess implant success.47-49
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Conclusion
Within the limits of this meta-analytic approach to the literature, we conclude that: (1) 
published long-term survival and success data for calcium phosphate plasma-spray 
coated dental implants are limited, (2) comparison of the data is difficult due to 
differences in success criteria among the studies, and (3) long-term cumulative 
success rates demonstrate very weak evidence for progressive complications around 
calcium phosphate plasma-spray coated dental implants.
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Introduction
Oral implants, generally made of pure titanium or titanium-based alloys, are widely 
used in the prosthetic rehabilitation of fully and partially edentulous patients. 
Furthermore, multiple long-term clinical studies on implant survival report on high 
clinical survival rates, reaching up to 100% after 5 years in function.1 The ultimate goal 
in implant therapy is to achieve an early and strong implant fixation into the native 
surrounding bone tissue. Although titanium is commonly used as a favorable bone 
implant material due to its mechanical properties, its bioactive and osteoconductive 
capacity are relatively low.2 Therefore, implant surface modification experiments intend 
to improve the early process of osseointegration, as characterized by an increased 
bone-to-implant contact and enhanced bone volume in the area surrounding the 
implant.3 For this purpose, different surface modification approaches have been 
explored to optimize the interaction between implants and native bone tissue. By 
altering either surface topography (i.e. gritblasting and acid etching) or changing the 
physicochemical properties of the surface (i.e. coating deposition), both the bioactive 
and osteoconductive properties of the surface can be improved.4 
 In view of topographical approaches, it is generally accepted that moderately 
roughened titanium implants have a superior influence on the bone response in 
comparison to polished ‘smooth’ implant surfaces.4 Alternatively, physicochemical 
surface alterations, such as coating deposition with osteopromotive compounds, 
have been shown to be of special interest in the contemporary field of research.5,6 
Calcium phosphate ceramics, predominantly hydroxyapatite (HA), are commonly 
used for this purpose.5 Multiple short in vivo animal studies on calcium phosphate 
coatings have indicated that the deposition of calcium phosphate onto metal implants 
enhances early bone remodeling due to the formation of a biological apatite layer that 
is formed after implant placement.7 Beside CaP ceramics, bioactive glasses (BGs) 
have been proposed to stimulate bone formation.8,35 BGs have been reported to 
possess superior bioactive properties compared to CaP.10 Additionally, it has been 
demonstrated that BGs are not only capable to directly bond to bone,11 but also have 
an osteopromotive effect on cells due to the formation of a hydrated silica layer and 
hydroxyl carbonate apatite (HCA) on the glass surface that resembles the inorganic 
phase of bone.12 In view of this, Gao and co-workers13 analyzed in vitro the effect of 
silica layers on cell behavior and reported enhanced osteoblast proliferation and 
 differentiation, concluding that bone growth on BG involves stimulatory mechanisms 
originating from both a chemical and a biological nature. Despite desirable biological 
characteristics, the use of BGs as a coating material for bone implants has been 
limited, due to the fact that BG-based coatings show low adhesive properties owing 
to the lack of chemical bonding between the glass and titanium substrates.14 In view 
of this, it has been suggested to co-deposit BG and HA in order to enhance the 
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adhesive properties of the coating.9,15 BG can be easily co-deposited with HA using 
radiofrequent (RF) magnetron sputtering, which generates thin, homogenous, 
well-adherent coatings onto titanium.16 Additionally, deposition via RF magnetron 
sputtering straightforwardly allows variations in the composition of HABG-sputter-
coatings by only adjusting the individual power on the target materials. Several studies 
have shown encouraging cell response on these composite coatings in vitro.17 
However, data on the in vivo performance of these coatings remain limited.15 In view 
of this, the aim of the current study was to evaluate the biological performance of 
HABG-sputtercoatings deposited on commercially available dental implants in a dog 
mandibular implantation model by histological and histomorphometrical analysis.
Materials and methods
Materials 
Forty eight (48) commercially available cylindrical titanium implants were kindly 
provided by Biocomp® Industries BV (diameter: 3.4 mm, length: 10 mm; Vught, the 
Netherlands). The implants featured a 2.0 mm region of microthreads, followed by 2.0 
mm conical screw-thread, a 2.0 mm smooth region, and a 2.0 mm screw-thread 
close to the apex of the implant. All were grit-blasted and acid-etched. Before coating 
deposition, the implants were cleaned ultrasonically in acetone (15 min) and isopropanol 
(15 min) and thereafter air-dried.
 For coating deposition, hydroxyapatite granulate (particle size 0.5-1.0 mm; Cam 
Bioceramics BV, Leiden, the Netherlands) and bioactive glass S53P4 (particle size 
90-315 µm; Vivoxid Ltd. Turku, Finland) were used.
Coating procedure
Coating deposition was performed using a commercially available RF magnetron 
sputter unit (Edwards High Vacuum ESM 100 system, Sussex, UK) as described 
previously (Wolke et al. 2005). Two materials (i.e. HA and BG) served as simultaneous 
targets for coating deposition to generate the experimental groups shown in Table 1.
 After coating deposition, all implants received an additional heat-treatment (HT) 
for 2 hours. The HA-coatings were heated at 650°C in an infrared furnace (E4-10-P, 
Research Inc. MN, USA). The composite HABG-coatings were heat treated at 550°C 
in a chamber furnace (UAF, Lenton, Hope Valley, England). As last step, all implants 
were sterilized by autoclavation (for 15min at 121°C) and stored at room temperature.
Coating characterization  
The composition of the deposited coatings was determined by Fourier-transform 
infrared spectroscopy (FTIR, Perkin- Elmer, Massachusetts, USA) and X-ray diffraction 
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(XRD, Philips θ-20 diffractometer). Average surface roughness values (Ra) and 
coatings thicknesses were analyzed by a Universal Surface Tester (UST; Innowep, 
Wurzburg, Germany).
Animal model and implantation procedure
Sixteen adult Beagle dogs (1-2 years old, weight 10-12 kg) were used. The research 
protocol was approved by the ethical committee of King Saud University (Riyadh, 
Kingdom of Saudi Arabia) and national guidelines for care and use of laboratory 
animals were observed. The animals were anesthetized and after intubation, general 
anesthesia was maintained with Isoflurane® (Rhodia Organique Fine Limited, 
Avonmouth, Bristol, England). To reduce peri-operative bleeding, local anesthesia 
(40 mg/ml xylocain; 5 µg/ml epinephrine) was given. The animals used in this study 
received mandibular implants from two experimental set-ups, of which each used 
one side of the mandible. The outcome of the other experiment are described 
separately elsewhere.
Extraction phase
Three premolars (P2-4) were delicately removed on the right side of the mandible. 
First,  hemisection of the roots was conducted by drilling a vertical sleeve. After 
reflection of a full thickness mucoperiostal flap, under direct vision the roots were 
removed by using elevators and forceps to prevent trauma of the alveolar rigde or 
labial bone. Intra- and postoperatively, a prophylactic dose of clindamycine (11 mg/
kg body weight) was administered for 10 days. Healing time for the extraction sockets 
was three months.
Implantation; time schedule
In the right side of the mandible of the 16 Beagle dogs in total, 48 implants were 
placed. Each animal received one implant of each experimental group. Implants were 
placed, according to a rotating randomized schedule, changing the sequence in 
implant location from mesial to distal for each dog (3 implants were placed per dog 
Table 1  Overview of the experimental groups that were generated after coating 
deposition by RF magnetron sputtering and additional heat treatment.
Group Target 1
(power)
Target 2
(power)
Deposition time
(hrs)
Heat treatment 
(°C)
HA HA (400W) HA (400W) 2.5 650
HABGLow HA (300W) BG (100W) 7 550
HABGHigh HA   (50W) BG (100W) 20 550
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at the right side of the mandible, resulting in 8 implants per group per observation 
period). Two implantation periods were used, i.e. 4 and 12 weeks.
Implantation procedure
Before surgery, the soft tissues were cleaned with a 10% Povidone-iodine. After a 
midcrestal incision and retraction of the soft tissues, the recipient sites were prepared 
according to the guidelines provided by the manufacturer (Biocomp® Industries BV). 
First, three pilot holes (diameter: 2.0 mm, depth: 10mm) were prepared. Subsequently, 
the cavity was gradually widened using drills with increasing diameter until the final 
diameter for implant placement was reached (diameter: 2.8mm; depth: 10mm). 
During low rotational drilling (maximum of 1200 rpm), continuous external irrigation 
(sterile 0.9% physiological saline) was applied. After preparation, the holes were 
cleaned and the implants manually placed. Subsequently, coverscrews (Biocomp® 
Industries BV) were placed and the soft tissues were closed with resorbable sutures 
(Vicryl® 4-0; Ethicon Products, Amersfoort, the Netherlands; Figure 1). To reduce 
post-operative pain, all dogs received a subcutaneous injection with Finadyne® 
and a broad spectrum antibiotic (Gentamycin 4mg/kg body weight) was given intra-
muscularly for 7 days.
Histological preparation 
After 4 and 12 weeks of healing, the dogs were euthanized by an overdose of sodium 
pentobarbital. The mandibles were removed and put into fixative of 10% neutral buffered 
formalin solution. Radiographs were made in bucco-lingual direction to identify the 
exact implant position. All specimens were dehydrated in a graded series of ethanol 
(70-100%) and eventually embedded in methylmethacrylate (MMA). Thin longitudinal 
sections (10-15 µm) were made in a bucco-lingual direction using a modified sawing 
microtome technique18 and stained with methylene blue/basic fuchsin.
Histological and histomorphometrical analyses
Histological evaluation was performed using a Zeis Axio Imager transmission light 
microscope. Histomorphometry was performed using digital image analysis software 
(Leica Qwin Pro- image Leica Imaging Systems, Cambridge, UK).
Three quantitative parameters were assessed: 
(a)  Percentage of bone to implant contact (BIC%). Bone contact was analyzed 
along the total length of the implant, starting at the first coronal microthread up 
to the apex of the implant. BIC% was defined as the percentage of the implant 
surface in direct contact with bone without intervening fibrous tissue layers;
(b)  Percentage of the peri-implant bone area (BA%). The relative bone area around 
the implant was analyzed in a rectangular region of interest (ROI) at the flat part 
of the implant (Figure 2). In addition, the ROI was divided in three zones, for 
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which separately the BA% was analyzed; an inner zone (I: 0-500µm), a middle 
zone (M: 500-1000µm) and an outer zone (O: 1000-1500µm). All measurements 
were performed for both sides of the implant on three histological sections per 
implant.
(c)  First bone-to-implant contact (1st BIC): The 1st BIC was defined as the distance 
between the implant shoulder (without coverscrew) and the most coronal bone-
to-implant contact (Figure 3). 
Statistical analysis
All measurements were statistically evaluated using GraphPad Instat version 3.10 
(GraphPad Software Inc. San Diego, CA, USA). Mean values and standard deviations 
(SD) were calculated. The method of Kolmogorov and Smirnov was used to confirm 
that the data were sampled from populations that follow Gaussion distributions. For 
Figure 1a-c  (a) preparation of osteotomies. (b) The implants installed and (c) closed 
by coverscrews.
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comparison of data, repeated measurements of one-way analysis of variance 
(ANOVA) were used with a Tukey’s post-hoc test.  Additionally, unpaired t-tests were 
performed for each experimental group to determine differences between the two 
implantation periods (4 and 12 weeks). Differences were considered statistically 
significant at p<0.05.
Results
Coating surface analysis 
XRD characterization and FTIR analysis corroborated earlier data by Wolke et al. 
showing that all as-sputtered coatings had an amorphous structure.16 After heat 
treatment (650°C), only the HA coating altered into a random orientated crystalline 
apatite structure with specific reflection peaks at 2θ= 25.9°,31,9°,32.4° and 34.0°. 
FTIR analyses showed for all HA and HABG coatings a cluster from 800-1150 cm-1 
attributed to the presence of phosphate peaks. Additionally, the HABG coatings 
showed a cluster from 550-600 cm-1 attributed to the presence of silicate peaks (data 
not shown). Final roughness of the coated implants ranged from Ra= 1.5 to 2.1µm 
Figure 2a-b  (a) Schematic representation of the quantification of relative bone area 
(BA%) in the region of interest (yellow box) and (b) the division in three different zones: the 
inner zone (I:0- 500µm), the middle zone (M:500-1000µm) and the outer zone (O:1000- 
1500µm).
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(HA=2.1µm; HABGLow=2.0µm; HABGHigh=1.5µm). Coating thickness varied for 
coating type; HA=0.6µm; HABGLow=2.0µm; HABGhigh=3.0µm.
Animal experiment
General observations
For all animals, the healing periods after tooth extraction and implant placement were 
uneventful. The soft tissues around the implants after 4 and 12 weeks did not show 
any sign of inflammation or adverse tissue reactions. All 48 implants were retrieved. 
However, three of the implants (one 4 week HABGLow implant, one 12 weeks HABGHigh 
and one 12 weeks HA) could not be used for evaluation due to implant loosening 
during histological processing.
Histological evaluation
A histological representation of the three experimental groups (HA, HABGLow  and 
HABGHigh) after 4 and 12 weeks of healing is shown in Figure 4.
4 weeks healing period
Analysis of the histological sections after 4 weeks revealed an intimate contact 
between implant and surrounding bone without any intervening layers of fibrous 
Figure 3  Schematic representation of the first bone-to-implant contact (1st BIC), defined 
as the distance from the implant shoulder, without measuring the coverscrew (1), to the 
most coronal bone-to-implant contact (2).
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tissue (Figure 5a) for all experimental groups. In more detail, newly formed bone, as 
characterized by the formation of trabeculae, could be observed on the implant 
surfaces (Figure 5d). Although bone formation was present in all experimental 
groups, the HA-coated implants showed a more uniform and continuous pattern in 
comparison to the composite HABG groups. Occasionally crestal bone resorption 
Figure 4  Histological representation of the three experimental groups (HA, HABGLow  
and HABGHigh) after 4 and 12 weeks of healing.
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could be observed, independent of the experimental group. As a result, micro threads 
at the coronal part of the implants were covered with soft tissues (Figure 5b). In some 
of the specimens the outline of the final drill at the apex of the prepared hole was still 
visible (Figure 5c).
12 weeks healing period
After 12 weeks, maturation of bone surrounding the implants could be observed by 
replacement of woven bone by lamellar bone as well as by the development of 
osteons close to the surface of the implant (Figure 6a). In more detail, ongoing osteo-
conductive bone formation into the grooves could be observed for most of the HA 
and HABGLow coated implants (Figure 6b). Less pronounced bone formation and 
maturation had occurred for the HABGHigh group, especially into the grooves of the 
implant (Figure 6c). In some specimens of the latter group, fibrous tissue could be 
observed along the contour of the implant (Figure 6d).
Figure 5a-d  These images illustrate the histological observations at the 4 week 
timepoint for all three experimental groups (HA, HABGLow and HABGHigh). (a) A tight 
connection with the native surrounding bone and the middle flat part (yellow box) 
of the implants. (b) Occasional bone resorption at the crestal level of the implant. 
(c) The outline of the final drill (yellow dashed line) at the tip of the osteotomie. (d) Woven 
bone close to the implant surface along the contour of the implant.
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Histomorphometrical analysis
4 weeks healing period
After 4 weeks of healing, BIC% measurements exhibited similar mean overall 
percentages for the HA (41.5% ± 19.7) and HABGLow coated implants (45.1% ± 19.3). 
Mean BIC% for the HABGHigh coated implants was 29.7% ± 12.5, which was 
significantly lower (p<0.05) in comparison to both HA and HABGLow coated groups 
(Figure 7).
 Mean values for overall BA% showed comparable values for both the HABGLow 
(58.3% ± 12.2) and HABGHigh (56.3% ± 4.0) coated groups. Data suggest a trend 
toward a relatively higher amount of bone surrounding HA-coated implants (67.8% ± 
0.9), although this was only significant compared to the HABGHigh group (Figure 8a). 
When observing the BA values for the outer, middle and inner zone for both HABG 
groups, a decreasing trend in BA% was observed, although this was only statistically 
significant for the HABGLow-coated implants. For the HA-coated implants, the BA% 
was similar in each zone (Figure 8b).
Figure 6a-d  These images represent the 12 weeks timepoint. (a) Prolonged bone 
formation along the surface for the HA and HABGLow-coated implants. (b) Maturation 
of bone surrounding the implants with development of osteons close to the surface 
in a higher magnification for all experimental groups. (c) Invasion of soft tissues along the 
implant surface, observed for some of the HABGHigh-coated implants. (d) Encapsulation 
of the implant with aligned fibrous tissues in a higher magnification.
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 Further, 1st BIC measurements showed that after 4 weeks of healing, the distance 
ranged from 1.34mm (± 0.57) for the HA-coated implants, to 1.76 (± 0.89) for the 
HABGHigh-coated implants. No statistical differences were found between the 
experimental groups after 4 weeks (p>0.05. Figure 9). 
12 weeks healing period
After 12 weeks of healing, overall BIC% ranged from 40.5% to 31.1% with no significant 
differences between the experimental groups. Compared to the 4 week time point, 
no temporal differences were observed after 12 weeks (Figure 7).
 Means for BA% ranged from 58.2% to 69.4% with no significant differences 
between the experimental groups nor compared to the 4 week time point. 
Measurements for the three zones around the implant (i.e. inner, middle and outer) 
after 12 weeks revealed no significant differences between the HA and HABGLow 
groups. However, for the inner and outer zone around the HABGHigh-coated a 
significant difference (p<0.05) was observed (Figure 8c).
 Data on 1st BIC illustrate that after 12 weeks of healing no significant differences 
were found between the experimental groups (p >0.05; Figure 9).
Figure 7  Results of histomorphometrical and statistical analyses showing the 
bone-to-implant contact percentage (mean ± SD) after 4 and 12 weeks of healing. 
*=p<0.05.
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Figure 8a-c  Results of histomorphometrical and statistical analyses of (a) overall 
bone area after 4 and 12 weeks for HA, HABGLow and HABGHigh. (b) Bone area specified 
for three zones (i.e. inner, middle, outer) near the implant surface, after 4 weeks and 
(c) after 12 weeks. (mean ± SD). *=p<0.05; **=p<0.01.
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Discussion
The aim of this in vivo study was to evaluate the biological performance of dental 
implants coated with different ratios of hydroxyapatite (HA) and bioactive glass (BG) 
in a dog mandible model. The histological and histomorphometrical analysis after 4 
and 12 weeks of implantation demonstrated that, in terms of bone-to-implant contact 
and peri-implant bone area measurements, adding BG to a HA coating failed to 
improve the biological performance compared to reference HA coating.
 When comparing the biological behavior of HA and BG as coatings, the inclusion 
of an experimental group consisting of a pure BG-coated implant is a logical step. 
However, this was not possible as traditional coating methods have serious limitations 
as far a bioactive glass coating is concerned.19 It is known that weak adhesion of a 
coated surface can cause delamination or fracture of the coating, leading to an 
unfavorable in vivo response.20 The weak adherence of BG coatings can be related 
to the used coating method. During sputtering, the power needs to be relatively low 
to prevent melting of the BG (100W vs. 400W for HA). As a result, the speed of the 
transported ions is lower, which has an influence on the adhesion of BG to the titanium 
surface. Additionally, the adhesive strength of the coating is limited due to the 
absence of a chemical bond between the TiO2 of the implant surface and the silica 
(SiO2) in the BG. Consequently, adhesion of the pure BG coatings mainly depends 
on the mechanical bonding with the underlying titanium surface roughness, which is 
created after etching or grit blasting the surface.14,17 In view of this, it has been 
suggested to deposit coatings that combine HA and BG as target materials.9 Wolke 
et al.17 analyzed RF magnetron sputtered composite coatings with different compositions 
of HA and BG in vitro, and observed that these composite HABG coatings can 
overcome the adhesive drawbacks of pure BG coatings, while maintaining osteogenic 
Figure 9  Results of the histomorphometrical measurements of 1st BIC after 4 and 
12 weeks for the three experimental groups (HA, HABGLow and HABGHigh).
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properties. In these studies, rapid nucleation of a crystalline apatite phase was found 
after soaking these samples in simulated body fluid solution. It was stated that the 
formation of this apatite phase in vitro was indicative for the bioactive behavior of 
these coatings in vivo. Although the composition of our HABG coatings was based 
on these studies, the obtained data of our animal study did not meet these 
expectations. With respect to BIC% and BA% measurements, no additional effect 
was observed for the HABG-composite coatings in comparison to the pure HA-coated 
surfaces. In contrast to what was expected, implants with a high amount of BG in the 
coating (HABGHigh) showed even a significant lower BIC% after 4 weeks.
 Implant surface properties play an important role in the early phase of peri- 
implant osteogenesis. Therefore, surface modification experiments intend to optimize 
the biological response by tailoring either the surface topography (i.e. gritblasting, 
acid etching) or chemical properties (i.e. coating deposition) of the implant surface. 
It is generally accepted that moderately rough surfaces (Ra=~2µm) have a superior 
influence on the bone response in comparison to polished ‘smooth’ implant surfaces,4 
due to an increased surface area for cell adhesion and bone formation. Additionally, 
regarding surface chemistry, calcium phosphate coatings have the potential to 
improve the early bone response. The beneficial effect of these coatings is ascribed 
to the great resemblance of the implant surface to the mineral phase of native bone. 
Still, literature remains inconclusive whether surface topography or chemistry is the 
decisive parameter in peri-implant bone formation. Gan et al.21 conclude from a short 
term in vivo study on porous sintered titanium structures in the femoral condyle of 
New Zealand White rabbits, that surface chemistry rather than topographical changes 
enhance peri-implant bone ingrowth. Suh et al.22 underline these findings. After 6 
weeks of healing, significantly higher BIC% for the CaP-coated implants was observed 
in comparison to the roughened titanium implants. Fontana et al.3 on the other hand, 
compared titanium implants with a porous oxide, or Ca-P-coated surface in a rabbit 
animal model. They were not able to find a beneficial effect for CaP-coated implants 
in comparison to the control group in terms of BIC% and mechanical testing (RTQ). 
On the contrary, the oxidized surface demonstrated higher RTQ values than the 
Ca-P-coated implants after 2, 4 and 9 weeks of healing. The goal of the present in 
vivo study was to evaluate the effect of incorporating BG into HA coatings. However, 
it is difficult to change the chemical composition of the implants, without interfering 
with the surface topography. Implants used for this study were grit-blasted and 
acid-etched resulting in Ra values of ~2.3µm. During the coating process, micro-po-
rosities of these roughened titanium surfaces were covered with ions from only the 
HA or both the HA and BG target. The approximation of similar coating thicknesses 
was attempted by increasing the deposition time for BG-containing coatings (Table 
1), as the power for the BG target is limited to prevent melting. Although this resulted 
in thin ceramic coatings for all three groups (range 0.6-3.0 µm), the relatively thicker 
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BG-containing coatings apparently decreased the original surface roughness 
(HABGLow Ra= 2.0 µm; HABGHigh Ra= 1.5µm). This decrease in roughness and 
surface area might have negatively affected the biological performance of 
BG-containing coatings.
 In previous in vitro studies,17 it was shown that RF magnetron sputtering is a 
successful technique to deposit HA and composite HABG coatings with good 
mechanical properties. However, the elemental composition of the target material 
changed after sputtering. As such, the weight percentage of SiO2 in BG decreased 
from 52.7% to less than 40%.17 As known from literature, only BG with a 40-60% SiO2 
-weight percentage is considered to be osteopromotive.8,23 Also, the preferential 
sputtering of the target material and hence the decrease in concentration SiO2 below 
40%, may be the cause of absence of an additional effect on bone healing for both 
composite HABG coatings.
 Another important factor that needs to be considered, is the crystallinity of the 
sputter coatings. Several studies demonstrated that highly crystalline HA coatings 
have low dissolution rates in vitro24 and show high resemblance to the crystallites in 
native bone.25 This can enhance early bone formation26 and can have a positive 
effect on the differentiation of primary cells to osteoblasts.27 X-ray diffraction of our 
coatings showed that the RF magnetron sputtered HA coatings had a highly 
orientated crystalline apatite structure after heat-treatment. Histomorphometrical 
analysis in the present study confirmed that these HA coatings can stimulate early 
bone formation and evoke relatively high BIC% and BA% after both 4 and 12 weeks 
of implantation. Similar results regarding favorable early bone response around HA- 
coated implants have been reported by numerous in vivo studies.28,34 The composite 
coatings, on the other hand, demonstrated a more amorphous-crystalline structure 
after RF magnetron sputtering and heat-treatment. Although dissolution of the 
coatings was not analyzed in this study, degradation of the HABG can explain the 
reduced bone healing (i.e. bone contact and bone area) around the HABG-coated 
implants after 4 and 12 weeks. In vitro studies performed by Adams et al.29, underline 
that an increase in interfacial ions may lead to cell death and damage newly formed 
bone.
 The relative amount of bone was measured in three zones around the implant 
(i.e. inner, middle, outer). It has been suggested that changes in the inner and middle 
zone are related to the surgical procedure and the properties of the implant surface, 
whereas the relative bone area in the outer zone reflects the bone density of the 
implant site.6 After 4 weeks, BA% was similar for the inner, middle and outer zone 
around the HA-coated implants, showing that bone formation around the HA-coated 
implants was present. On the contrary, both HABG coatings had a tendency to have 
a decreased relative bone area toward the inner zone. After 4 weeks, this was 
significant for the HABGLow-coated implants, whereas after 12 weeks a significant 
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difference between the inner and outer zone was observed for the HABGHigh-coated 
group. As such, these observations indicate that the surface composition indeed 
affects bone formation and that this bone formation is inferior for HABG-composite 
coatings compared to HA coatings.
 The dog mandible is a suitable and commonly used model for the analysis of 
surface modifications of titanium bone implants.26,30 Histological examination 
showed bone formation around all implants after 4 and 12 weeks of healing, although 
occasionally significant loss of marginal bone height around the crestal part of the 
implants could be observed. The exact reason for this bone loss remains unclear, but 
might be related to the ratio of implant diameter and the width of the alveolar ridge. 
Previous studies on marginal tissue reactions after implant placement emphasize 
that the position of the implant in relation to the buccal bone is of crucial importance31,32 
and that the distance between the buccal wall and the implant should be at least 
2mm to maintain the alveolar bone level at the implant platform.32 In our study, 
however, the majority of the implants were placed within these 2 mm of the buccal 
bone. Another reason might be the reflection of the soft tissues and periosteum from 
the alveolar bone.33 
 The absence of significant differences after 12 weeks of healing between the 
experimental groups in terms of BIC% and BA%, do not correspond with recent in 
vivo studies by Xie et al.15 In these studies, the osseointegration of composite coatings 
with nano-HA and BG on titanium implants to conventional HA coatings in the 
femoral condyle of New Zealand rabbits was compared, for which they observed 
higher BIC% values for the HABG coatings after 12 weeks in comparison to the 
coatings without the addition of bioactive glass. This discrepancy might be related to 
differences in implantation site and animal species. The dog mandible is a well 
established animal model for the evaluation of peri implant bone healing in clinically 
comparable conditions.26,30 It can be hypothesized that the high bone quality and 
quantity at the implant site overshadowed a possible significant difference between 
the experimental group. 
Conclusion
Within the limitations of this study, it can be concluded that the incorporation of BG to 
a HA reference sputter coating does not enhance the biological performance of a 
dental implant in implantations sites with good bone quality and quantity. On the 
contrary, coatings containing high concentrations of BG resulted in inferior performance 
during the early post-implantation healing phase.
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Introduction
Dental implants have significantly increased the treatment possibilities in partially 
and fully edentulous patients. Although high survival and success rates have been 
reported1, still clinical failures are considerable in cases with reduced bone quantity 
and quality.2-4 With an aging world population, increasing numbers of implants are 
and will be placed in challenging conditions, e.g. characterized by poor wound 
healing due to diabetes, metabolic malconditions, radiation therapy and osteoporosis.5 
Implant success and survival will be seriously impaired in these conditions.6,7 In 
addition, to reduce patient discomfort and fulfill demanding patient wishes, early or 
even immediate loading protocols have been introduced, thereby introducing 
increased risks on implant failure.8-10 In all these cases, optimal initial implant stability 
and accelerated osseous fixation are crucial in maintaining implant stability during 
the healing phase and eventually to ensure sufficient load bearing properties of the 
implant.11.12 
 Primary implant stability is related to the total amount of bone-to-implant contact 
at the time of implant placement13 and is influenced by implant site related factors, 
such as bone quality, quantity and the ratio of cortical to trabecular bone.14 
Additionally, implant geometry, surface characteristics (e.g. topography, chemistry, 
surface charge, and wettability) as well as surgical technique are important 
parameters in the initial stability of the implant.15-17 After implant placement, primary 
implant stability decreases due to remodeling of (necrotic) bone, and simultaneously 
secondary implant stability increases by the formation of newly formed bone at the 
implant/bone interface. As a result, the stability pattern during the healing phase is a 
result of the dynamic process of primary and secondary bone-to-implant contact.18 
 In recent years, refinements in implant surface characteristics have proven to 
enhance the biological healing response at the implant-bone interface.19-20 These 
alterations focus on either surface topography (texture or roughness) or surface 
chemistry. There is consensus on the beneficial effect of surface roughening (titanium 
plasma spraying, grit blasting and anodization) on implant stability and bone healing 
because of surface area enlargement and enhanced cell attachment.21-24 
 Alternatively, coating deposition with bioactive ceramics, such as calcium phosphates 
(CaPs; predominantly hydroxyapatite, HA) are commonly used to enhance peri-implant 
bone formation. The bioactive properties of these coatings are based on the structural 
similarities to bone mineral and the formation of a biological apatite layer.25 Recently, 
bioactive glasses (BG) have been introduced as coating materials because of 
proclaimed superior osteopromotive characteristics in comparison to other bioactive 
ceramics.26-28 It has been demonstrated that BGs can form bone more rapidly due to 
the formation of hydrated carbonate apatite (HCA) and hydrated silica layers on the 
BG surface. These materials can not only improve the early bone response based on 
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structural similarities to the inorganic phase of bone, but can also form a chemical 
bond that has a favorable effect on osteoblast-like cell differentiation and 
proliferation.27,29-31  Unfortunately, it has been demonstrated that BG-based coatings 
possess low adhesive properties, since there is no chemical bonding between the 
glass (SiO2) and the titanium substrate.32 Alternatively, CO2 laser treatment has been 
used to create BG coatings, which retain bioactive properties of glass in terms of 
osteoconduction. However, CO2 laser derived glass coatings are brittle and relatively 
thick.28 Therefore, it was suggested to develop coatings that combine bioactive glass 
with a commonly used calcium phosphate ceramic, e.g. HA. Radio Frequent (RF) 
magnetron sputtering is a suitable procedure for the co-deposition of BG and HA.33 
RF magnetron sputtering generates well-adherent, thin and homogenous coatings. 
Mechanical testing and in vitro analyses have shown that these sputtered composite 
HABG coatings have appropriate adhesive properties that can overcome the 
mechanical drawbacks.34 However, available in vivo data of these coatings are 
limited.35 
 In addition, enhanced surgical techniques, such as undersized drilling protocols 
and bicortical implant placement, are suggested to increase initial implant stability 
and reduce the healing time before loading the implant.16.36 The latter technique is 
based on the fact that cortical bone provides superior primary implant stability over 
trabecular bone, because of a higher bone density, and higher elastic modulus in 
comparison to porous trabecular bone.37 In line with this, Sennerby and coworkers 
showed in a rabbit implantation model that the thickness of cortical bone penetration 
is correlated to the removal torque force.38 Although histomorphometrical data 
showed more bone around implants that were placed in trabecular bone, higher 
torque values were needed to mobilize the implants that were placed in cortical bone. 
Based on these results, it was suggested that bicortical implant placement is 
preferable for cases with low bone density.38 However, bicortical implant placement 
has been questioned in literature. Several clinical cases report on relative minor 
complications, such as rupture of the sinus membrane, up to even life-threatening 
emergencies because of damage to the sublingual or submental artery.39 Although 
surface modifications and surgical protocols may individually affect the osseointe-
gration process and implant stability, it has been indecisive which factor dominates 
the final bone response and clinical outcome.40 Hence, it seems crucial to expand 
the knowledge on the influence of the combined effect of both variables on the 
biological and mechanical quality of the implant/bone interface. Therefore, this in vivo 
study in the iliac crest of a goat was performed to determine whether the biological 
and mechanical properties at the implant/bone interface of screw-type dental 
implants are influenced by (i) the type of surgical technique used for implant 
placement (i.e. mono- vs. bicortical), and (ii) the presence of a bioactive HA- or 
composite HABG-coating.
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Materials and methods
Implant cleaning, coating deposition and characterization
Commercially available cylindrical screw-type titanium implants (diameter 4.0 mm; 
length 12 mm; Biocomp® Industries BV, Vught, the Netherlands) were used. All 
implants were grit-blasted using Al2O3 particles and acid-etched in nitric acid 10% 
(GAE). Subsequently, implants were cleaned ultrasonically in acetone (15 min) and 
isopropanol (15 min) and thereafter air-dried. HA and HABG composite coatings 
were produced by a commercially available RF sputter deposition system (Edwards 
ESM 100) as previously described in detail by Wolke et al.41 Hydroxyapatite granules 
(particle size 0.5-1.0 mm; CAM Bioceramics BV, Leiden, the Netherlands) and 
bioactive glass S53P4 (particle size 90-315 µm; Vivoxid Ltd. Turku, Finland) served as 
target materials, resulting in a coating thickness of ~2 µm (Table 1).
 After coating deposition, the HA-coated implants received an additional infrared 
heat treatment for 30 sec at ~650°C (Quad Ellipse Chamber, Model E4-10-P, 
Research Inc. Eden Prairie, MN, USA) as indicated previously.42 HABG- coated 
implants were heat treated at 550°C in a chamber furnace (UAF, Lenton, Hope Valley, 
England). Subsequently, all implants were sterilized by autoclavation (for 15min at 
121°C) and stored at room temperature. Before implantation, average surface 
roughness values (Ra) and coating thickness were analyzed on coated titanium disks by 
using a Universal Surface Tester (UST; Innowep, Wurzburg, Germany). Additionally, 
Fourier- transform infrared spectroscopy (FTIR, Perkin- Elmer, Waltham, Massachusetts, 
USA) and X-ray diffraction (XRD, Philips θ-20 diffractometer) to characterize the 
molecular and crystal structure of the coating.
Animals and surgical procedure
Eight healthy female Saanen goats (weight ~60kg, age ~24 months) were used. The 
research protocol was approved by the ethical committee of the Radboud University 
Nijmegen, Nijmegen, the Netherlands (RUDEC 2010-029) and national guidelines for 
care and use of laboratory animals were observed. Preoperatively and for 3 days 
after surgery, intramuscular injections of antibiotic Albipen® (Albipen 15%, 3ml/50kg 
pre-operative, Intervet BV, Boxmeer, the Netherlands) were administered to reduce 
Table 1  Topographic analysis of the implants used in the study.
Experimental Group Abbreviation Coating thickness (µm) Ra (µm)
Gritblasted/Acid-etched GAE - 1.32 ± 0.13
Hydroxyapatite HA 2.0 ± 0.1 1.43 ± 0.03
Hydroxyapatite/Bioactive glass HABG 2.1 ± 0.2 1.23 ± 0.04
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the risk of peri- and post-operative infection. The animals were anesthetized and after 
intubation, general anesthesia was maintained with Isoflurane® (Rhodia Organique 
Fine Limited, Avonmouth, Bristol, England). Before surgery, the soft tissues were 
disinfected with a 10% Povidone-iodine. The surgical approach was performed as 
described in detail by Schouten et al.43 In brief, on both sides of the vertebral column 
a transverse skin incision was made in lateral direction, starting from the anterior 
superior iliac spine towards the posterior superior part of the iliac crest. After 
separating the soft tissues and elevation of the underlying periosteum, the iliac crest 
was exposed. Subsequently, six pilot holes (diameter 2.0mm, depth 12mm) were 
made in the left and right iliac wing. Three holes were drilled on top of the iliac 
processus, for monocortical implant placement. Three other osteotomies were 
prepared on the frontal side of the iliac wing to ensure bicortical implant placement 
(Figure 1a). The osteotomies were gradually widened using low rotational drills 
(800rpm) with increasing diameter and continuous external cooling with sterile saline 
solution. The distance between the holes was 3-4 mm (Figure 1b). Implants were 
placed according to a randomization schedule (Table 2), for which every animal 
Figure 1a-b  Schematic illustration of the iliac crest and the surgical model that 
allows for mono- and bicortical implant installation. b) Clinical overview of the surgical 
procedure in the iliac crest; i) exposure of the bone ii) preparation of the osteotomies 
and  iii) implants placed mono- and bicortically.
A
B
i ii iii
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received three implants per implantation site, one of each experimental group (n=8). 
Although implants were placed manually, the final turn was performed by a Digital® 
torque gauge instrument (model MGT 50, Mark-10 Corporation, New York, USA) to 
measure the peak insertion torque values (ITQ) of all implants. Implants placed in the 
left iliac wing were used for removal torque testing (RTQ). Implants on the right were 
planned for histological and histomorphometrical analysis. Subsequently, cover - 
screws (Biocomp® Industries BV) were placed and the soft tissues were closed with 
resorbable sutures (Vicryl® 4-0; Ethicon Products, Amersfoort, the Netherlands). 
Finally, all goats received a subcutaneous injection with Finadyne® (Schering-Plough, 
Brussels, Belgium) to reduce post-operative pain.
Implant retrieval and analysis
After 4 weeks of healing, the animals were euthanized by an overdose of Nembutal® 
(Apharmo, Arnhem, the Netherlands), the iliac wings were harvested and divided into 
two groups. The left iliac wings were stored on ice for mechanical removal torque 
testing (RTQ) for the placed implants at the day of sacrifice. The specimens from the 
right iliac wings were fixed in 4% formaldehyde (7 days) and placed in 70% ethanol, 
for further histological processing.
RTQ measurements
Implant fixation was determined by measuring the peak removal torque force using a 
Digital® torque gauge instrument (model MGT 50, Mark-10 Corporation, New York, 
USA). Specimens from the left iliac wing were fixated in a mold with gypsum. The 
Table 2  Randomization scheme for implant location and experimental groups.
Left Right
Monocortical Bicortical Monocortical Bicortical
Goat 1 2 3 1 2 3 1 2 3 1 2 3
1   A B C* A B C A B C A B C
2 B C A B C A B C A B C A
3 C A B C A B C A B C A B
4 A B C A B C A B C A B C 
5 B C A B C A B C A B C A
6 C A B C A B C A B C A B
7 A B C A B C A B C A B C
8 B C A B C A B C A B C A
*A= GAE; B= HA; C=HABG
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instrument was attached to the internal connection of the implant. The instrument and 
mold were placed in a tensile bench to ensure perpendicular forces on the implant. A 
gradually increasing rotational force was applied until the bone-to-implant interface 
failed. The peak force at implant loosening was registered and used for statistical 
analyses.
Histological and histomorphometrical analysis
Specimens from the right iliac wing were fixed in 4% formaldehyde solution for one 
week, dehydrated, and embedded in methyl methacrylate (MMA) for histological and 
histomorphometrical evaluation. Non-decalcified, thin longitudinal sections (10-15 µm) 
were made (at least 3 per implant) using a modified sawing microtome technique65 
and stained with methylene blue/basic fuchsin. Cross- sections were made along the 
axis of the implant.
 To histologically analyze the bone/implant interface, sections were viewed, digitalized 
(at 20x magnification), and evaluated, using a Zeiss Axio Imager transmission light 
microscope. Quantitative measurements were carried out using a computer-based 
image analysis technique (Leica Qwin Pro-image analysis software; Leica Imaging 
Systems, Cambridge, UK). An individual region of interest (ROI) was determined per 
Figure 2  Schematic overview of the quantification of a) bone- to- implant contact 
(BIC%) and b) bone area (BA%). The amount of BIC% was defined as the percentage 
of direct contact between bone and implant surface (green). The relative bone area 
(BA%) was determined in three peri-implant regions (I: 0-500 µm; M: 500-1000 µm; 
O: 1000-1500 µm).
B
A
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section. The ROI originated from the top of the bony crest, along the axis of the 
implant, up to the final part of the implant that originally penetrated the iliac crest 
(Figure 2a-b). Within the ROI, bone-to-implant contact (BIC%) and the relative bone 
area (BA%) in three peri-implant regions (0-500 µm; 500-1000 µm; 1000-1500 µm) 
were determined for three sections per implant.
Statistical analysis
All measurements were statistically evaluated using GraphPad Instat version 3.10 
(GraphPad Software Inc. San Diego, CA, USA). Mean values and standard deviations 
(SD) were calculated. The method of Kolmogorov and Smirnov was used to determine 
if data were sampled from populations that follow Gaussian distribution. Paired 
T-tests were used to evaluate significant differences in bone morphological 
parameters (BIC%, BA%) between the different surface conditions. Additionally, 
paired T-tests were performed to determine differences in placement modality 
(mono- or bicortical). Spearman correlation coefficient was used to determine the 
correlation in RTQ-BIC% and RTQ-BA% for both mono- and bicortical implant 
placement. Differences were considered statistically significant at a probability value 
of P<0.05.
Results
Physicochemical characterization of the coatings
Physicochemical characterization of the coatings by X-ray diffraction (XRD) and FTIR 
analysis demonstrated an amorphous structure for the HA and HABG as-sputtered 
coatings without specific reflections. After heat treatment, XRD analysis (data not 
shown) confirmed that the HA-coating adopted a random orientated crystalline 
apatite structure with characteristic apatitic reflection peaks (2θ= 25.9°, 31,9°, 32.4° 
and 34.0°). The heat-treated HABG retained an amorphous/crystalline structure. FTIR 
analyses showed phosphate peaks present in both HA and HABG coatings, also 
silicate peaks could be observed for coatings in the latter group. Coating thickness 
for HA and HABG was ~2 µm. Surface roughness for the different surface conditions 
ranged between Ra= 1.2 and 1.4 µm (Table 1).
Clinical observations in vivo experiment
Surgical procedures were performed without complications. All animals remained in 
good general health during the experimental period without any clinical signs of 
discomfort or wound complications. At implant explantation after 4 weeks, no macroscopic 
adverse tissue reactions were apparent around the implant sites and all implants 
were retrieved.
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Mechanical testing of the implant/bone interface
Results obtained from insertion (ITQ) and removal torque (RTQ) measurements are 
schematically and graphically displayed in Table 3 and Figure 3. Mean ITQ for 
bicortical implants (38.2 ± 8.8 Ncm) was significantly higher (p<0.001) compared to 
monocortical implants (28.6 ± 14.2 Ncm). No significant differences in ITQ were 
observed regarding surface conditions, irrespective for the type of anchorage (Figure 
3a). After 4 weeks of healing, a significant decrease (p<0.05) in RTQ (21.0 ± 19.1 
Ncm) was observed for monocortical implants compared to ITQ (28.6 ± 14.2 Ncm). 
In contrast, bicortical implants showed similar ITQ and RTQ values (38.2 ± 8.8 Ncm 
and 40.1 ± 24.8 Ncm, respectively; p>0.05). RTQ values for bicortical implants (40.1 
± 24.8 Ncm) were significantly higher (p<0.001) compared to monocortical implants 
(21.0 ± 19.1 Ncm). No significant differences were found in RTQ regarding the 
different surface conditions, neither for mono- or bicortical implants.
Ta
b
le
 3
  C
om
pa
ris
on
 o
f i
ns
er
tio
n 
an
d 
re
m
ov
al
 to
rq
ue
 v
al
ue
s 
(m
ea
n 
±
 S
D
) f
or
 a
ll 
im
pl
an
ts
 s
ur
fa
ce
s 
(G
A
E,
 H
A
, H
A
B
G
) i
n 
m
on
o-
 a
nd
 
bi
co
rt
ic
al
 im
pl
an
t p
la
ce
m
en
t a
fte
r 4
 w
ee
ks
 o
f h
ea
lin
g.
P
ai
re
d 
T-
Te
st
a
M
ea
n 
±
 S
D
M
D
 (
95
%
 C
I)
P
 v
al
ue
 
In
se
rt
io
n 
To
rq
ue
 (
TR
Q
-in
)
M
on
oc
or
tic
al
G
A
E
29
.6
 ±
 1
5.
8
G
AE
 v
s 
H
A
2.
69
 (-
5.
46
, 1
0.
83
)
0,
46
07
H
A
26
.9
 ±
 1
3.
3
G
AE
 v
s 
H
AB
G
-1
.0
7 
(-
21
.8
4,
 1
9.
70
)
0.
90
37
H
A
B
G
29
.5
 ±
 1
5.
5
H
A 
vs
 H
AB
G
-5
.8
6 
(-
21
.9
5,
 1
0.
23
)
0.
40
73
B
ic
or
tic
al
G
A
E
37
.9
 ±
 7
.3
G
AE
 v
s 
H
A
1.
64
 (-
3.
62
, 6
.9
1)
0.
47
40
H
A
38
.0
 ±
 8
.3
G
AE
 v
s 
H
AB
G
-0
.9
3 
(-
13
.0
2,
 1
1.
16
)
0.
85
71
H
A
B
G
38
.6
 ±
 1
1.
2
H
A 
vs
 H
AB
G
-0
.5
6 
(-
11
.5
5,
 1
0.
42
)
0.
90
70
M
on
oc
or
tic
al
To
ta
l
28
.6
 ±
 1
4.
2
M
on
o-
 v
s 
B
ic
or
tic
al
-1
0.
75
 (-
15
.8
5,
 -5
.6
5)
0.
00
03
d
B
ic
or
tic
al
To
ta
l
38
.2
 ±
 8
.8
R
em
ov
al
 T
or
q
ue
 (
TR
Q
-o
ut
)
M
on
oc
or
tic
al
G
A
E
20
.9
 ±
 2
2.
5
G
AE
 v
s 
H
A
-2
.6
9 
(-
19
.4
2,
 1
4.
05
)
0.
71
54
H
A
23
.6
 ±
 2
1.
0
G
AE
 v
s 
H
AB
G
2.
63
 (-
21
.4
8,
 2
6.
73
)
0.
80
42
H
A
B
G
18
.3
 ±
 1
3.
2
H
A 
vs
 H
AB
G
5.
31
 (-
17
.4
8,
 2
8.
11
)
0.
59
87
B
ic
or
tic
al
G
A
E
40
.1
 ±
 2
6.
5
G
AE
 v
s 
H
A
-1
.2
9 
(-
18
.6
3,
 1
6.
06
)
0.
86
20
H
A
41
.6
 ±
 3
1.
4
G
AE
 v
s 
H
AB
G
3.
46
 (-
35
.3
4,
 4
2.
26
)
0.
83
46
H
A
B
G
38
.7
 ±
 1
8.
3
H
A 
vs
 H
AB
G
2.
90
 (-
32
.6
0,
 3
8.
40
)
0.
85
23
M
on
oc
or
tic
al
To
ta
l
21
.0
 ±
 1
9.
1
M
on
o-
 v
s 
B
ic
or
tic
al
-2
1.
34
 (-
28
.3
8,
 -1
4.
30
)
0.
00
03
a
B
ic
or
tic
al
To
ta
l
40
.1
 ±
 2
4.
8
In
se
rt
io
n 
vs
 R
em
ov
al
 T
or
qu
e
In
O
ut
M
on
oc
or
tic
al
28
.6
 ±
 1
4.
2
21
.0
 ±
 1
9.
1
TR
Q
-in
 v
s 
TR
Q
-o
ut
7.
41
 (0
.7
7,
 1
4.
06
)
0.
03
04
b
B
ic
or
tic
al
38
.2
 ±
 8
.8
40
.1
 ±
 2
4.
8
TR
Q
-in
 v
s 
TR
Q
-o
ut
-1
.9
2 
(-
11
.5
2,
 7
.6
7)
0.
68
15
a  
 M
ea
n 
di
ffe
re
nc
e 
(M
D
), 
95
%
 c
on
fid
en
ce
 in
te
rv
al
 (C
I) 
an
d 
P
 v
al
ue
 w
er
e 
p
re
se
nt
ed
. P
ai
re
d 
T-
te
st
s 
w
er
e 
p
er
fo
rm
ed
 fo
r t
he
 c
om
pa
ris
on
 b
et
w
ee
n 
th
e 
ex
p
er
im
en
ta
l g
ro
up
s 
an
d 
fo
r t
he
 im
pl
an
t p
la
ce
m
en
t m
od
al
ity
 (
i.e
. m
on
o-
 o
r b
ic
or
tic
al
).
b  
si
gn
ifi
ca
nt
 d
iff
er
en
ce
 (
p<
0.
05
)
d  
si
gn
ifi
ca
nt
 d
iff
er
en
ce
 (
p<
0.
00
1)
Figure 3  Results from insertion (ITQ) and removal torque (RTQ) measurements for 
(a) both mono- and bicortical implants with (b) different surface conditions. a = ITQ/
RTQ monocortical < bicortical (P < 0.001); b = monocortical RTQ < monocortical ITQ 
(P < 0.05).
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Histological evaluation of bone dynamics
After 4 weeks of healing, histological observations of the specimens demonstrated 
new bone formation along the entire implant surface for both mono- and bicortical 
implants (Figure 4a-b). An intimate contact at the implant-bone interface was 
observed without the presence of an intervening layer of fibrous tissue and new bone 
(NB) was formed within the implant threads (Figure 4c). For monocortical implants, 
most of the implant was surrounded by trabecular bone with open trabeculae and 
expanded marrow cavities in the peri implant region. At the crestal part, the implant 
surface was covered with thick bone lamella, originating from dense cortical bone. 
Further, the bone-to-implant contact in these areas was without interruptions of 
Figure 4  Representative histological images after 4 weeks of healing. New bone 
formation was visible along the entire implant surface for both (a) monocortical and 
(b) bicortical implants, with no apparent differences between the different surface 
conditions. (c) An intimate contact at the implant-bone interface with new bone (NB) 
formation within the implant threads. (d) New cortical bone formation beyond the 
original apical border of the iliac crest.
B D
A C
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intermediate marrow cavities. This observation seemed to be even more pronounced 
for the bicortical implants, for which an intimate contact with cortical bone was 
observed not only in the crestal part, but also in the apical region of the implant. In 
some specimens, the tip of the implant had penetrated the apical cortical plate and 
new cortical bone was formed beyond the original apical border of the crest (Figure 
4d). Finally, no apparent differences in pattern of bone formation were observed 
between the different surface conditions.
Histomorphometrical evaluations
Bone-to-implant contact (BIC%)
Histomorphometrical analyses regarding BIC% for the three surface conditions in 
mono- and bicortical implant placement are schematically and graphically depicted 
in Table 4 and Figure 5a-b. After 4 weeks of healing, BIC% in the region of interest 
appeared to be significantly higher (p<0.001, Figure 5a) for bicortical implants (63.3 
± 13.0%) compared to monocortical implants (46.6 ± 18.2%). Regarding the different 
surface conditions (Figure 5b), HABG-coated implants demonstrated significantly 
higher (p<0.05) BIC% in monocortical (54.2 ± 18.4%) and bicortical (66.7 ± 11.5) 
implant placement in comparison to GAE surfaces (40.7 ± 13.2 and 57.5 ± 8.5, 
respectively).
Bone area (BA%)
Mean values for overall BA% are shown in Table 4 and Figure 6a-b. The region of 
interest was divided into three different zones: 0-500µm, 500-1000µm and 
1000-1500µm. Within the 0-500µm region, BA% was significantly higher (p<0.001) 
for bicortical implants (43.6 ± 9.0%) compared to monocortical implants (32.0 ± 
10.4%), whereas no significant differences were observed for the 500-1000µm and 
1000-1500µm regions (p>0.05). For bicortical implants, BA% in the 0-500µm 
peri-implant region (43.6 ± 9.0%) was significantly higher (p<0.01, Figure 6a) 
compared to both the 500-1000µm (32.5 ± 9.4%) and 1000-1500µm zone (33.3 ± 
7.6%). For all surface conditions, BA% within the 0-500µm peri-implant region was 
higher for bicortical compared to monocortical implants (p<0.05). Bicortical 
HA-coated implants revealed significantly (p<0.05) higher BA% (47.0 ± 6.3) in the 
inner peri-implant region (0-500 µm) compared to bicortical GAE implants (39.7 ± 
9.1; Figure 6b).
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Figure 5  Bone-to-implant contact %. (a) Overall effect of mono- and bicortical implant 
placement. a = monocortical < bicortical (P < 0.001). (b) Surface modification effects 
for mono- and bicortical implants. a = BIC% for GAE < HABG for mono- and bicortical 
implants. b = BIC% monocortical < bicortical (P < 0.001).
Figure 6  Bone area %. (a) Overall effect of mono- and bicortical implant placement, 
specified in three zones (I: 0–500 µm; M:500–1000 µm; O: 1000–1500 µm) a = BA% in 
0–500 µm is monocortical < bicortical (P < 0.001). 
A
B
A
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Figure 6  Continued. b = significant difference in BA% between the inner zone and 
middle and outer zone (P < 0.01). (b) Surface modification effects for mono- and 
bicortical implants. a = HA monocortical < bicortical in 0–500 µm region
B
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Correlation between RTQ and BA% or BIC%
Correlation analyses in monocortical implants showed a statistically significant 
correlation between RTQ values and BIC% (r=0.4657; p=0.022) as well as between 
RTQ values and BA% (r=0.5192; p=0.011, Figure 7a-b). For bicortical implants, the 
correlation between RTQ values and BA% was not statistically significant (r=0.2481; 
p=0.2536), nor was the correlation between RTQ values and BIC% (r=0.3501; 
p=0.094, Figure 7a-b).
Figure 7  Correlation analyses between (a) removal torque (RTQ) and BIC%, and 
(b) removal torque (RTQ) and BA%, for both mono- and bicortical implant placement.
A
B
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Discussion
The aim of the present study was to evaluate whether the biological and mechanical 
properties of dental bone implants are influenced by (i) the type of surgical technique 
used for implant placement (i.e. mono- vs. bicortical), and (ii) the presence of a 
bioactive HA- or composite HABG-coating. Mechanical implant stability was 
determined by ITQ and RTQ measurements. The biological response was evaluated 
using histological and histomorphometrical analyses. At implant placement, ITQ 
values were significantly higher for bicortical compared to monocortical implants. 
Further, after 4 weeks of healing in the iliac crest of a goat, bicortical implants 
demonstrated significantly higher mean RTQ values compared to monocortical 
implants. For the latter group, RTQ values were significantly lower after 4 weeks of 
healing compared to ITQ values. Histomorphometrical data confirmed these findings, 
showing both significantly higher bone-to-implant contact and bone area within the 
0-500µm peri-implant region for bicortical implants compared to monocortical 
implants. Regarding surface conditions, comparable mechanical and histomorpho-
metrical data were obtained for HA-coatings, HABG-coatings and GAE surfaces, 
irrespective to the type of anchorage.
 A large variety of animal models are available to evaluate the osteogenic 
performance of newly developed implant surfaces.44-46 For the present study, a well 
documented and validated iliac crest goat model43,47 was used and slightly modified 
to allow for both mono-and bicortical implant placement. The iliac crest consists of 
different types of bone, with mainly porous trabecular structure in the middle of the 
crest and a thin layer of dense cortical bone at the peripheral borders.43 Therefore, 
the model is suitable for evaluating the biological performance of experimental 
implants in low density bone.47 Additionally, the iliac goat model represents analogy 
to human bone composition and remodeling especially in low quality bone.43,48 
Nevertheless, caution should be taken when extrapolating in vivo animal data to the 
human situation.49 Although the iliac crest is described as a non-loading model, it is 
subjected to multivectorial forces from the connected muscles and tendons when the 
animal is mobile. Therefore, the implants that were placed monocortically on the top 
of the iliac crest are subjected to different stress forces than the implants that were 
placed bicortically on the lateral side of the crest, where shear forces from cortex are 
directed parallel to the implant surface. Continuous micro-movements of the implants 
may stimulate the surrounding bone, which results in increased bone mass in the peri 
implant region.50,51 This might contribute partly to the differences in biomechanical 
fixation between mono- and bicortical implants observed in this study.
 Analysis of RTQ data after 4 weeks of healing revealed a decrease in bio -
mechanical stability for monocortical implants, which corroborates previous (pre)
clinical data.13,52 In a review of the clinical literature on early peri-implant healing, 
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Raghavendra and coworkers concluded that the decreased biomechanical stability is 
most likely caused by the peri-implant bone remodeling process.18 More particularly, 
they demonstrated that primary implant stability decreases in time because of osteo- 
clastic replacement of old bone. Subsequently, new bone is formed by osteoblastic 
activity, leading to an increase in secondary biological stability in time with the 
maturation of newly formed bone. However, this process takes 8-12 weeks to 
complete.18,53 In view of this, the healing period for the present study was set at 4 
weeks to evaluate whether surface modifications or surgical technique has an effect 
in the critical period with suboptimal implant stability between primary and secondary 
implant stability.
 The fact that bicortical implants reveal higher RTQ values in comparison to 
monocortical implants demonstrates that a modified surgical technique (i.e. bicortical 
implant placement) can compensate for the frequently observed decrease in implant 
stability between implant placement and appropriate bone remodeling processes. 
Mechanical torque testing demonstrated higher ITQ and RTQ values for bicortical 
implants compared to monocortical implants with equal ITQ and RTQ values for 
bicortical implants. These findings confirm the hypothesis that bicortical anchorage 
enhances primary implant stability and preserves implant stability during the early 
healing phase. For bicortical implants, higher levels of bone-to-implant contact and 
bone area (in the inner peri-implant region) were observed compared to monocortical 
implants; this points toward a positive correlation between mechanical and biological 
data. Indeed, a positive correlation between RTQ values and bone-to-implant contact 
and bone area was demonstrated for monocortical implant placement. In contrast, 
for bicortical implants no significant correlation between RTQ values and bone-to-
implant contact and bone area was observed. Probably, not only higher bone-to- 
implant contact and bone area are responsible for increased removal torque values, 
but also the biomechanical properties of the adjacent bone at the interface.54,55 
As cortical bone possesses a higher density and visco-elasticity than trabecular 
bone, implants that penetrate two cortical layers are supported by more compact 
mineralized bone and hence require more force when unscrewing the implant. In view 
of the higher ITQ values for bicortical compared to monocortical implants, this initial 
firm mechanical fixation in two cortical bone plates might not become significantly 
improved by an increase in peri-implant bone area between the cortical plates, for 
which RTQ values and bone area only significantly correlate for monocortical 
implants. Therefore, we postulate that monocortical implants are more dependent on 
biological interaction, in which higher bone-to-implant contact and bone area have 
more influence on the total biomechanical and biological implant stability.
 Histological examination of the bicortical implants demonstrated marked bone 
formation at the apical and coronal part of the implant, occasionally even beyond the 
apex of the implant when penetrating the apical cortex. This is possibly a result of a 
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periosteal reaction. Elevation of the periosteum during implant installation creates a 
socket at the apical side of the implant that facilitates thrombus stabilization and 
bone formation. The described findings are in agreement with reports from others.54,56 
Histomorphometrical density measurements by Slaets and coworkers demonstrated 
that newly formed bone adjacent to the cortex has a higher maturation capacity, 
which concomitantly leads to a faster fixation of the implants in time.57 Further, higher 
survival rates have been reported in clinical trials for implants penetrating into the 
maxillary sinuses.58 However, Brånemark et al. described higher failure rates for 
maxillary implants penetrating the nose and antral sinus.36 Also in a retrospective 
clinical study by Ivanoff and coworkers59, higher failure rates were reported in the 
long-term for bicortical in comparison to monocortical anchored implants because of 
higher stress forces surrounding these implants. Therefore, further randomized 
clinical trials seem to be required to elucidate these paradoxical observations.
 Histomorphometrical analyses after 4 weeks of healing demonstrated a favorable 
bone response toward all three experimental implant surfaces. Interestingly, the results of 
the present study demonstrated that the incorporation of BG into a conventional RF 
magnetron sputtered HA-coating improves the early bone apposition in comparison 
to the GAE in both mono- and bicortical implant placement. These observations 
corroborate with previously published data on the beneficial osteopromotive charac-
teristics of BG.28,64
 Although significant additional biological effects were visible for HA- and HABG- 
composite coatings in comparison to the GAE surfaces in terms of BIC% and BA% in 
both placement modalities, no significant differences in biomechanical stability were 
observed between the surface modifications. This is in contrast with numerous in vivo 
studies that demonstrated a beneficial effect on the early bone-to-implant response 
and mechanical fixation of HA-coated implants in comparison to non-coated 
surfaces.40,60,61 Explanations for this observation can be multiple. With respect to 
surface topography, it can be hypothesized that comparable values in surface 
roughness of all three surface conditions, which was within the optimal range (0.5 – 
2.0µm), provoked a similar reaction in early peri-implant bone formation.62 Another 
important issue that needs to be addressed is the heterogeneity of the animal 
population in the present study. Since the animals demonstrated high variation in 
bony structure at the iliac crest, high standard deviations were obtained in the histo-
morphometrical data analysis and therefore statistical significance was not reached.
Additionally, the iliac crest is known for its superior site-specific osteogenic properties. 
The iliac crest is clinically often used for bone grafting indications, because it contains 
high amounts of vital bone with large numbers of osteogenic cells and growth factors. 
It was realized that excellent site-specific osteogenic properties of the iliac crest 
perhaps overshadowed a consistent biological beneficial response of a HA or 
HABG-coating to the implant surface. These observations are in line with previous 
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non-compromised studies comparing GAE with HA-coated surfaces in the iliac crest 
goat model also demonstrated no beneficial effect for HA-coatings.17 These authors 
also concluded that the optimal osseous environment (large amounts of dense 
cortical bone and relatively low amount of cancellous bone) and the press-fit surgical 
approach possibly overshadowed a potential positive effect on the biological 
performance of these coatings. Comparative studies on HA-coatings in compromised 
gap-models, demonstrated that HA-coated implants significantly improve the 
peri-implant bone responses to bone implants.63
Conclusion
This study demonstrated that bicortical implant placement beneficially affects implant 
stability during the early phase of osseointegration. For monocortical implants, a 
significant correlation between removal torque and bone-to-implant contact and 
bone area was observed, but not for bicortical implants. Therefore, histomorphomet-
rical data should be interpreted with caution to predict the biomechanical implant 
fixation of bone implants over time. Regarding surface modifications, in the present 
implantation model, the addition of BG to an RF magnetron sputtered HA coating 
enhanced the biological behavior of the coating compared to gritblasted/acid-etched 
implants.
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Introduction
The concept of osseointegration describes the healing process at the implant-bone 
interface. Subsequently, implant surface modification experiments intend to improve 
the properties of the implant surface and to encourage the bone healing response.1,2 
The applied surface modifications are physical or chemical alterations, or a combination 
thereof. The final goal of the surface modification is to make the implant surface more 
osteophilic, i.e. attractive for bone forming cells.1,3
 Calcium phosphate (CaP) coatings are known to promote in vitro cell attachment 
and the production of extracellular matrix (ECM), whereas in vivo studies confirmed 
the increased osteoconductive properties of CaP coating in comparison to non- 
coated implant.4,5 This favorable property of CaP coatings is supposed to be due to 
the similarity in chemical composition between synthetic CaP and CaP as present in 
natural bone. Despite this chemical similarity, the deposited coatings do not show 
structural or biological similarity with bone tissue. As bone is not only composed of 
the inorganic CaP phase, but includes also an organic matrix, i.e. collagen and non- 
collagenous proteins. Therefore, currently new techniques, like electrostatic spray 
deposition (ESD), are explored to provide implants with surface coatings that mimic 
the inorganic as well as organic components of living bone.1,6 The organic part of the 
bone extracellular matrix (ECM) is composed of collagen type-1 fibrils embedded in 
an amorphous substance, which consists of glycosaminoglycans (GAGs) and 
various bone proteins. The ECM components participate actively in the regulation 
of cellular processes and responses. Therefore, implant surface modifications with 
components of bone ECM appears attractive to modulate specific intrinsic osteogenesis 
directly at the bone-implant interface.1,7 The ECM works as a scaffold for bone 
forming cells and influences migration, adhesion and differentiation of these cells.8,9 
So far, only a limited number of ECM molecules have been successfully deposited 
on an implant surface.10 For instance, collagen type-1, the major structural protein in 
ECM, has been used as an organic implant coating material. Recent studies have 
demonstrated the effective role of a collagen coating in stimulating cellular responses, 
increasing bone growth, and improving bone to implant contact.8,11-13
 To date, few research labs succeeded to deposit homogeneous inorganic and/
or organic coatings onto titanium implants. In previous in vitro experiments,14 the 
electrospray process was already used to deposit nano-CaP, collagen and alkaline 
phosphatase (ALP) coatings on titanium surfaces to improve the adhesion of osteo-
blast-like cells and to enhance their mineralization. The studies confirmed that these 
newly-developed coatings are promising for an early and direct apposition of bone 
mineral to the implant surface. Further, in a small animal model, thin CaP/ALP 
composite coatings demonstrated to accelerate early bone formation starting from 
the implant surface.15 The next step for evaluating the potential of organic and/or 
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inorganic coatings involves in vivo implantation in an established preclinical animal 
model. Considering the suggested need for dental implants with improved osseo-
integration, it is necessary that newly-designed implant surfaces are not only assayed 
under optimal experimental conditions, but rather also under challenging clinical 
conditions. For example, in the clinical situation, gaps between an implant and bone 
will arise during surgery and as a result of anatomical variation in healthy as well as 
compromised bone. The fit of the implant in the drilled implant bed can influence the 
final bone-to-implant contact. Carlsson et al.16 proved already that the critical gap 
between bone and a cylindrical titanium implant that prevents direct bone apposition 
on the implant is close to zero.
 In view of this, the aim of the present study was to evaluate the biological 
performance of electrosprayed nanocrystals CaP and collagen coatings in vivo in order to 
determine to what extent these coatings can improve the osteogenic potential of the 
implant surface in a 1 mm gap-model during implantation periods from 4 to 12 weeks.
Materials and methods
Implants
Cylindrically shaped implants (diameter: 3.2 mm; length: 8 mm) provided with a radial 
gap (1 mm) were made of commercially-pure titanium (Figure 1A). All implants were 
cleaned ultrasonically in nitric acid 10% (15 min), acetone (15 min), and ethanol (15 
min) successively and thereafter air dried. Then, implants were left as-prepared or 
provided with two types of ESD coating.
Coating deposition
ESD coatings were deposited using the process previously described by de Jonge 
et al. 8. The following standardized conditions were applied: 15% relative humidity; 
30oC substrate holder temperature; 40 mm nozzle-to-substrate distance; 0.15 ml h-1 
liquid flow rate; and 8-10.5 kV applied voltage. For deposition of nano-CaP coatings, 
nano-sized crystalline carbonate apatite particles (Berkely Advanced Biomaterials 
Inc., San Leandro, USA) were diluted in a 10:90 vol.% ethanol:ddH2O solution prior to 
electrospraying. To deposit the collagen coatings, commercially available rat tail 
collagen type 1 (BD Biosciences, MD, USA) was used.  Coating deposition was done 
in three separate runs (with in between implant turning of 120o) of 30 min each to obtain 
complete coating coverage. Only the middle (gap) part of the implants was coated. 
Top and apical portion of the implants were used to provide their initial stability and 
did not receive surface modification. All coated implants were stored at -20°C, after 
which lyophilization was applied. The non-coated implants were autoclaved before 
implantation.
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Animal model and surgical procedures
The animal protocol was approved by the animal ethical committee of King Saud 
University, College of Dentistry, Riyadh, Saudi Arabia and national guidelines for care 
and use of laboratory animals were obeyed. A total of 48 implants (n = 8 for each 
experimental group at each implantation period) were inserted in the mandible of 16 
Beagle dogs (1-2 years old and weighing 10-15 kg) for a period of 4 and 12 weeks. 
The dogs first underwent extraction of left mandibular premolars (P2, P3, and P4) and 
the extraction sockets were allowed to heal for three months. Thereafter, implants 
were installed (n = 3 per animal, i.e. nano-CaP, collagen and non-coated).
Extraction procedure
Teeth were extracted under general anesthesia. An intramuscular (IM) injection of 
ketamine hydrochloride (5 mg/kg) and diazepam (1mg/kg) was used to sedate the 
animals before the proce dure. The oral tissues were disinfected with a 10% 
 Povidone-iodine. Then, local anesthesia (lidocaine 2% with 1:100,000 epinephrine) 
was injected around the lower premolars. Following complete anesthesia, three 
lower premolars (P2, P3 and P4) in the left side were extracted atraumatically. After 
re flection of full-thickness mucoperiosteal flaps, the roots were separated using a 
high-speed dia mond bur with saline coolant. Thin elevator and forceps were used to 
luxate and to remove the separated roots gently. Flaps were closed with resorbable 
sutures (Vicryl 4.0 sutures). Gentamycin (4 mg/kg) was administered intramuscu larly 
for 7 days.
Implantation procedure
After a healing period of 3 months, implants were installed. Before surgery, the dogs 
were sedated and local anesthe sia was injected in the field. Subse quently, an incision 
was made at the bone crest and a mucoperiosteal flap was reflected on both ridge 
sides (buccal and lingual). Implant sites were prepared using a low-speed drill series 
with saline irrigation. Final drill diameter was 3.2 mm. Thereafter, implants were 
inserted manually below the crestal bone level. To ensure complete randomization, 
the implants were placed according to a rotating design, in which the position of each 
implant shifted up one position compared to the previous dog. Finally, the flaps were 
closed using Vicryl (4/0) sutures to achieve primary soft tissue closure. Gentamycin 
(4 mg/kg) was administered intramuscu larly for 7 days. The dogs were kept on a soft 
diet for 2 weeks after the surgical procedure.
Analysis
After implantation periods of 4 and 12 weeks, the animals were euthanized via an 
overdose of sodium pentobarbital (20mg/kg). The mandibles including the implants 
were harvested and immediately fixed in 10% neutral buffered formalin solution after 
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removal of excess tissue. Using a diamond circular saw, the samples were divided 
into smaller specimens suitable for micro-CT scanning and histological processing.
Micro-computed tomography
Prior to scanning, bone blocks containing only one implant each, were dehydrated in 
ethanol 70% and wrapped in Parafilm (SERVA Electrophoresis GmbH, Heidelberg, 
Germany) to prevent drying during scanning. For a quantitative 3D analysis, the 
specimens were placed vertically onto the sample holder of a Skyscan 1072 desktop 
X-ray Micro-computer tomography (micro-CT) system (Skyscan, Kontich, Belgium), 
with the long axis of the implant perpendicular to the scanning beam. Subsequently, 
a high resolution scan was recorded at a 30µm voxel resolution. Then, using Nrecon 
V1.4 (Skyscan, Kontich, Belgium), a cone beam reconstruction was performed on the 
projected files. Thereafter, a constant region of interest (ROI) was set along the length 
of the implant gap, using CTAn V1.8 (Skyscan, Kontich, Belgium). The ROI included 
the complete gap area surrounding the implant core (total standardized distance of 
interest of 3000 µm). Finally, for all images a threshold was manually selected to 
isolate bone tissue and to preserve its morphology, while excluding the implant 
material. Per implant, the parameters of bone volume (BV) and tissue volume (TV) 
were measured, after which the amount of bone volume was calculated.
Histological preparations
Subsequent to micro-CT scanning, the specimens were dehydrated in a graded 
series of ethanol (70-100%), washed with acetone, and embedded in methyl methacrylate 
(MMA). After polymerization, non-decalcified thin sections (~10 µm) were prepared 
(at least three of each implant), using a modified sawing microtome technique 17 and 
stained with methylene blue and basic fuchsin. Cross-sections were made perpendicular 
to the long axis of the implant.
Histomorphometrical evaluation
To evaluate the bone response in the gap around the implants, histological evaluation 
was carried out using a light microscope (Axio Imager Microscope Z1, Carl Zeiss 
Micro Imaging GmbH, Göttingen, Germany). Histomorphometrical analysis was 
performed using a computer-based image analysis technique (Leica Qwin Pro-image 
analysis software; Leica Imaging Systems, Cambridge, UK). Quantitative measurements 
were performed for three histological sections per implant (at magnification 25x). 
The average of these measurements was used for statistical analysis. One of the 
quantitative parameters as assessed was the peri-implant bone volume in the gap. 
Therefore, the amount of bone area was determined by setting of a region of interest 
(ROI) for each individual sample section. This ROI was individually set by determining 
the peripheries of the gap (the original margins of the drill hole) and placing a circle 
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(Figure 1A, B). To determine the amount of bone volume (BV), three different circular 
zones were defined starting at the implant surface, i.e. inner (0-300 µm), middle 
(300-600 µm) and outer (600-1000 µm) (Figure 1B). Per section, the amount of bone 
area per zone was calculated as the area percentage of bone inside the circle. Bone 
bridging of the gap was also calculated for each section. Using Qwin software, 180 
lines were automatically drawn 360° around the implant surface. Each line started 
from the implant surface and stopped when bone was contacted. The lengths of lines 
were displayed in millimetres and indicated the distance between implant surface 
and bone. As the original width of the gap was known, the obtained data were used 
to estimate the average bone ingrowth distance for each sample (Figure 2).
Statistical analysis
For statistical analysis, SPSS 16.0 (SPSS Inc., Chicago, IL, USA) was used. Paired 
and unpaired T-tests were used to evaluate the effects of the implant surface 
modifications on the peri-implant bone volume and bone ingrowth distance at 4 and 
12 weeks of implantation. For each statistical comparison, the model (paired vs. 
unpaired T-test) which showed the most precise outcomes (with narrowest width of 
the 95% confidence interval of the difference) was only considered. Statistical 
Figure 1  Schematic drawing of the implant design and the preparation of the 
histological transverse sections. A) The amount of bone volume (BV) in the gap was 
determined by setting of a region of interest (ROI). B) For each individual cross-
sectional sample, a set of 3 different zones were used for histomorphometrical 
analysis. Inner, middle and outer zones were marked as circles, starting at implant 
surface with distance of 0-300 µm, 0-600 µm, and 0-1000 µm.
A B
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comparisons of bone volume between all implant types were also performed for 
three different zones (inner, middle, outer) around each implants. Differences were 
considered significant at probability (p) values smaller than 0.05.
Results
All animals remained in good health during the experimental period and did not show 
any postoperative wound healing complications. At sacrifice, no signs of inflammation 
or adverse tissue reaction were seen around the implants. Table 1 depicts the number 
of implants placed and retrieved after implantation. Of the 48 installed implants, 
a total of 42 implants could be retrieved. In 4-weeks group, 4 implants were lost 
(1 non-coated, 1 nano-CaP-coated, and 2 collagen-coated), while in 12-weeks group 
only 2 collagen-coated implants were lost.
Figure 2  Method of measuring bone bridging-gap was performed using specific 
software. 180 Green lines were automatically drawn from the surface of the implant. 
Each line stopped when bone was hit. As the width of the gap and the lengths of lines 
were known, the obtained data were used to estimate the average bone ingrowth 
distance for each sample.
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Descriptive histological evaluation
Light microscopic examination demonstrated that generally all sections showed 
bone apposition and ingrowth of newly-formed bone into the gap around the implants 
(Figure 3). At both implantation times, the margins of the original drill hole were still 
visible and in no inflammatory reactions were observed in any of the specimens. 
Bone remodeling activity was observed inside all implant gaps, irrespective of the 
implant surface modification. The cross-sections showed an apparent histological 
difference in bone response and adaptation to the 3 different implant surfaces. At 4 
weeks, histological sections revealed that the bone tissue was never in tight contact 
with the implant surface, but a fibrous tissue layer of varying thickness was interposed 
between the implant and bone. For the surface-coated implants (nano-CaP and 
collagen), the bone present in the gap appeared to have grown closer to the implant 
surface. For the non-coated implants, the intervening fibrous layer was always 
apparently thicker. After 12 weeks, an evident increase of bone ingrowth had occurred 
for all implants compared to 4 weeks of implantation with compact lamellar bone 
filling most of the gap area. Bone ingrowth had also proceeded into close proximity 
of all the implant surfaces. Nevertheless, direct bone contact with the implant surface 
was never observed and a fibrous tissue layer was still interposed between the bone 
tissue and implant surface.
Micro-CT analysis
For all experimental groups, mean data regarding bone volume measurements at 4 
and 12 weeks are listed in Table 2. Although the absolute mean value for bone volume 
at 4 and 12 weeks post-implantation was higher for the collagen coated implants, 
statistical testing revealed that the observed difference was not significant (p>0.05).
Table 1  Summary of number of implants placed and retrieved for the study analyses.
No. of implants 
placed
No. of implants 
retrieved 
4 weeks Nano-CaP 8 7a
Collagen 8 6b
Non-coated 8 7a
12 weeks Nano-CaP 8 8
Collagen 8 6b
Non-coated 8 8
a One implant fell out during wound healing period 
b Two implants fell out during wound healing period
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Histomorphometrical analysis
Mean data and the outcome of statistical analyses regarding bone area percentage 
and gap healing measurements for the experimental groups at 4 and 12 weeks are 
presented in Tables 3 & 4 and Figures 4 & 5.
Figure 3  Transverse histological images obtained for each surface modification 
at 4 and 12 weeks. The margins of the original drill hole (arrows) were still visible 
between new bone (NB) and old bone (OB). Fibrous tissue (F) was always interposed 
between the implant and bone. At 4 weeks, the bone front appeared to be closer to 
the coated surfaces. Nano-CaP implants showed a higher number of marrow spaces 
compared to the other implants. After 12 weeks, regions of lamellar compaction and 
a high histological bone density with just a few marrow spaces adjacent to all implant 
surfaces.
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Table 2  Micro-CT data and the outcome of statistical analyses regarding bone 
volume (%) for all implant surface groups at 4 and 12 weeks.
T-testa
Mean 
±SD 
Model MD [95% CI] P value
4 weeks Nano-CaP 45.7 ±6.9 Nano-CaP vs. Collagen UP -7.5 [-16.3, 1.3] 0.087
Collagen 53.2 ±7.5 Nano-CaP vs. Non-coated P -2.1 [-10.4, 6.3] 0.569
Non-coated 47.7 ±10.7 Collagen vs. Non-coated P 2.0 [-5.8, 9.8] 0.542
12 weeks Nano-CaP 45.9 ±9.9 Nano-CaP vs. Collagen UP -10.0 [-21.6, 1.6] 0.084
Collagen 55.9 ±9.7 Nano-CaP vs. Non-coated P -4.4 [-11.7, 2.8] 0.184
Non-coated 49.4 ±12.2 Collagen vs. Non-coated P 2.2 [-6.8, 11.3] 0.553
a  Paired (P) and unpaired (UP) T-test models were performed. Mean deference (MD), 95% confidence 
interval (CI), and P value were presented for the most precise model (with narrowest width of CI)
Table 3  Histomorphometrical data and the outcome of statistical analyses regarding 
overall bone volume (%) between the various implant surface groups at 4 and 12 
weeks.
T-testa
Mean 
±SD 
Model MD [95% CI] P value
4 weeks Nano-CaP 49.5 ±11.8 Nano-CaP vs. Collagen P -7.5 [-16.2, 1.2] 0.077
Collagen 61.4 ±9.7 Nano-CaP vs. Non-coated UP 2.1 [-11.2, 15.3] 0.741
Non-coated 47.5 ±11.0 Collagen vs. Non-coated UP 13.9 [1.2, 26.7] 0.035b
12 weeks Nano-CaP 67.2 ±10.9 Nano-CaP vs. Collagen UP -5.6 [-18.9, 7.7] 0.380
Collagen 72.7 ±11.9 Nano-CaP vs. Non-coated P 0.8 [-8.37, 10.0] 0.833
Non-coated 65.1 ±10.9 Collagen vs. Non-coated UP 7.6 [-5.7, 21.0] 0.235
a  Paired (P) and unpaired (UP) T-test models were performed. Mean deference (MD), 95% confidence 
interval (CI), and P value were presented for the most precise model (with narrowest width of CI)
b Indicate significant  difference ( p<0.05)
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Table 4  Bone volume (%) and statistical analyses for inner, middle, and outer zones 
between the various implant surface groups at 4 and 12 weeks.
T-testa
Mean ±SD Model MD [95% CI] P value
Inner zone
4 weeks Nano-CaP 23.1 ±11.8 Nano-CaP vs. Collagen P -4.0 [-15.6, 7.7] 0.424
Collagen 28.4 ±10.1 Nano-CaP vs. Non-coated UP 12.6 [1.9, 23.4] 0.025b
Non-coated 10.5 ±5.6 Collagen vs. Non-coated UP 18.0 [7.1, 28.7] 0.005c
12 weeks Nano-CaP 38.2 ±15.7 Nano-CaP vs. Collagen UP -14.2 [-32.2, 3.8] 0.111
Collagen 52.4 ±14.7 Nano-CaP vs. Non-coated UP 0.7 [-17.2, 18.6] 0.933
Non-coated 37.5 ±17.6 Collagen vs. Non-coated P 16.7 [-1.1, 34.5] 0.060
Middle zone
4 weeks Nano-CaP 57.1 ±18.3 Nano-CaP vs. Collagen UP -17.4 [-37.6, 2.8] 0.085
Collagen 74.5 ±14.1 Nano-CaP vs. Non-coated UP -3.4 [-23.7, 16.8] 0.717
Non-coated 60.5 ±16.4 Collagen vs. Non-coated UP 13.9 [-4.9, 32.8] 0.132
12 weeks Nano-CaP 81.5 ±12.8 Nano-CaP vs. Collagen UP 1.3 [-14.2, 16.8] 0.860
Collagen 80.2 ±13.6 Nano-CaP vs. Non-coated UP 3.3 [-9.4, 16.0] 0.590
Non-coated 78.3 ±10.8 Collagen vs. Non-coated UP 2.0 [-12.2, 16.1] 0.765
Outer zone
4 weeks Nano-CaP 69.1 ±17.0 Nano-CaP vs. Collagen UP -13.1 [-32.2, 6.0] 0.159
Collagen 82.3 ±13.8 Nano-CaP vs. Non-coated UP -3.4 [-20.3, 13.5] 0.670
Non-coated 72.5 ±11.6 Collagen vs. Non-coated UP 9.7 [-5.8, 25.2] 0.195
12 weeks Nano-CaP 82.1 ±11.1 Nano-CaP vs. Collagen UP -3.0 [-16.2, 10.1] 0.625
Collagen 85.2 ±11.4 Nano-CaP vs. Non-coated P 7.3 [-1.3, 15.8] 0.082
Non-coated 77.3 ±10.3 Collagen vs. Non-coated UP 7.8 [-4.9, 20.5] 0.203
a  Paired (P) and unpaired (UP) T-test models were performed. Mean deference (MD), 95% confidence 
interval (CI), and P value were presented for the most precise model (with narrowest width of CI) 
b  Indicates significant difference (p<0.05)  
c  Indicates significant difference (p<0.01)
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Figure 4  Overall bone volume and statistical analysis between the various experimental 
groups at 4 and 12 weeks. (*) indicates significant difference is p<0.05. (**) indicates 
significant difference is p<0.01.
Figure 5  Representation of bone ingrowth measurements respective the various implant 
surface coatings after 4 and 12 weeks.
CHAPTER 7
142
Bone volume (%)
Regarding overall bone volume, significant differences were observed only between 
the collagen (61.4%) and non-coated (47.5%) groups at 4 weeks (p<0.05; Table 3). 
Additionally, the overall bone volume values for only the nano-CaP (p=0.010) and 
non-coated (p=0.008) groups showed significant differences between the 4 and 12 
weeks time point (Figure 4). For the different peri-implant zones (inner, middle and 
outer), nano-CaP as well as collagen-coated implants showed at 4 weeks of 
implantation a significantly higher bone volume in the inner zone compared to 
non-coated implants (p<0.05 and p<0.01; Table 4). For collagen-coated implants, 
the absolute bone volume values were highest in the middle and outer zone, but the 
differences were not statistically significant (Table 4). After 12 weeks of implantation, 
bone formation increased significantly for collagen (p=0.008) and non-coated 
implants (p=0.002) in the inner zone compared with 4 weeks as well as for nano-CaP 
(p=0.009) and non-coated implants (p=0.026) in the middle zone. However, further 
statistical analysis of the 12 weeks data revealed comparable amounts of bone 
volume in the various zones between all implant groups.
Implant-gap healing
The gap bridging data, as presented in Figure 5, confirmed the bone volume 
measurements. At 4 and 12 weeks of implantation, the absolute average values for 
bone ingrowth distance were highest for collagen-coated implants, but these 
differences were not significant (p>0.05).
Discussion
The current study aimed to evaluate the osteogenic effect of two implant surface 
coatings (nano-CaP and collagen) after 4 and 12 weeks, using a so-called implant-gap 
model with non-coated implants as controls. The results suggested that the colla-
gen-coated implants seemed to have a favourable effect on bone formation inside 
the gap, but the observed difference was not consistently significant.
 Six implants were lost during the 3 months evaluation period, which is likely due 
to the design of the used implants, i.e. cylindrical and non-threaded. In the current 
study, the site preparation was the same as the implant diameter and a good fit was 
achieved for all implants due to the high-density bone of the dog mandible. However, 
it has to be emphasized that the implants were not provided with screw-threads and 
had only an initial stability at their apical and crestal side. Therefore, their initial 
stability is not suited for the chewing forces that usually result in serious loading even 
for the edentulous mandible.18 This is confirmed by the position of the lost implants, 
as most of them were situated in the middle position, which is more prone to insult 
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due to chewing forces, while the mesial and distal implants are protected by the 
neighboring natural teeth. In addition, the drilling procedure to create the implant bed 
is always accompanied by bone damage, which is known to occur till a distance of 
about 1 mm from the original drill walls. Bone damage is associated with necrosis of 
bone, which may decrease the fixation of non-threaded implants during initial 
healing.19 It has to be noticed that the implant surfaces were left non-coated or 
provided with just a collagen or nano-CaP coating. Implants were not provided with 
a composite coating composed of collagen and nano-CaP. Although use of such 
composite coatings was described for in vitro studies using titanium disks,8 the 
current implant design and coating set-up did not allow the deposition of such 
composite coatings.
Implant-gap healing model
The histological evaluation showed clearly that bone was extending from the 
pre-existent surrounding bone into the implant gap. However, bone was never seen 
in direct contact with the three different implant surfaces and fibrous tissue was 
always interposed between the implant surface and the newly-formed bone. Evidently, 
the applied coatings were not able to allow complete bridging of the created 1 mm 
wide gap. Compared to other studies20-22 that also used a gap model, it has to be 
concluded that the deposited coatings in their current composition lack the 
appropriate osteogenic properties to enable complete gap closure. Still, it has to be 
emphasized that differences existed between the current study and the previously 
performed studies. For example, the implants in the earlier studies were installed into 
the goat femoral condyle, while we inserted the implants in the dog mandible. 
Craniofacial bone is described to evolve into a different implant bone healing 
compared to that in long bones.23
 The lack of effect of complete gap closure for the coated implants can also be 
caused by the design of the implants as explained before. The effect of loss of implant 
fixation will be more deleterious in the oral cavity compared to implants installed in 
the long bones. The ingress and chewing of food will always result in serious loading 
of both the mandibular bone and the installed implants. Implant movement during the 
initial healing phase has an unfavourable effect on the osseointegration of oral 
implants.19 Perhaps, this effect was even enhanced because the currently used 
implants had only an initial bone contact at their apical and crestal side. This effect 
even can have been enhanced because the implants used in some of the previous 
studies had a somewhat different design. For example, Clemens et al.20 used 
separate cylindrical titanium plugs with spacers on both endings to ensure sufficient 
implant stability, while Manders et al.22 manufactured an implant, in which the gap 
area was composed of a flat surface and still partly 100% initial bone contact existed 
over the complete length of the implant. As a consequence, not only the stability of 
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those implants will have been higher compared to the ones of the present study, but 
also conduction of bone over the implant surface into the gap area will be increased.
 Recent studies of Jung et al.24 and Lai et al.25 indicated that bone-to-implant 
contact can be achieved even when gaps of up to 2 mm are present between the 
pristine bone and the implant surface. The current study could not confirm these 
results, which can be due to the different study design. Jung et al.24 and Lai et al.25 
created circumferential coronal defects around the implants, whereas in the present 
study gaps were created within the implants design. Accordingly, the coronal defects 
are expected to have superior bone apposition because the healing enhanced from 
the lateral and apical bone walls of the defects.26 However, the bone healing in the 
current study was only achieved form the lateral bone side. Finally, this study showed 
no satisfactory bone-bridging of the gap after a 12-week healing period. Therefore, it 
could be assumed that an extended follow-up was needed.
Collagen coating for titanium implants
The biological benefits of type-1 collagen, the major ECM protein, on bone 
regeneration are well recognized.1 An in vitro study by de Jonge et al.8 showed that 
electrosprayed collagen deposition on titanium discs stimulated the osteogenic 
behavior of bone marrow stromal cells (MSCs). The interaction of the MSCs with the 
collagen coating stimulated alkaline phosphatase activity and increased mineral 
deposition. In addition, type 1 collagen is known to be able to bind relevant proteins 
(fibronectin and vitronectin), which affect the early adhesion of bone cells and their 
precursors cells.9,27 Previous in vivo studies have suggested that the initial biological 
events occurring at the implant interface may also be tailored by the deposition of 
organic collagen matrix on titanium surfaces. In these studies, use was made of 
adsorption or biomimetic processes to deposit type-1 collagen on titanium 
implants.7,11-13,28,29 In a canine model, Schliephake et al.28 used screw-type implants 
with a collagen coating anchored on the surface by adsorption, which resulted in a 
significant increase in bone formation after one month. A positive effect of this type of 
coating was also shown in rat tibiae by Rammelt et al.11 Further, a pig mandible was 
chosen to evaluate the suitability of ECM-based coatings as applied on square 
designed implants.29 The type-1 collagen coatings showed satisfactory rates of de 
novo bone formation especially within the first weeks to months. The same research 
group used circular implants with two defined recesses30 and found that the 
biomimetic application of calf skin collagen coating has an advantageous effect on 
peri-implant bone formation.
 Although in the current study the amount of newly-formed bone was greater 
around the collagen-coated implants, no consistent significant favorable effect of 
collagen coatings on the bone response could be proven. Several explanations can 
be given for this discrepancy in observation compared with earlier in vitro as well as 
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in vivo studies. First, the currently used implant design represents a clear challenge 
to bone formation at the implant surface as the occurrence of osteoconduction is 
almost excluded and new bone formation has to be evoked by the osteogenic 
properties of the implant surface. Secondly, the initial fixation of the used implants 
was more unfavourable in the dog mandible as explained above. Thirdly, the other 
groups that observed in vivo improvement of bone healing around implants applied 
a bovine collagen coating.7,9,11,28 In this study, commercially available rat tail collagen 
type-1 was used.8 Presently, it cannot be excluded that this source of the collagen 
evokes an antigenic effect in a different species, like the dog. Future studies have to 
pay attention to these issues in order to determine the final efficacy for organic 
ECM-based coatings to improve osseointegration of implant.
CaP nanoparticle coatings
CaP coatings are known to enhance bone formation at the implant-bone interface. To 
overcome some drawbacks of commonly used coating techniques, electrostatic 
spray deposition (ESD) was intro duced to allow the production of nanometer thin 
coatings with a standardized morphology as well as chemical composition.1,31 A 
recent in vitro study showed an increased adhesion of osteoblast-like cells to such 
coatings.14 This in vitro effect was confirmed in a rat study, which proved that an ESD 
deposited nano-CaP coating significantly improved bone-to-implant contact 
compared to non-coated surfaces.32 Nevertheless, the ESD nano-CaP-coated 
implants did not increase the overall peri-implant bone formation in a significant 
manner in the current dog study compared to non-coated surfaces. Still, it has to be 
noticed that at 4 weeks after implantation, the nano-CaP-coated implants showed 
more bone deposition at the inner zone compared to the non-coated implants. The 
reason why no effect was seen at 12 weeks and why the nano-CaP coating was not 
able to evoke complete gap bridging after 12 weeks of implantation is not clear. It is 
possible that the prolonged presence of a fibrous layer around the gap designed 
implants results in too early and faster dissolution of a nano-thin CaP coating.5 In 
agreement, an in vivo study by Meirelles et al.33 was also unable to confirm the 
supportive effect of nano-CaP coatings on bone formation. In their experimental 
set-up, implants were placed in the rabbit tibia with a surgical gap of 0.35 mm on 
each implant side. Implant stability was warranted by a fixation plate and two 
additional screws. On the other hand, an advantageous effect of discrete crystalline 
deposition (DCD) of nano-CaP onto dual acid-etched (DAE) implants was reported 
in various dog as well as human clinical trials.34-37 However, Mendes et al.38,39 
hypothesized on basis of their rat studies that the increase in the created complexity 
of the implant surface is probably more the reason for the bone-bonding mechanism 
than the calcium phosphate chemistry.
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Conclusion
Within the limitations of the used experimental gap-model, the obtained data did not 
provide a final answer on the possible favorable effect on bone formation of an 
ESD-deposited collagen coating on a titanium implant after 3 months of implantation 
in the dog mandible. Similarly, the data could not confirm the effect of a nanometer 
thin CaP coating to enhance bone healing into a gap-implant model. It can be 
hypothesized that the source of the collagen as well as the limited osseous 
environment overshadowed a possible effect of the applied implant surface 
modifications.
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Summary
General introduction
Against a background of demographic changes in the world population, the medical 
field encounters increasing numbers of patients with compromised medical conditions, 
medication-related issues and unfavourable anatomical factors. With respect to the 
field of orthopedics and implant dentistry, a growing number of patients are treated 
with endosseous implants to restore deteriorating joints or replace lost teeth because 
of trauma, decay or periodontal diseases. Nowadays, patients ask for a high standard 
of care, minimally invasive surgical interventions, and reliable implants that provide 
long-term survival and restore a high degree of quality of life. In the last decade, the 
clinical use of endosseous implants has evolved into a predictable treatment modality in 
both orthopedic and dental practices. Despite promising survival data of endosseous 
implants in favorable clinical conditions, still implant placement in more challenging 
clinical cases remains a challenge with increased failure rates as a result.
 Survival of endosseous implants starts with a biomechanical fixation into the 
surrounding bone tissue that evolutes into a biological fixation without an intervening 
layer of fibrous tissue, often referred to as osseointegration. Important parameters for 
successful osseointegration of endosseous implants include 1) the surgical technique 
and skills of the surgeon, 2) bone quality and quantity at the recipient site, 3) implant 
surface characteristics, and 4) healing time to achieve osseointegration (loading 
protocols).
 Surface modification techniques attempt to improve the early osseointegration of 
bone implants by either focusing on the physical properties (i.e. roughness) or the 
chemical properties (i.e. coating deposition) of the implant surface. A variety of 
surface modifications and coating procedures have shown to exhibit beneficial in vivo 
potential in the early process of peri-implant bone formation. However, the physico- 
chemical properties responsible for this biological effect are still unclear. From a 
clinical perspective, it has been demonstrated that a surface modification can be 
beneficial in the early peri-implant osteogenesis. However, the clinical indication for 
the use of surface-modified implants is still unclear.
 Therefore, the main objectives of the current thesis were to 1) evaluate the osteophilic 
properties of a broad panel of surface modifications for endosseous implants using 
different, well-established, preclinical animal models, and 2) elucidate whether the 
application of a coating on an endosseous implant surface is justified for future 
clinical indications in implant therapy. More specifically, the following sections will 
recapitulate specific sub-aims using the obtained scientific data.
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Evaluation of the osteophilic capacity of different ceramic-based 
coatings in comparison to titanium surfaces obtained via different 
subtractive procedures within one in vivo experimental setup
An expanding and aging world population increases the demand for implantable 
devices and scaffolds to replace damaged tissues. A wide range of surface 
modifications and coating procedures has shown to exhibit beneficial potential in the 
early process of peri-implant bone formation. Still, straightforward comparison and 
extrapolation of different in vitro and in vivo results for each individual study remains 
bothersome due to a lack of suitable models that allow for simultaneous evaluation of 
multiple surface modifications. In Chapter 2, a study was initiated to evaluate the 
osteophilic capacity of a broad range (i.e. seventeen) of different ceramic-based 
coatings in comparison to different titanium surfaces obtained via subtractive 
procedures (i.e. Ti, GB and GAE) within one in vivo experimental setup. For this 
purpose, a bone conduction chamber cassette model was used on the transverse 
process of a goat. After 12 weeks, histological and histomorphometrical analyses in 
terms of relative bone-to-implant contact (BIC%), relative bone area (BA%) and 
maximum bone height (BH) were determined. The results of this study indicated that 
under the current experimental conditions, plasma-sprayed CaP coatings have a 
superior osteophilic effect compared to non-coated titanium surfaces and a wide 
range of CaP and/or bioactive glass-based coatings deposited using alternative 
techniques.
Appraisal to address the long-term survival data of CaP-coated 
dental implants in clinical trials using a meta-analytical approach
Our in vivo observations in Chapter 2 confirmed that CaP-based plasma-sprayed 
coatings have the potential to compensate for challenging bone conditions, such as 
delayed or impaired bone healing and low bone quantity or density. Thus, the 
increasing universal prevalence of subjects with such challenging bone conditions 
might be paralleled by an enhanced global use of CaP ceramic-coated dental 
implants. However, it is speculated that the long-term clinical survival of CaP-coated, 
predominantly plasma-sprayed, dental implants, might be adversely affected by 
coating delamination. Therefore, in Chapter 3, a meta-analysis was performed to 
systematically appraise long-term survival data of CaP-coated dental implants in 
clinical trials. For this purpose, a literature search was carried out to identify 
randomized controlled clinical trials (RCT), prospective clinical trials (PCT) as well as 
retrospective analysis of cases (RA) presenting survival data on the topic of 
CaP-coated dental implants. Only studies in humans were included with a follow-up 
of at least five years. Furthermore, the reference lists of related review articles and 
publications selected for inclusion in this analysis were systematically screened. The 
primary outcome variable was relative annual failure rate and the secondary outcome 
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variable was relative cumulative survival rate. The electronic search in the database 
of the National Library of Medicine, The Cochrane Central Register of Controlled 
Trials and the ISI Web of Knowledge, resulted in the identification of 385 titles. These 
titles were initially screened by two independent reviewers for possible inclusion. 
According to the predefined inclusion criteria for this study, five of the original research 
reports were selected for evaluation. No additional publications were identified by 
manual search. The meta-analysis revealed that neither annual failure rates of 
CaP-coated dental implants increased progressively nor that long-term cumulative 
survival rates for CaP-coated dental implants were inferior to survival rates of 
non-coated implants. Therefore, we concluded in Chapter 3 that 1) published 
long-term survival data for CaP-coated dental implants are very limited, 2) annual 
failure rates of CaP-coated dental implants do not increase progressively, and 3) 
long-term cumulative survival rates for CaP-coated dental implants are comparable 
to survival rates of non-coated implants.
Appraisal to evaluate the long-term success data of CaP 
plasma-spray coated dental implants in clinical trials using a 
 meta-analytical approach
Overall cumulative implant survival is often used to describe the long-term prognosis 
of a dental implant system. However, implant survival does not concern the quality of 
the remaining device. Ongoing marginal bone loss might jeopardize long-term 
implant survival. Therefore, it is of clinical relevance to appraise the relevant literature 
to elucidate the bone resorption dynamics of CaP-coated dental implants in time. In 
Chapter 4, a second meta-analysis was performed to systematically appraise and 
evaluate long-term success data of CaP plasma-spray coated dental implants in 
clinical trials with at least 5 years of follow-up. A literature search complemented by 
manual searching was conducted to identify prospective and retrospective clinical 
trials dealing with reports about the success rate of CaP-coated dental implants with 
at least 5 years of follow-up. To describe the long-term efficacy of functional implants, 
the primary outcome variable was relative annual failure rate (AFR). The secondary 
outcome variable was relative cumulative success rate (CSR), as presented in the 
selected articles. The search in the database of the National Library of Medicine, The 
Cochrane Central Register of Controlled Trials and the ISI Web of Knowledge, yielded 
645 titles. A subsequent title and abstract exploration resulted in the identification of 
20 full text articles. On the basis of the inclusion criteria, 8 studies were finally included 
for the estimation of overall success percentage. Chapter 4 concluded that: 1) 
published long-term survival and success data for CaP-coated dental implants are 
limited, 2) comparison of the data is difficult due to differences in the success criteria 
among the studies, and 3) long-term cumulative success rates for CaP-coated dental 
implants show evidence of progressive bone loss around CaP-coated implants.
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Evaluation of the biological performance of dental implants coated 
with different ratios of hydroxyapatite (HA) and bioactive glass (BG) 
in a dog mandible model
Although titanium is commonly used as a favorable bone implant material due to its 
mechanical properties, its bioactive and osteoconductive capacity are relatively low. 
CaP ceramics, predominantly hydroxyapatite (HA), have been frequently used for 
coating purposes to improve the bioactive properties. In addition to CaP coatings, 
bioactive silicate-based glass (BG) coatings are suggested to exhibit osteopromotive 
characteristics. It has been demonstrated that the formation of a hydrated silica layer 
and hydroxyl carbonate apatite on the glass surface have a osteopromotive effect on 
osteoblast proliferation and differentiation.
 Plasma-spraying is a popular procedure in the field of dentistry and orthopedics 
for the deposition of CaP-based coatings on metallic bone implants.  Still, the clinical 
use of these coatings is hampered by concerns regarding coating delamination and 
fragmentation at the implant/coating interface that jeopardizes the long-term 
performance of these implants, as demonstrated in Chapter 4. Magnetron sputter 
coatings overcome these problems and this coating deposition technique has 
demonstrated to generate thin, well-adherent coatings, while preserving the bioactive 
properties of the CaP ceramic. In view this, Chapter 5 aimed to evaluate the effect of 
BG incorporation into HA coatings on implant performance in terms of bone contact 
and bone area. For this, a total of 48 screw type titanium implants with magnetron 
sputter coatings containing different ratios of HA and BG (HA, HABGLow and 
HABGHigh) were placed into the mandible of 16 Beagle dogs. After 4 and 12 weeks, 
their performance was evaluated histologically and histomorphometrically. Peri- 
implant bone area (BA%) was determined in three zones (inner: 0-500µm; middle: 
500-1000µm; and outer: 1000-1500µm). Bone-to-implant contact (BIC%) and first 
bone-implant contact (1st BIC) were also assessed for each sample. After 4 weeks of 
healing, relative bone area around the HA-coated implants was significantly higher in 
comparison to HABGHigh. After 12 weeks, all experimental groups showed similar 
bone-to-implant contact and no differences in bone area were found. Therefore, it 
was concluded that the incorporation of BG into HA sputter coatings does not 
enhance the performance of a dental implant at implantations sites with good bone 
quality and quantity. In contrast, coatings containing high concentrations of BG 
resulted in inferior performance during the early post-implantation healing phase.
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Evaluation of the biological and mechanical performance of 
screw-type dental implants with a bioactive HA- or composite 
HABG-coating related to the type of surgical technique used  
for implant placement (i.e. mono- vs. bicortical)
Although surface modifications and surgical protocols may individually affect the 
 osseointegration process and implant stability, it has been indecisive which factor 
dominates the final bone response and clinical outcome. Hence, it appears crucial to 
expand the knowledge on the influence of the combined effect of both variables on 
the biological and mechanical quality of the implant/bone interface. Therefore, in 
Chapter 6 an in vivo study using the iliac crest of a goat was performed to determine 
whether the biological and mechanical properties at the implant/bone interface of 
screw-type dental implants are influenced by 1) the presence of a bioactive HA or 
composite HABG coating, and 2) the type of surgical technique used for implant 
placement (i.e. mono- vs. bicortical). A total of 96 titanium (Ti) implants w/- coatings 
(Ti, Ti-HA & Ti-HABG) were mono- or bicortically placed in the goat iliac crest. At 
installation and after 4 weeks, implant stability was determined using insertion and 
removal torque testing (ITQ & RTQ), respectively. The peri-implant bone response 
was histologically and histomorphometrically evaluated by means of bone-to-implant 
contact (BIC%) and the relative bone area (BA%) in three peri-implant regions 
(0-500µm; 500-1000µm; 1000-1500µm) were calculated. Bicortical implants showed 
higher RTQ values (40.1 ± 24.8 Ncm) than the monocortical implants (21.0 ± 19.1 
Ncm). For monocortical implants, significant differences were observed between the 
ITQ (29.5 ± 15.5 Ncm) and RTQ (18.3 ± 14.9 Ncm) for Ti-HABG. Histomorphometri-
cal evaluation demonstrated higher BIC% for bicortical compared to monocortical 
implants. Bone volume in the inner peri-implant region (0-500µm) was significantly 
higher for bicortical implants in comparison to monocortical implants. In Chapter 6, it 
was concluded that bicortical implant placement is a technique to enhance early 
implant stability. Regarding surface modifications, neither Ti-HA nor Ti-HABG 
increased early bone formation compared to Ti. Hence, it was concluded that the 
addition of BG to an RF-magnetron sputtered HA coating does not enhance the 
biological behavior of the coating in the present implantation model.
Evaluation of the in vivo bone response to electrosprayed CaP 
nanocrystals and collagen type-I coatings at an implant surface in 
challenged conditions (i.e. a 1 mm gap-model)
In Chapter 7, the osteogenic potential of electrosprayed CaP nanocrystals and 
collagen coatings was evaluated in a gap-model over 4 and 12 weeks implantation in 
a dog mandible. Sixteen Beagle dogs received experimental titanium implants in the 
mandible 3 months after removal of all premolars. Three types of implants were 
evaluated in each animal: 1) non-coated implants, 2) implants with nano-CaP coating, 
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3) implants with type 1 collagen coating. Both micro-CT imaging and histomorpho-
metrical analyses were performed after 4 and 12 weeks to assess bone volume and 
bone bridging of the gap by the newly formed peri-implant bone. Bone area (BA%) 
was determined in three different circular zones (inner: 0-300µm; middle: 300-600µm 
and outer: 600-1000µm). After 4 weeks of healing, both nano-CaP and collagen-coat-
ed implants showed a significant higher bone volume in the inner zone compared to 
non-coated implants. After 12 weeks, histomorphometrical data revealed comparable 
amounts of bone volume in the various zones between all experimental groups. 
Based on Chapter 7, it was concluded that the obtained histomorphometrical data 
failed to provide a consistent favorable effect on bone formation of the collagen 
coating over 3 months of implantation. If there is biological effect on peri-implant 
bone healing that can be ascribed to the presence of an organic or inorganic ESD 
coating, it is limited to the first 4 weeks after implantation. It can be speculated 
that the source of the collagen (i.e. rat tail) as well as the limited osseous environment 
(i.e. gap-model) overshadowed a possible effect of the applied implant surface 
modifications.
Closing Remarks
The use of endosseous implant materials has become a widely accepted treatment 
modality in both the fields of orthopedics and implant dentistry. Thanks to extensive 
research and preclinical testing, a wide variety of implantable endosseous implant 
materials are nowadays available for the rehabilitation of patients suffering from 
deteriorating joints and failing teeth. To date, in some clinical indications, endosseous 
implant placement has even become the first choice restorative strategy to improve 
chewing efficiency, esthetics and overall quality of life. Today, patients ask for shorter, 
more straightforward surgery with reduced post-operative morbidity. With this, a 
tendency toward early and even immediate loading protocols has emerged that 
increase the risk in implant failures. Also, more implants are placed in compromised 
clinical cases with reduced bone quality, quantity and impaired wound healing 
because of systemic malconditions (e.g. osteoporosis, diabetes) or after radiotherapy 
in the head-neck region. Survival of endosseous implants is highly depending on 1) 
the surgical technique and skills of the operator, 2) the host response, and 3) the 
surface characteristics of the implant. Ongoing basic research on surface 
modifications is essential to improve early bone healing and stimulate osseointegra-
tion, especially in challenging clinical conditions.
 In this thesis, a broad spectrum of different ceramic-based coatings and titanium 
surfaces obtained via subtractive procedures have been evaluated to give more 
insight into which surface characteristics are important in the early phases of bone 
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healing. Further, different in vivo animal models with varying osseous environments 
were used to determine the effect of different bone quality and quantity on the 
osteophilic properties of these surface conditions.
 Our in vivo experiments demonstrated that the addition of a ceramic-based 
coating can have an advantage in the osteophilic properties of the implant surface 
(Chapter 2), without hampering the long-term prognosis of the implant (Chapters 3 & 4). 
It needs to be emphasized that the addition of a coating based on bioactive 
components can increase peri-implant bone formation in comparison to non-coated 
implant surfaces, especially in challenging bony environments (Chapter 2 & 7). 
However, the positive effect of a coating is less pronounced at implant sites with 
optimal bone quality and quantity (Chapter 5 & 6).
 Not only surface characteristics are determining factors for the predictable osseo - 
integration of endosseous implants. Also surgical skills and refined surgical techniques 
(i.e. bicortical and undersized implant placement) are of major importance in minimizing 
trauma to the native bone at the implant site, as it improves the primary stability of 
the implant and stimulates a favorable biological bone response (Chapter 6).
Future Perspectives
Considering the in vivo results of our experimental studies, it needs to be emphasized 
that the addition of a bioactive coating can be of significant importance for the early 
onset of bone formation around endosseous implants, especially in challenging 
conditions. Within the upcoming years, patient populations will dramatically change 
in both the fields of orthopedic and dental implantology. As patients become older, 
clinicians will be confronted with increasing numbers of patients with compromised 
conditions, including reduced bone healing capacity related to systemic 
malconditions. In these situations, endosseous implant placement will remain a 
challenge despite highly skilled surgeons and the continuous development of 
endosseous implants with optimized osteophilic characteristics. On the other hand, 
clinicians will also be confronted with healthy patients without any medical issues that 
need treatment with endosseous implants. In these cases, also bone quality and 
bone quantity can be suboptimal, although this is accompanied by normal wound 
healing. Especially in cases that involve immediate implant placement after tooth 
extraction, a gap can be present between the implant and the surrounding native 
bone tissue. In these cases, surgical expertise and implant hardware should go hand 
in hand. Refined surgical techniques and implant hardware are requested to maximize 
primary implant stability, but also optimal osteophilic surface conditions, in particular 
bioactive coatings, are essential to stimulate the early bone-to-implant response and 
promote the early phases of osseointegration.
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 Based on the results of the different in vivo experiment and knowledge as 
obtained in the present thesis and, it has been demonstrated that thin magnetron 
sputtered CaP coatings can be successfully applied on endosseous implant material, 
however the biological response to the CaP magnetron sputtered coatings was less 
pronounced than what we anticipated. No significant differences could be observed 
between the CaP-coated implants and the roughened surfaces by means of BIC% 
and BA% in the different in vivo models. A reason for this can be found in the mostly 
un-compromised bony environments for most of the different in vivo experiments.
 In the near future, endosseous implantable solutions with optimal osteophilic 
properties are required to meet the expectations and demands of our patients. 
Ideally, clinicians should have the opportunity to select the most appropriate implant 
design, surgical technique and surface condition for each specific clinical situation. 
Especially in compromised clinical cases, the development of instructive tailor made 
solutions is crucial to accelerate the process of osseointegration, to shorten loading 
times and to reduce overall financial costs for our patients. For this purpose, ongoing 
research is needed to evaluate surface conditions in more challenging conditions to 
understand the fundamental pathways in the bone formation process that account 
for the early bone formation response and to unravel which physico-chemical 
property is responsible for this effect.
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Samenvatting 
In de komende jaren zal de levensverwachting van de wereldbevolking sterk stijgen. 
Met deze demografische veranderingen zullen clinici steeds vaker geconfronteerd 
worden met medisch gecompromitteerde patiënten waarbij sprake is van medicatie 
gerelateerde gebitsproblemen, leeftijd gerelateerde aandoeningen en/of ongunstige 
anatomische factoren. Op het gebied van de orthopedie en de orale implantologie 
zal de vraag daarom toenemen naar enossale implantaten voor functioneel herstel 
van gewrichten, of ter vervanging van tanden en kiezen die als gevolg van trauma, 
cariës of parodontale aandoeningen verloren zijn gegaan. Tegenwoordig verwachten 
patiënten een  hoge kwaliteit van zorg, een minimaal invasieve aanpak en betrouwbare 
implantaten met een voorspelbare en lange levensduur, die uiteindelijk zorgen voor 
herstel van kwaliteit van leven.  In het afgelopen decennium heeft het klinisch gebruik 
van enossale implantaten zich ontwikkeld tot een voorspelbare behandelmethode in 
zowel orthopedische als tandheelkundige praktijken. De overlevingscijfers van enossale 
implantaten in gunstige klinische omstandigheden zijn hoog. Echter plaatsing van 
een botimplantaat in gecompromitteerde klinische situaties met een verhoogde kans 
op mislukking, blijft een uitdaging.
 Overleving van enossale implantaten begint met de biomechanische fixatie van 
het implantaat in het omliggende bot weefsel, zonder tussenkomst van fibreus 
weefsel. Deze primaire stabiliteit gaat in de tijd over in een biologische fixatie. Dit 
continue proces wordt ook wel osseointegratie genoemd. Belangrijke parameters 
voor succesvolle osseointegratie van enossale implantaten zijn 1) de chirurgische 
techniek van implantaatplaatsing en de chirurgische ervaring van de operateur, 2) de 
locale botkwaliteit en botkwantiteit bij de patient 3) de oppervlakte eigenschappen 
van het implantaat en 4) de genezingsperiode, die in acht genomen wordt, voordat 
het implantaat klinisch belast mag worden (loading protocollen).
 Technieken voor oppervlaktemodificatie ter bevordering van snelle osseointegratie 
zijn gericht op aanpassing van de fysische eigenschappen van het implantaat-
oppervlak, met name door het opruwen van het implantaatoppervlakte. Daarnaast 
kunnen de chemische eigenschappen van het oppervlakte aangepast worden door het 
aanbrengen van een coating. Diverse oppervlaktemodificaties en coating procedures 
hebben in vivo aangetoond dat zij het proces van vroege peri-implantaire botvorming 
positief kunnen beïnvloeden. Desondanks is nog steeds onduidelijk welke fysisch-
chemische eigenschappen nu precies verantwoordelijk zijn voor dit biologische effect. 
Ook vanuit een klinisch perspectief is het bewezen dat oppervlaktemodificaties een 
toegevoegde waarde kunnen hebben in de vroeg peri-implantaire osteogenese. 
Het algemene doel van het onderzoek beschreven in het onderhavige proefschrift was 
daarom 1) evalueren van de mate van botvorming rondom een scala aan oppervlakte-
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modificaties, gebruik makend van diverse, gevalideerde, preklinische dierenmodellen, 
en 2) verklaren of de applicatie van een coating op een enossaal implantaat oppervlak 
gerechtvaardigd is bij klinische implantologie indicaties. Hieronder worden de 
subdoelen van het proefschrift weergegeven met voor ieder subdoel een samenvatting 
van het uitgevoerde experimentele onderzoek en de verkregen wetenschappelijke 
data.
Evaluatie van de osteogene eigenschappen van diverse keramische 
coatings in vergelijking tot gemodificeerde titanium oppervlaktes, 
verkregen middels verschillende subtractieve procedures, binnen 
één experimentele in vivo opstelling
Door de toenemende en vergrijzende wereldbevolking, neemt de vraag naar implanteer-
bare hulpmiddelen toe.  
 In de literatuur is aangetoond dat een breed scala aan oppervlaktemodificaties 
en coating procedures de eerste fase van peri-implantaire botvorming kan 
bevorderen. Omdat één model, waarin tegelijkertijd meerdere oppervlaktemodifica-
ties worden vergeleken, niet voor handen is, blijft het niettemin complex om de 
verschillende in vitro en in vivo resultaten voor iedere afzonderlijke studie met elkaar 
te vergelijken en te extrapoleren. Het experiment, zoals beschreven in  hoofdstuk 2, 
had als doel om de bot stimulerende eigenschappen van een breed scala (zeventien) 
van verschillende keramische coatings en oppervlaktemodificaties verkregen via 
subtractieve procedures (TI, GB, GAE) binnen één experimentele setup te evalueren 
en met elkaar te vergelijken. Hiervoor werd een cassettemodel gebruikt, dat geplaatst 
werd op de transversale lumbale wervels van een geit. Na 12 weken werden 
histologische en histomorfometrische analyses uitgevoerd waarbij voor iedere 
experimentele groep het relatieve bot-implantaat-contact (BIC%), het relatieve 
botoppervlakte (BA%) en de maximale bothoogte (BH) werden bepaald.  De 
resultaten van deze studie toonden aan dat, onder de huidige experimentele 
omstandigheden, plasma gespoten CaP- coatings hogere osteogene eigenschappen 
hadden in vergelijking met niet-gecoate titanium oppervlaktes en CaP en/of bioactief 
glas (BG) coatings op basis van alternatieve technieken. 
Een meta-analytische benadering naar de lange termijn overleving 
van CaP gecoate orale implantaten in klinische trials
 In vivo waarnemingen in hoofdstuk 2 demonstreren dat plasma gespoten CaP- 
coatings de potentie hebben om de osteogene eigenschappen van een implantaat 
oppervlakte te verbeteren. Dit kan een voordeel zijn in uitdagende condities met 
vertraagde of verminderde botgenezing en lage botkwantiteit of dichtheid. Zo zou de 
toenemende groep van patiënten met dergelijke botaandoeningen gebaat zijn met 
het gebruik van de plasma gespoten CaP-gecoate implantaten. Sommige literatuur 
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studies speculeren dat de klinische overleving van CaP-gecoate, voornamelijk 
plasma gespoten, orale implantaten, nadelig kan worden beïnvloed door delaminatie 
van de coating. Daarom werd in hoofdstuk 3 een meta-analyse uitgevoerd om de 
lange termijn overleving van CaP-gecoate implantaten in klinische studies 
systematisch te beoordelen. Voor dit doel werd een literatuuronderzoek uitgevoerd 
om gerandomiseerde gecontroleerde klinische trials (RCT), prospectieve klinische 
trials (PCT), evenals retrospectieve analyses (RA) te identificeren die gegevens 
presenteren over de lange termijn overleving van CaP-gecoate implantaten. Alleen 
humane studies werden opgenomen met een follow-up van tenminste vijf jaar. 
Bovendien werden de referentielijsten van verwante review artikelen en publicaties 
doorgenomen om eventueel gemiste artikelen alsnog te selecteren. Uitkomstmaten 
waren de relatieve jaarlijkse uitval en de relatieve cumulatieve overlevingskans. Het 
elektronisch zoeken in de database van de National Library of Medicine, The 
Cochrane Central Register of Controlled Trials en de ISI Web of Knowledge, 
resulteerde in de identificatie van 385 titels. Deze titels werden eerst gescreend door 
twee onafhankelijke beoordelaars. Met aanvullend handmatig zoeken werden geen 
extra publicaties geïdentificeerd voor eventuele inclusie. Volgens de vooraf 
gedefinieerde inclusiecriteria werden vijf van de oorspronkelijke onderzoeksrapporten 
geselecteerd voor verdere evaluatie. Uit de meta-analyse bleek dat noch de jaarlijkse 
uitval van CaP-gecoate implantaten, noch de lange termijn cumulatieve overlevings-
kansen voor CaP-gecoate implantaten, inferieur waren aan de overlevingskansen 
van niet-gecoate implantaten. Daarom werd in hoofdstuk 3 geconcludeerd dat 
1) publicaties met gegevens over de lange termijn overleving voor CaP-gecoate 
tandheelkundige implantaten zeer beperkt zijn, 2) de jaarlijkse uitval van CaP-gecoate 
implantaten niet blijkt toe te nemen, en 3) de lange termijn cumulatieve overleving van 
CaP-gecoate tandheelkundige implantaten vergelijkbaar zijn met de overlevingskansen 
van niet-gecoate implantaten.
Een meta-analytische benadering naar lange termijn succes van 
CaP gecoate orale implantaten in klinische trials
Om de prognose van een oraal implantaat op de lange termijn te beschrijven, wordt 
vaak gebruik gemaakt van de gemiddelde cumulatieve implantaatoverleving. Echter, 
implantaatoverleving heeft geen betrekking op de ‘kwaliteit van overleving’ van het 
implantaat. Zo kan voorschrijdend marginaal botverlies op de lange termijn uiteindelijk een 
gevaar vormen voor de overleving van het implantaat. Daarom is het klinisch relevant om 
aan de hand van de beschikbare literatuur de dynamiek van peri- implantaire 
botresorptie bij CaP-gecoate implantaten in de tijd te evalueren. In hoofdstuk 4 werd 
een tweede meta-analyse uitgevoerd om systematisch het succes op de lange 
termijn van plasma-gespoten CaP-gecoate implantaten te evalueren in klinische 
studies met een follow-up van tenminste 5 jaar. Een elektronisch literatuuronderzoek, 
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aangevuld met een handmatige zoekactie, werd uitgevoerd met als doel om 
prospectieve en retrospectieve klinische studies te identificeren met gegevens over 
de succespercentages van CaP-gecoate orale implantaten met een minimale 
follow-up van 5 jaar. Uitkomstmaten om de effectiviteit van functionele implantaten 
op de lange termijn te beschrijven waren 1) het relatieve jaarlijkse complicatie 
percentage (ACR) en 2) het relatieve cumulatieve slagingspercentage (CSR). Deze 
gegevens werden overgenomen zoals vermeld in de publicaties. De zoekstrategie in 
de database van de National Library of Medicine, The Cochrane Centraal Register of 
Controlled Trials en de ISI Web of Knowledge, resulteerde in 645 titels. Door abstracts 
te screenen bleven 20 full-text artikelen over. Op basis van de inclusiecriteria werden 
8 studies uiteindelijk geaccepteerd, waarvan uit 6 studies gegevens konden worden 
gedestilleerd voor de schatting van de lange termijn succes percentages van CaP- 
gecoate implantaten. Uit Hoofdstuk 4 kan geconcludeerd worden dat: 1) publicaties 
over de lange termijn overleving en succes gegevens voor CaP-gecoate implantaten 
beperkt zijn 2) vergelijking van de studie-uitkomsten moeilijk is vanwege verschillen 
in succescriteria, zoals gehanteerd in de verschillende studies en 3) langdurige 
cumulatieve succespercentages voor CaP-gecoate implantaten in beperkte mate 
tekenen van progressief botverlies rond CaP-gecoate implantaten laten zien. 
Evaluatie van de biologische performance van magnetron 
gesputterde gecoate orale implantaten, met verschillende 
verhoudingen van hydroxyapatiet (HA) en bioactief glas (BG), 
geplaatst in de mandibula model van een hond 
Hoewel titanium gebruikt wordt als materiaal voor orale implantaten vanwege de 
gunstige mechanische eigenschappen, zijn de bioactieve en osteoconductieve 
capaciteiten van het materiaal relatief laag. Daarom wordt CaP keramiek, vooral 
hydroxyapatiet (HA), gebruikt als coating ter verbetering van de bioactieve 
eigenschappen van titanium. In aanvulling op CaP-coatings, zijn bioactieve silicaat 
gebaseerde glas (BG) coatings geïntroduceerd als coating materiaal vanwege de 
osteogene kenmerken van het materiaal. Zo heeft de vorming van een siliciumdioxide 
laag en hydroxyl carbonaat apatiet op het glasoppervlak een positief effect op de 
proliferatie en differentiatie van botvormende cellen; de osteoblasten.
 Plasma-sprayen is een populaire procedure, zowel binnen de tandheelkunde, 
als ook de orthopedie, voor het produceren van CaP-coatings op metalen implantaten. 
Toch is het klinisch gebruik van deze coatings beperkt door berichten over delaminatie 
en fragmentatie van de coating ter hoogte van het implantaat/coating interface 
waardoor de implantaatoverleving op de lange termijn in gevaar kan komen, zoals 
bediscussieerd in hoofdstuk 4. Magnetron gesputterde coatings kunnen delamina-
tie-problemen ondervangen. Met deze coating techniek is het namelijk mogelijk om 
dunne, goed hechtende coatings te genereren, met behoud van de bioactieve 
SAMENVATTING, SLOTOPMERKINGEN EN TOEKOMSTPERSPECTIEVEN
9
169
eigenschappen van het CaP keramiek. Met dit in het achterhoofd, lag de focus in 
hoofdstuk 5 op de evaluatie van het effect van de incorporatie van bioactief glas 
(BG) in HA-gesputterde coatings. De osteogene eigenschappen van dit implantaat-
oppervlakte werden geëvalueerd door de percentages bot-implantaat-contact en de 
relatieve botoppervlakte te meten. Hiervoor werden in totaal 48 schroefvormige 
titanium implantaten voorzien van magnetron sputter coatings met verschillende 
verhoudingen van HA en BG (HA, HABGLow en HABGHigh) geplaatst in de onderkaak 
van 16 Beagle honden. Na 4 en 12 weken, werden de implantaten histologisch en 
histomorfometrisch geëvalueerd. De relatieve peri-implantaire botoppervlakte (BA%) 
werd bepaald in drie zones rondom het implantaat (binnen: 0-500µm; midden: 
500-1000µm en buiten: 1000-1500µm). Bot-implantaat-contact (BIC%) en het eerste 
bot-implantaat-contact (1st BIC) werden ook beoordeeld voor elk sample. Na een 
ingroei periode van 4 weken was de relatieve botoppervlakte rondom de HA-gecoate 
implantaten significant hoger in vergelijking met HABGHigh gecoate implantaten. Na 
12 weken vertoonden alle experimentele groepen vergelijkbare BIC-percentages en 
werden ook geen verschillen gevonden in het relatief botoppervlakte. Derhalve werd 
geconcludeerd dat de incorporatie van BG in een HA magnetron sputter coating de 
performance van een tandheelkundig implantaat geplaatst in botweefsel met goede 
botkwaliteit en kwantiteit, niet verbetert. Juist andersom, sputter-coatings met hoge 
concentraties BG gaven inferieure botvorming tijdens de vroege genezingsfases na 
implantatie.  
Evaluatie van de biologische en mechanische performance van 
schroefvormige implantaten met een bioactieve HA- of HABG 
composiet coating in relatie tot de toegepaste chirurgische techniek 
voor implantatie (mono- versus bicorticaal)
Oppervlakmodificaties en chirurgische protocollen kunnen beide gevolgen hebben 
voor het osseointegratie proces en de stabiliteit van het implantaat. Echter, op dit 
moment is nog onduidelijk welke factor de uiteindelijke peri-implantaire botrespons 
domineert. Cruciaal is de kennis over de invloed van het gecombineerde effect van 
beide variabelen op zowel de biologische, als mechanische kwaliteit van de 
implantaat/bot interface. Daarom werd in hoofdstuk 6 een in vivo studie uitgevoerd 
om te bepalen of de biologische en mechanische eigenschappen van schroefvormige 
implantaten worden beïnvloed door 1) de aanwezigheid van een bioactief HA- of 
composiet HABG-coating, en 2) de aard van de chirurgische techniek die wordt 
gebruikt voor de plaatsing van het implantaat, dat wil zeggen mono- versus bicortical. 
 Een totaal van 96 titanium (Ti) implantaten, met of zonder coating (Ti, Ti-HA & 
Ti-HABG) werden mono- of bicorticaal geplaatst in de bekkenkam van een geit. 
Tijdens implantaat plaatsing, en na 4 weken, werd de implantaatstabiliteit bepaald 
door middel van het meten van het maximaal benodigde krachtmoment (torque) voor 
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het plaatsen c.q. verwijderen van het implantaat (ITQ & RTQ). De peri-implantaire bot 
respons werd histologisch en histomorfometrisch geëvalueerd door het bot-implan-
taat-contact (BIC%) en het relatieve bot-oppervlakte (BA%) in drie peri-implantaire 
regio’s (0-500µm; 500-1000µm; 1000- 1500µm) te berekenen. Geconcludeerd werd 
dat voor bicorticaal geplaatste implantaten hogere RTQ waarden werden gemeten 
dan voor monocorticale geplaatste implantaten. Voor monocorticaal geplaatste 
HABG-gecoate implantaten, werden significante verschillen waargenomen tussen 
de ITQ- en RTQ-waarde. Histomorfometrische evaluatie toonde hogere BIC% voor 
bicorticaal ten opzichte van monocorticaal geplaatste implantaten. Het botvolume in 
de binnenste peri-implantaire zone (0-500µm) was significant hoger voor bicorticaal 
geplaatste implantaten ten opzichte van monocorticaal geplaatste implantaten. In 
hoofdstuk 6, werd geconcludeerd dat bicorticaal plaatsen van implantaten een 
techniek is om de primaire stabiliteit van implantaten te verbeteren. Met het oog op 
de oppervlakmodificaties, werd vervolgens geen verschil in botvorming gezien 
tussen Ti-HA of Ti-HABG en Ti. Daarom werd geconcludeerd dat in het onderhavige 
implantatie model de toevoeging van BG aan een RF-magnetron gesputterde 
HA-coating het biologische gedrag van de coating niet verbetert. 
Evaluatie van de osteogene eigenschappen van een electrosprayed 
CaP nano-kristal coating versus een collageen type-1 coating op 
het implantaatoppervlak in een 1 mm gap-model
In hoofdstuk 7 werden de osteogene eigenschappen van een electrosprayed  CaP 
nano-kristal coating versus een collageen type-1 coating in een gap-model 
geëvalueerd na een implantatie periode van 4 en 12 weken. In zestien Beagle honden 
werden experimentele titanium implantaten geplaatst in de onderkaak, 3 maanden 
na verwijdering van alle premolaren. Drie soorten implantaten werden geëvalueerd in 
ieder dier: 1) een ongecoat implantaat, 2) een implantaat met een nano-kristal 
CaP-coating, 3) een implantaat met collageen type-1 coating. Peri implantaire 
botvorming en de mate van botingroei in de gap werden 4 en 12 weken na implantatie, 
zowel met micro-CT, als histomorfometrisch, geanalyseerd. De relatieve 
botoppervlakte (BA%) werd histomorfometrisch bepaald in drie verschillende 
cirkelvormige peri-implantaire zones (binnen: 0-300µm; midden: 300-600µm en 
buiten: 600-1000µm). Vier weken na implantatie was het relatieve botvolume, voor 
zowel de  nano-kristal CaP, als collageen type-1 gecoate implantaten, significant 
hoger in de binnenste zone in vergelijking met niet-gecoate implantaten (respectieve-
lijk p<0.05 en p<0.01). 
 Na 12 weken toonden histomorfometrische analyses geen significante verschillen 
meer in botvolume in de verschillende zones tussen de experimentele groepen. Op 
basis van deze histomorfometrische data werd daarom in hoofdstuk 7 geconcludeerd 
dat geen consistent gunstig effect op de peri-implantaire botvorming aangetoond 
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kon worden voor type-1 collageen gecoate implantaten noch voor nano-kristal 
CaP-gecoate implantaten. Als er al sprake is van een biologisch effect op de peri-
implantaire botgenezing, dan kan dit worden toegeschreven aan de aanwezigheid 
van een organische of anorganische coating en is deze beperkt tot de eerste 4 weken 
na implantatie. De herkomst van het collageen (staart van een rat) alsmede de 
uitdagende botomgeving (gap-model) maskeren een mogelijk effect van het 
toegepaste implantaatoppervlakte modificatie
Slotopmerkingen
Het gebruik van enossale implantaatmaterialen is een algemeen geaccepteerde be-
handelmodaliteit, zowel op het gebied van de orthopedie als de orale implantologie. 
Dankzij intensief fundamenteel onderzoek en preklinische studies is tegenwoordig 
een breed scala aan implanteerbare enossale implantaatmaterialen beschikbaar 
voor functioneel herstel van patiënten die problemen hebben met falende gewrichten, 
of verloren gegane gebitselementen. Om kauwcomfort te herstellen, esthetiek te 
verbeteren en de algehele kwaliteit van leven te herstellen voor de patiënt is het 
gebruik van orale implantaten in veel klinische indicaties zelfs de eerste keuze van 
behandeling geworden. Vandaag de dag vragen patiënten steeds meer om minimaal 
invasieve chirurgische ingrepen met zo min mogelijke postoperatieve nabezwaren. 
Hierdoor neemt de vraag naar ‘vroege’ en zelfs ‘directe belasting’ van implantaten 
toe, waardoor logischerwijs het risico op implantaatverlies óók toeneemt. Daarnaast 
worden steeds meer orale  implantaten geplaatst bij medisch gecompromitteerde 
patiënten, bij wie sprake is van een verminderde botkwaliteit, kwantiteit en gestoorde 
wondgenezing ten gevolge van ongunstige systemische factoren, zoals osteoporose 
of diabetes mellitus, of als gevolg van radiotherapie in het hoofdhalsgebied. 
 Implantaatoverleving is sterk afhankelijk van 1) de chirurgische techniek en 
vaardigheden van de operateur, 2) de gastheer respons en 3) de oppervlakte-eigen-
schappen van het botimplantaat. Fundamenteel onderzoek en de continue ontwikkeling 
van nieuwe oppervlaktemodificaties voor implantaten zijn dus essentieel om meer 
inzicht te krijgen in de processen van de peri-implantaire botgenezing en het proces 
van osseointegratie, met name onder klinisch uitdagende omstandigheden. 
 In deze thesis werd een breed spectrum van keramische coatings en titanium 
implantaatoppervlaktes, op basis van subtractieve procedures, geëvalueerd om 
meer inzicht te krijgen in welke oppervlakte-eigenschappen belangrijk zijn in de vroege 
fases van peri-implantaire botgenezing. Daarnaast werden diverse in vivo diermodellen 
gebruikt om de osteogene eigenschappen van de oppervlaktemodificaties te 
evalueren in situaties met een variërende botkwaliteit en botkwantiteit. De in vivo 
experimenten in het onderhavige proefschrift hebben aangetoond dat toevoeging 
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van een keramische coating van voordeel kan zijn vanwege de osteogene eigen -
schappen van het implantaatoppervlakte (hoofdstuk 2), zonder dat dit evident 
schadelijk is voor de prognose van het implantaat op de lange termijn (hoofdstuk 3 
en 4). Daarnaast werd geconcludeerd dat toevoeging van een coating op basis van 
bioactieve componenten de peri-implantaire botvorming kan verhogen in vergelijking 
met niet-gecoate implantaat oppervlakken, vooral in een gecompromitteerde 
botomgeving met beperkte botkwantiteit (hoofdstuk 2 en 7). Het positieve effect van 
de coating is minder uitgesproken in implantaatlocaties waarbij sprake is van een 
optimale botkwaliteit en kwantiteit (hoofdstuk 5 en 6).
 Niet alleen aanpassingen aan de oppervlakte-eigenschappen van implantaten 
zijn bepalend voor de voorspelbare osseointegratie van implantaten. Ook de chirurgische 
techniek van implantaatplaatsing is van groot belang voor het minimaliseren van 
trauma aan het originele peri-implantaire bot. Daarnaast zijn technieken, zoals bicorticaal 
en ondermaats plaatsen van implantaten, geïntroduceerd ter verbetering van de 
primaire stabiliteit en vroege biologische fixatie van het implantaat. In het onderhavige 
proefschrift werd bevestigd dat een goede primaire stabiliteit van het implantaat een 
gunstige biologische peri-implantaire botrespons bevordert (hoofdstuk 6 ).
Toekomstperspectieven
De in vivo resultaten uit de experimentele onderzoeken in dit proefschrift tonen aan 
dat de toevoeging van een bioactieve coating van groot belang kan zijn voor de 
vroege fase van botvorming rond enossaal geplaatste implantaten, vooral in een 
gecompromitteerde botomgeving. In de komende jaren zullen patiëntenpopulaties 
aanzienlijk veranderen, zowel op het gebied van de orthopedische als tandheel-
kundige implantologie. Met het oog op deze demografische veranderingen van een 
ouder wordende patiëntenpopulatie zullen clinici meer worden geconfronteerd met 
toenemende aantallen medisch gecompromitteerde patiënten waarbij sprake zal zijn 
van complexe klinische parameters, waaronder een verlaging van de botgenezing 
capaciteit. Dit is vaak gerelateerd aan systemische malcondities en/of (langdurig) 
medicatie gebruik.
 Anderzijds worden clinici in toenemende mate geconfronteerd met weliswaar 
gezonde patiënten, maar bij wie de botkwaliteit en botkwantiteit suboptimaal zijn, 
zoals in situaties waarbij onmiddellijk (immediaat) na een tand of kiesextractie 
gekozen wordt om een implantaat te plaatsen en te belasten (immediate loading). 
Hier is vaak een gap aanwezig zijn tussen implantaat en de oorspronkelijke 
botcontour. Ook bij deze patiëntengroep kan een bioactieve coating een meerwaarde 
zijn om de osseointegratie te bevorderen. 
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 Op basis van de resultaten van de verschillende in vivo experimenten in dit proefschrift 
werd aangetoond dat dunne magnetron gesputterde CaP-coatings met succes 
kunnen worden toegepast op titanium implantaten. De biologische respons op de 
CaP magnetron gesputterde coatings was echter minder uitgesproken dan verwacht. 
Geen significante verschillen in BIC% en BA% werden gemeten tussen de magnetron 
gesputterde CaP-gecoate implantaten en de opgeruwde implantaatoppervlakken in 
de verschillende in vivo modellen. Een reden hiervoor kan worden gevonden in de 
klinische set-up van de verschillende in vivo experimenten waarin meestal sprake 
was van een gunstige botomgeving, wat betekent dat de botkwaliteit en botkwantiteit 
niet gecompromitteerd waren.
 In de nabije toekomst zijn enossale implantaten met optimale osteogene eigen -
schappen nodig om te kunnen voldoen aan de verwachtingen van de steeds meer 
eisende patiënt. Idealiter zouden clinici de mogelijkheid moeten hebben om voor elke 
specifieke klinische situatie het meest geschikte implantaatontwerp, chirurgische 
techniek en oppervlaktemodificatie te kunnen selecteren. Vooral in gecompromitteerde 
klinische situaties is de ontwikkeling van een ‘op-maat-gemaakte’ implantaatoppervlak 
cruciaal om daarmee de meest optimale peri-implantaire botvorming te kunnen 
uitlokken. Hierdoor wordt de genezingsfase verkort, waardoor het implantaat eerder 
belast kan worden, en de kosten, alsmede de patiëntbelasting worden verlaagd. 
Daarom blijft het van groot belang om te ontrafelen welke fysisch-chemische 
eigen schappen van het implantaatoppervlakte voor peri-implantaire botvorming 
 verantwoordelijk zijn. Tot slot dient in humane studies uiteindelijk bewezen te worden 
dat dergelijke oppervlaktemodificaties een klinisch voordeel bieden.
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